Evaluation of12-LeadElectrocardiogramReconstruction Methods forPatientMonitoring by Nelwan, S.P. (Stefan)
Evaluation of 12-Lead Electrocardiogram Reconstruction
Methods for Patient Monitoring
Evaluation of 12-Lead Electrocardiogram Reconstruction Methods for Patient Monitoring
Stefan Paul Nelwan
Ph.D. Thesis, Erasmus MC, November 2005
ISBN 90-8559-083-3
NUR 954; 981
Printed by Optima Grafische Communicatie
Cover design ©Mark Wouters
© S.P. Nelwan. Alle rechten voorbehouden. Niets uit deze uitgave mag worden verveelvoudigd,
opgeslagen in een geautomatiseerd gegevensbestand, of openbaar gemaakt, in enige vorm of op
enige wijze, hetzij elektronisch, mechanisch, door fotokopieën, opnamen, of op enig andere ma-
nier, zonder voorafgaande schriftelijke toestemming van de rechthebbende(n).
© S.P. Nelwan. All rights reserved. No part of this publication may be reproduced, stored in a re-
trieval system, or transmitted, in any form or by anymeans, electronic, mechanical, photocopying,
recording, or otherwise, without the prior permission in writing from the proprietor(s).
Evaluation of 12-Lead
Electrocardiogram Reconstruction
Methods for Patient Monitoring
Evaluatie van 12-afleidingen electrocardiogram
reconstructiemethoden voor patiëntbewaking
Proefschrift
ter verkrijging van de graad van doctor aan de
Erasmus Universiteit Rotterdam
op gezag van de
rector magnificus
Prof.dr. S.W.J. Lamberts
en volgens besluit van het College voor Promoties.
De openbare verdediging zal plaatsvinden op
woensdag 9 november 2005 om 13.45 uur
door
Stefan Paul Nelwan
geboren te Rotterdam
Promotiecommissie
Promotor:
Prof.dr. M.L. Simoons
Overige leden:
Prof.dr.ir. A.F.W. van der Steen
Prof.dr. J. van der Lei
Prof.dr. A.A.M. Wilde
Copromotor:
Dr.ir. J.A. Kors
Financial support by the Netherlands Heart Foundation for the publication of this thesis
is gratefully acknowledged.
Contents
1 Introduction 1
Part I ECG Reconstruction 7
2 Minimal Lead Sets for Reconstruction of 12-Lead Electrocardiograms 9
Journal of Electrocardiology 2000;33:163-166
3 Reconstruction of the 12-Lead Electrocardiogram fromReduced Lead Sets 17
Journal of Electrocardiology 2004;37:11-18
Part II Clinical Evaluation 29
4 Assessment of Derived 12-Lead ECGs usingGeneral and Patient-Specific Recon-
struction Strategies at Rest and During Transient Myocardial Ischemia 31
American Journal of Cardiology 2004;94:1529-1533
5 Efficacy of a Reduced Lead Set for Pre-Hospital Triage of Thrombolytic Strate-
gies 43
Computers In Cardiology 2004;31:5-9.
6 Simultaneous Comparison of Three Derived 12-Lead ECGs with Standard ECG
at Rest and During Percutaneous Coronary Occlusion 51
Submitted
Part III Patient Monitoring 63
7 Detection and Correction of Body Position Changes 65
Submitted
8 Correction of ECG Variations due to Non-Standard Electrode Positions 79
Computers In Cardiology 2001;28:317-319
9 Discussion 89
Appendix: Methodology 103
Bibliography 124
Summary 137
Samenvatting 141
Dankwoord 145
Curriculum Vitae 147
Publications 149
1Introduction
2 Chapter 1
Background
With the introduction of coronary care units in the late 1950s, electrocardiogram (ECG)
monitoring devices were developed to facilitate rapid response to life-threatening ar-
rhythmias in patients with acute myocardial infarction (Julian, 1987; Fye, 1994). Since
then ECGmonitoring has become widely available in other hospital units, such as inten-
sive care environments, ambulatory telemetry units, operating theatres, and emergency
rooms. Startingwith basic single-lead registration, ECGmonitoring goals have expanded
to the detection of complex arrhythmias, identification of prolonged QT intervals, and
ST-segment/ischemia monitoring (Drew et al., 2004).
For these extended purposes, multilead ECGmonitoring has become a requirement.
In recent years, patient monitoring equipment has been developed to facilitate the si-
multaneous registration and analysis of all leads of the standardized 12-lead ECG. Fig-
ure 1.1 contains the electrode placements of the 12-lead ECG on the chest and abdomen.
Figure1.1: Electrode positions of the 12-leadECG systemusing proximal placement (Mason-Likar)
of electrodes RA, LA, RL, and LL. The left torso depicts all 10 required electrode positions. The torso
(middle) and hexial reference diagram (right) depict the leads I, II, III and augmented leads aVR,
aVL, and aVF in the frontal plane.
The 12-lead ECG system consists of six frontal plane leads (I, II, III, aVR, aVL, and aVF)
and six chest leads (V1-V6). Three frontal plane leads are bipolar leads (I, II, and III) and
three are augmented leads (aVR, aVL, and aVF). Of these six frontal plane leads, only two
leads need to be known to calculate the remaining four. In practice,most ECGequipment
only stores leads I and II to save space without loss of information. The remaining leads
can be calculated by the equations in 1.1.
I I I = I I − I
aV R = − 12 (I + I I )
aV L = I − 12 I I
aV F = I I − 12 I
(1.1)
In the 1930s, Wilson et al. (1932) introduced a so-called central terminal whichmade
it possible to measure unipolar chest leads. By connecting a 5 kΩ resistor to each ter-
minal of the limb electrodes (RA, LA, and LL), the Wilson central terminal is defined by
WCT = 13 (RA+LA+LL). With this reference central terminal, six unipolar chest leads
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Figure 1.2: Diagram of an ECG complex with the characteristic P, Q, R, S, and T waves illustrated
by Einthoven (1902) (a). The ST segment is located between the end of the S wave (J point) and the
start of the T wave. The second ECG complex (b) shows lead V3 of a patient at rest and the right
figure (c) shows an abnormal ECG complex with ST elevation during an ischemic episode.
were defined by the AmericanHeart Association (1943). These chest leads were intended
as exploratory leads and followed the right to left atria and ventricles. Nowadays, the
six chest leads can be obtained simultaneously, but contain redundant information (Lux
et al., 1995; Kors and van Herpen, 2002).
An illustration of a single heartbeat with the characteristic P, Q, R, S, and T waves is
presented in Figure 1.2a. The P wave and QRS complex reflect the electrical activation
of the respective atria and ventricles. The segment between the QRS offset and the end
of the T wave reflects the return to the electrical resting state, known as repolarization.
The ST segment is a transition from the end of the S wave (J point) to the start of the T
wave. Elevation of the ST segment is a distinctive characteristic of myocardial ischemia
and injury. Figures 1.2b and 1.2c contain an example of an ECG complex of the same
patient prior (b) and during an ischemic episode (c).
Continuous multilead ST-segment monitoring devices have been developed to mea-
sure, display, and compare ST-T changes in real-time (Krucoff et al., 1988; Dellborg et al.,
1991) for the evaluation of patients with acute coronary syndromes. The most impor-
tant applications of these devices include: (1) assessment of reperfusion, prolonged is-
chemia, or re-ischemia after thrombolytic therapy (Veldkamp, 1996; Klootwijk, 1998), (2)
detection of reocclusion during and after percutaneous coronary intervention, and (3)
detection of transient myocardial ischemia in patients with acute coronary syndromes
(Akkerhuis et al., 2001; Pelter et al., 2002).
Continuous ECG registration problems
Long-term, continuous, 12-lead ECG and ST-segment monitoring is often difficult in
daily practice. Patient management and the nursing burden is increased in order to
maintain a high-quality recording and to reduce false alarms. Several problems related
to patient monitoring can be identified:
First, registration of one or more leads may be of low quality because of problems
related to the attachment of electrodes. For example, as a result of patient movement,
lead wires may not be firmly attached to the electrodes and may distort the recorded
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signals. Other sources of noise artifacts may include those caused by muscle movement
or poor skin preparation (Schijvenaars, 2000).
Second, certain ECG leads may not be available at all. For example, during and after
cardiac surgery often electrodes V1 and V2 cannot be attached. Furthermore, when a pa-
tient is transferred to a telemetry department, only a limited set of electrodes is available.
Third, patients may turn on their left or right side, which may have a profound effect
on QRS and ST-segment measurements (Adams and Drew, 1997; Jernberg et al., 1997),
and may lead to false alarms. Moreover, most diagnostic ECG programs assume that the
patient is in supine position. This need not be true during continuous monitoring in an
intensive care unit.
Fourth, the ECG of an intensive care patient may have been recorded with different
extremity electrode positions than the routinely recorded resting ECG (Sevilla et al., 1989;
Krucoff et al., 1994; Norgaard et al., 2000). As a result of these different electrode place-
ments, ECG variationsmay occur in the extremity leads, such as (dis)appearing Qwaves,
changes in R and ST amplitudes, and shifts in the frontal QRS axis.
Lead reconstruction
Reconstruction of leadsmay help to address these problems during continuous ECGmo-
nitoring. Most lead reconstruction techniques are aimed at synthesizing unavailable or
noisy ECG leads by making use of the (inherent) redundancy of information in the 12-
lead ECG (Cady, 1969; Levkov, 1987; Lux et al., 1995).
Based on the assumption that cardiac electrical activity can be represented by a di-
pole model, it is sufficient to measure three orthogonal leads. Over the last 60 years,
vectorcardiographic (VCG) lead systems have been based on this assumption with the
Frank lead system being the most widely used. The vectorcardiogram has been used for
diagnostic interpretation (Kors et al., 1990), exercise testing (Simoons et al., 1975), and
continuous ST monitoring (Dellborg et al., 1991). The VCG to 12-lead ECG conversion
by Dower’s transformation (Dower et al., 1980) has shown that the 12-lead ECG can be
reconstructed in good approximation. Therefore, fewer selectively chosen leadsmay still
contain enough diagnostic information to represent the full 12-lead ECG.
Several investigators have reconstructed the VCG by taking a subset of the 12-lead
ECG: II, V2, V6 (Kors et al., 1986), aVF, V2, V6 (Bjerle and Arvedson, 1986) and I, II, V2 (Kors
et al., 1990). Earlier work also concentrated on synthesizing the 12-lead ECG from the
Frank VCG (Dower et al., 1980; Smith et al., 1975). Recently, Dower et al. (1988) intro-
duced a modified Frank VCG consisting of only five electrodes (EASI), from which the
12-lead ECG can be derived. The other way around, synthesizing the VCG from the 12-
lead ECG, has also been explored (Levkov, 1987; Edenbrandt and Pahlm, 1988). Almost
all of these methods use a general transformation matrix. The disadvantage of a general
transformation matrix is that the reconstructed ECGmay not be valid for all patients.
To overcome differences among patients, patient-specific transformation matrices
have also been used, first by Cady (1969), followed by Scherer et al. (1989). This method
requires a reference 12-lead ECG for each patient and calculations of a transformation
matrix for each individual patient.
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Overview
The aims of this thesis were to investigate, develop, and clinically validate lead recon-
struction algorithms using reduced lead sets of the 12-lead ECG and to address continu-
ous ECG registration problems which may occur as a result of changes in body position
and differences between standard versus monitoring lead configurations.
Part I: ECG reconstruction
The first part of the thesis (Chapters 2, 3, and Appendix A) describes the design and eval-
uation of the ECG reconstruction methods based on subsets of the leads. The following
questions were asked during the design and evaluation phase:
1 How many leads and which lead subset should be used for accurate reconstruction
of the 12-lead ECG?
The questions of how many and which leads to use are addressed in Chapter 2.
The reconstruction method is described and is evaluated on a large data set of 10-
second, 12-lead ECGs. For each 12-lead ECG, precordial leads were systematically
removed. These absent precordial leads were reconstructed with the remaining
limb and precordial leads. Reconstruction performance was assessed by corre-
lation coefficients and root mean square errors between the original and recon-
structed leads.
2 Which method is preferred: general or patient-specific reconstruction?
The study in Chapter 2 contains a comparison of general coefficients based on a
learning set and patient-specific coefficients calculated from a previously recorded
12-lead ECG of the same patient.
3 How accurate are derived lead systems over time?
Chapter 3 presents a study which investigates whether the general and patient-
specific reconstruction methods are influenced by time. For this purpose, ECG
registrations from a 24-hour ischemia monitoring study were used and split in an
equally-sized learning and test set. General and patient-specific reconstruction
coefficients were computed and applied on the ECGs in the test set at various time
instants during the recording period.
Part II: Clinical evaluation
The second part of the thesis, comprising Chapters 4-6, presents three validation studies
inwhich the general andpatient-specific reconstructionmethods are applied in a clinical
setting. The following issues were considered for clinical validation and application:
4 How accurate are the reconstruction methods in a clinical setting?
In Chapter 4, the general and patient-specific reconstruction methods are vali-
dated in recordings of patients undergoing a percutaneous coronary intervention
procedure. During these procedures balloon inflations were performed, which
may cause ischemia and ST-T changes on the ECG. Accuracy is assessed on the
ST differences between the original and reconstructed leads.
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5 Application of a reduced lead set for pre-hospital triage
In Chapter 5, the general reconstructionmethod is applied to pre-hospital decision
making on patients with symptoms of acute myocardial infarction. In this setting,
a reduced number of electrodes and easy to find locations may save time.
6 Comparison of different derived 12-lead methods
Chapter 6 describes a study which compares the general and patient-specific re-
constructionmethodswith awidely used commercially available reduced lead sys-
tem, the EASI system. The 12-lead ECG and the three reduced lead systems (EASI,
general, and patient-specific) are simultaneously recorded during PCI procedures.
Accuracy between themethods and the original registration is assessedwith corre-
lation coefficients, root mean square errors, and ST-segment differences prior and
during balloon inflations.
Part III: Patientmonitoring
In the last part of the thesis (Chapters 7 and 8) methods for detection and correction of
ECG-variations caused by body position changes and different electrode placements are
investigated.
7 ECG variations caused by body position changes
Chapter 7 presentsmethods to detect and correct for body position changes which
may occur during long-term ECGmonitoring. Using a data set of known body po-
sitions and the 12-lead ECG, a detector is presented. A body position correction
method with general and patient-specific reconstruction techniques is also evalu-
ated.
8 Correction of ECG variations due to non-standard electrode positions
The standard limb lead placement of the 12-lead ECG at the wrists and ankles is
often not applied in continuous ECG monitoring environments. Instead, the limb
electrodes are often placed at the Mason-Likar positions (Mason and Likar, 1966).
However, these electrode changes may produce changes on the registered ECG as
compared to an ECG recorded with standard positions, making serial comparison
difficult or even impossible. Chapter 8 presents a study to quantify the effects of
these alternative electrode placements and evaluates a detection and correction
method.
Discussion, summary, and conclusions
A discussion of these investigations, conclusions, and recommendations for future work
are presented in Chapter 9.
Part I
ECG Reconstruction

2Minimal Lead Sets for Reconstruction
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Abstract
Background
It may not always be possible to record all precordial leads of the standard 12-lead elec-
trocardiogram (ECG). Especially inmonitoring situations, aminimal lead set fromwhich
the 12-lead ECG can be reconstructed, would be valuable. In this study we assessed how
well absent precordial leads could be synthesized from the remaining leads of the 12-lead
ECG.
Methods
A total of 2372 diagnostic 12-lead ECG recordings were obtained from subjects with chest
pain suggestive of acute myocardial infarction. The Modular ECG Analysis System was
used to compute representative average beats. The recordings were divided into a learn-
ing set and a test set. We considered all lead sets with one or more precordial leads
removed, but always including limb leads I and II. Using the learning set, general re-
construction coefficients were computed to synthesize the missing precordial leads in
each lead set. Performance of the synthesis was assessed by correlation coefficients be-
tween the original and the reconstructed leads. Also, patient-specific reconstruction co-
efficients were derived for each ECG in the test set and correlations were determined.
Results and conclusions
High correlation coefficients were found with both reconstruction techniques. For dif-
ferent sizes of lead sets, the best patient-specific reconstructions had higher correlation
values than the general reconstructions. For example, when two precordial leads were
excluded, the best patient-specific median correlation was 0.994 compared to 0.963 for
the best general reconstruction correlation. General reconstruction allows synthesis of
two or three excluded precordial leads in good approximation. When patient-specific re-
construction can be applied, a minimal lead set including the limb leads and only two
precordial leads suffices.
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Introduction
Recording all leads of the standard 12-lead electrocardiogram (ECG) may be impractical
or even impossible. In critical care or emergency situations, a continuous 12-lead ECG
monitoring device may not always be available. In intensive care situations, electrodes
might fall off, sometimes unnoticed because of time-demanding other activities. Some
electrodes also need to be removed when diagnostic tests such as echocardiograms or
X-rays are required. It may also be impossible to place electrodes because bandages or
drains occupy the electrode position.
It is well-known that the eight independent leads of the 12-lead ECG contain redun-
dant information (Cady, 1969; Lux et al., 1995). It should therefore be possible to recon-
struct the 12-lead ECG accurately from a subset of leads. In this study, we want to assess
for all lead subsets how well the 12-lead ECG can be reconstructed and which subset of a
given size is best.
Methods
Study population
From January 1992 until April 1994, 2484 subjects with chest pain suggestive of myocar-
dial infarction in the Rotterdam municipal area were evaluated by the general practi-
tioner and subsequently referred to the hospital for specialized cardiological care (Grij-
seels, 1996; Grijseels et al., 1996). A 10-second, diagnostic 12-lead ECG was recorded on
the spot.
A total of 2484 ECGs were digitally recorded with a small portable battery-powered
computer ECG device (Sicard P+, Siemens Elema, Sweden). The ECG electrodes were
mounted on a rubber mat with the extremity electrodes positioned at the shoulder and
abdomen to ensure rapid placement of electrodes.
The digital 10-second ECG recordings were analyzed with the Modular ECG Analysis
System (van Bemmel et al., 1990). ECGs with electrode reversals and recording problems
were excluded (n=112). Representative average beats were computed for every included
ECG. For further analyses, samples were taken from the QRS-T interval of each lead. The
QRS-T interval was selected because this time interval represented information (such
as a possible Q wave, the ST segment, and T wave) that was important to synthesize
correctly.
ECG reconstruction
The remaining 2372 recordings were divided into a learning set and test set of equal size.
We considered all lead sets with one ormore precordial leads removed. The independent
limb leads I and II were always included. Thus, a total of 62 lead sets were examined.
We differentiated between a general, population-based synthesis and a patient-
specific synthesis. Reconstruction coefficients were derived by linear regression. We also
synthesized leads with patient-specific reconstruction coefficients that were derived for
each recording separately.
12 Chapter 2
Reconstruction accuracy was evaluated on the test set. A reconstructed lead was syn-
thesized for eachmissing lead in a particular lead set. To quantify the degree of similarity
between the original and synthesized lead, we computed Pearson’s correlation coeffi-
cient. For each case, a performancemeasure was computed by averaging the correlation
coefficients of the reconstructed leads. The median of these averaged correlations for a
particular lead set was used to determine the best among lead sets of a given size.
Results
Median (inter-quartile range) correlation results of all lead subsets for general and
patient-specific reconstruction methods are shown in Figure 2.1. High performances
were obtained with lead sets missing one or two precordial leads. Table 2.1 contains the
best lead subsets of a given size.
0.5
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0.9
1.0
0 10 20 30 40 50 60
Precordial Leads Removed
1 lead
2 leads
3 leads
4 leads
5 leads
General Reconstruction
0.5
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2 leads
3 leads
4 leads
5 leads
Patient-specific Reconstruction
Figure 2.1: Median (inter-quartile range) correlation coefficients of 62 lead sets with one or more
precordial leads removed for general (top) and patient-specific reconstruction (bottom).
General synthesis performed overall lower than the patient-specific. There was no
difference between the synthesis methods in lead sets of a given size, except for the lead
sets with two leads removed. In this case, the second best lead set of one reconstruction
method was the same as the best lead set of the other. Overall, differences in correla-
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I V1 dV1 dV1
II V2 V2 V2
III V3 dV3 dV3
aVR V4 dV4 dV4
aVL V5 V5 V5
aVF V6 dV6 dV6
Original General Patient-specific
Figure 2.2: Example of general and patient-specific reconstruction of leads V1, V3, V4, and V6 with
a lead subset of I, II, V2, and V5.
tion between lead sets of the same size were small. However, this difference gradually
increased in lead sets containing fewer precordial leads.
For general reconstruction, a performance decrease was observed when more than
three precordial leads were removed. For the patient-specificmethod, a similar decrease
was seen after removal of more than four precordial leads.
An example of general and patient-specific reconstruction is shown in Figure 2.2. The
first and second columns contain the averaged beats of the original 12-lead ECG record-
ing. In the third and fourth column, the precordial leads V1, V3, V4, and V6 have been
reconstructed from the lead subset I, II, V2 and V5. In this example, the general recon-
struction performance was 0.946, while the patient specific reconstruction performance
was 0.987.
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The reconstruction and evaluation procedure was repeated again with samples of
the QRS interval instead of the whole QRS-T interval, but this led to a slight decrease in
performance.
Discussion
In this study, missing leads can be reconstructed in good approximation. With general
reconstruction coefficients, performance of lead sets with two or three missing precor-
dial leads remained high, while near perfect correlations were found when only one pre-
cordial lead was excluded. When patient-specific reconstruction was used, a lead set
including the limb leads and only two precordial leads appeared sufficient.
Patient-specific reconstruction has an overall higher performance than general re-
construction. However, patient-specific reconstruction may not always be possible, be-
cause it requires a baseline 12-lead ECG from which the reconstruction coefficients can
be calculated.
General reconstruction is only valid if the used precordial electrodes are placed on
the standard electrode positions. With patient-specific reconstruction, this requirement
may be less strict. A valid reconstruction is still likely if the remaining electrodes stay on
the same position as to when the baseline ECG was taken.
The patient-specific 3-lead set (I, II, and V2) recommended by Scherer et al. (1989) for
12-lead ECG reconstruction was also the best lead set in our general and patient-specific
synthesis. However, we saw a substantial increase in performance between a 3-lead set
and a 4-lead set in general and patient-specific reconstruction. For both methods, the
best set with four leads contained a left- and right-precordial lead. In another investiga-
tion (Cady, 1969), leads V2 and V6 were recommended, while in this study V2 and V5 had
the best performance results.
A different approach of dealing with the impracticalities imposed by the 12-lead ECG
system is to use a lead system that requires fewer and more conveniently located elec-
trodes. One such lead system is the EASI lead system (Dower et al., 1988), which uses a
3-lead (five electrodes) configuration of which three electrode positions have been based
on the Frank lead system. A derived 12-lead ECG can be calculated from the three EASI
leads and empirically obtained reconstruction coefficients (Dower et al., 1988). Drew
et al. (1999) have shown that the diagnostic information in the derived and original 12-
lead ECG is comparable, even though there is still individual variation between the lead
signals (Levkov, 1987). The best minimal lead sets in this study use only a fewmore elec-
trodes (seven electrodes) than the EASI lead system, but all limb leads and at least one
precordial lead still remain original. However, further investigation is needed to evaluate
both lead set strategies in a similar setting, possibly during simultaneous registration.
In this study, we did not investigate the accuracy of patient-specific reconstruction
over time. Scherer et al. (1989, 1992) emphasize that their coefficients remain valid, but
it is unknown if synthesis performance ismaintained during interventions or events such
as thoracic surgery and ischemic episodes. Furthermore, the reconstruction coefficients
are also sensitive to the quality of the baseline ECG recording. Noisy leads may have a
detrimental effect on subsequent reconstruction.
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Conclusion
Reconstruction of missing precordial leads in the 12-lead ECG is possible based on the
redundant information that is available in the remaining leads. The precordial leads of
the 12-lead ECG can still be accurately synthesized with general reconstruction coeffi-
cients when two or three precordial leads are removed. Patient-specific reconstruction
yields high performances even with four precordial leads removed, but requires a full
12-lead baseline ECG.
3Reconstruction of the 12-Lead
Electrocardiogram fromReduced Lead
Sets
Stefan P. Nelwan, Jan A. Kors, Simon H. Meij, Jan H. van Bemmel, Maarten L. Simoons
Reprinted from Journal of Electrocardiology;37:11-18,
© 2004, with permission from Elsevier
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Abstract
Background
In clinical practice, continuous recording of all leads of the 12-lead electrocardiogram
(ECG) is often not possible. We wanted to assess how well absent, noisy, or defective
leads can be reconstructed from different lead subsets and how well lead reconstruction
performs over time.
Methods
A data set of 234 24-hour ECG recordings was divided into an equally sized training and
test set. Precordial leads were systematically removed, and for all lead subsets including
the limb leads and at least one precordial lead, the absent leads were reconstructed using
general and patient-specific reconstruction templates. Reconstruction performance was
measured by correlation between the original and reconstructed leads over the QRS and
T waves, by average and maximum absolute ST differences, and by agreement when a
clinical decision rule was applied. Reconstruction performance over time was evaluated
at baseline, at 20 minutes, and 1, 6, 12, and 24 hours after the start of each recording.
Results
Reconstruction accuracy was high (correlation ≥ 0.932, average ST difference ≤ 30 µV,
agreement ≥ 94.9%) with general reconstruction for lead sets with one or two precordial
leads removed but was less satisfactory when more leads were missing. Patient-specific
reconstruction performed well when up to 4 precordial leads were removed (correlation
≥ 0.967, average ST difference≤ 26 µV, agreement≥ 95.7 %). Patient-specific reconstruc-
tion performance initially slightly decreased and then stabilized over time but remained
much better than general reconstruction after 24 hours.
Conclusion
Accurate reconstruction of the 12-lead ECG from lead subsets is possible over time. Gen-
eral reconstruction allows reconstruction of one or two precordial leads, whereas up to
four leads can be reconstructed well using patient-specific reconstruction.
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Introduction
Continuous monitoring of the 12-lead electrocardiogram (ECG) is a practical, sensitive,
noninvasive tool for detection and quantification of myocardial ischemia and infarction
(Klootwijk et al., 1997;Drew andKrucoff, 1999; Thygesen et al., 2000). However, recording
of all leads of the standard 12-lead electrocardiogrammay be cumbersome, impractical,
or even impossible. For example, electrodes may need to be removed when certain di-
agnostic tests such as echocardiograms are required. If bandages or drains occupy the
electrode positions, it will be impossible to record the corresponding leads. In telemetry
situations, only a subset of leads is currently recorded because of practical and technical
limitations. Moreover, electrodes may fall off, sometimes unnoticed because of time-
demanding other activities.
Reconstruction of the 12-lead ECG in these situations is desirable particularly for
continuous ischemia monitoring and may be possible by making use of the redundant
information in the eight independent leads of the 12-lead ECG (Cady, 1969; Lux et al.,
1995; Nelwan et al., 2000). In this study, we assessed how well the 12-lead ECG can be re-
constructed from different lead subsets and how well lead reconstruction performs over
time.
Methods
Data set
Experiments were done on a data set consisting of 236 continuous 12-lead ECG record-
ings from patients enrolled in the PURSUIT ECG ischemia monitoring study (PURSUIT
Trial Investigators, 1998). In summary, patients were eligible if they presented within
24 hours of an episode of ischemic chest pain (>10 minutes) and had transient ST-
segment elevation (>50 µV), transient or persistent ST-segment depression (>50 µV), T-
wave inversion (>100 µV), or elevation of the creatine kinase-MB fraction above the up-
per limit of normal. The study protocol excluded patients with persistent (>30 minutes)
ST-segment elevation and those with ECG abnormalities interfering with ST-segment in-
terpretation, such as left bundle branch block, third-degree atrioventricular block, per-
sistent arrhythmias, or pacemakers. There were no restrictions regarding age.
Patients were monitored for 24 hours with a continuously updated 12-lead ECG
recording system (Mortara Instruments, Milwaukee, WI). The extremity electrodes were
placed in monitoring positions at the Mason-Likar locations (Mason and Likar, 1966).
The system computed median ECG complexes of the 12 leads every 20 seconds, and an
ECG was stored every five minutes.
Electrocardiographic processing
The ECG recordings were manually scanned and edited for artifacts and detection er-
rors. Two recordings were excluded because of recording problems in one or more leads.
The remaining 234 recordings contained 5796 hours of data. The median duration of a
recording was 24 hours with an inter-quartile range of 10 hours. For each recording, me-
dian complexes were obtained at baseline, at 20 minutes, and 1, 6, 12, and 24 hours after
the start of the recording.
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Lead reconstruction
We generated all lead subsets of the eight independent ECG leads (I, II, V1-V6), always
including limb leads I and II, and at least one precordial lead. Thus, a total of 62 different
reduced lead sets were evaluated.
The ECG recordings were randomly divided into a learning set and a test set of equal
size. For each lead subset, general reconstruction coefficients to synthesize the absent
leads were derived from the baseline ECGs in the learning set using linear regression
(Levkov, 1987; Nelwan et al., 2000). These coefficients were subsequently applied to the
ECGs of the test set. Patient-specific coefficients were derived from each baseline ECG
in the test set. These reconstruction coefficients were applied to the ECGs at baseline, 20
minutes, and 1, 6, 12, and 24 hours after the start of the recording.
ECG analysis
For each lead subset, reconstruction accuracy of the missing leads was evaluated on
three different levels. First, overall waveform similarity for each ECG was assessed by
averaging, over the reconstructed leads, the correlations between the originals and their
reconstructions. The correlations were based on all samples in the QRS-T complex.
Second, reconstruction accuracy was determined for a clinically importantmeasure-
ment, the amplitude of the ST segment at 60 milliseconds after the J point (ST60). We de-
termined the average of the absolute differences between the original and reconstructed
ST60 amplitudes. In addition, themaximum absolute difference at ST60 was determined.
Third, reconstruction accuracy was assessed at the diagnostic level. We applied a
clinically accepted decision rule for detection of myocardial ischemia and evolving my-
ocardial infarction (Thygesen et al., 2000) to the original ECG and to the reconstructed
ECG and determined the agreement defined as the percentage number of cases in which
decisions concurred. The decision rule holds true when two or more contiguous leads
show ST elevations of ≥ 200 µV in leads V1, V2, or V3, or ≥ 100 µV in the other leads
(Thygesen et al., 2000).
Results
The median (inter-quartile range) of maximum ST60 deviation of the baseline ECGs was
105 (70–145) µV in the learning set and 100 (67–188) µV in the test set. Six ECGs in the
learning set and eight ECGs in the test set were found positive according to the decision
rule (Thygesen et al., 2000) at baseline.
Tables 3.1-3.3 show the median and range of the general and patient-specific results
of lead subsets of a given size on the baseline recordings of the test set. Patient-specific
reconstruction performed better than general reconstruction. For general reconstruc-
tion, median correlations of 0.932 or higher were obtained for lead subsets with one or
two precordial leads removed; considering the best lead subsets, removal of even three
precordial leads yielded similar high correlations. With patient-specific reconstruction,
lead subsets with four precordial leads removed had median correlation coefficients of
0.967. The best lead subset with five precordial leads removed still had a correlation of at
least 0.921.
The average and the maximum absolute ST-amplitude differences for general recon-
struction were about twice as high as the differences for patient-specific reconstruc-
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Table 3.1:Median (range) correlation results of general and patient-specific reconstruction meth-
ods on the baseline ECGs of the test set (n=117), for lead sets with an increasing number of precor-
dial leads removed.
Number of Correlation Coefficient
Precordial Leads General Patient-specific
Removed
1 0.988 (0.966 – 0.995) 0.999 (0.994 – 0.999)
2 0.978 (0.932 – 0.988) 0.998 (0.991 – 0.999)
3 0.965 (0.844 – 0.977) 0.995 (0.980 – 0.997)
4 0.938 (0.807 – 0.964) 0.989 (0.967 – 0.994)
5 0.854 (0.642 – 0.912) 0.964 (0.921 – 0.978)
Table 3.2:Median (range) ST60 differences of general and patient-specific reconstructionmethods
on the baseline ECGs of the test set (n=117), for lead sets with an increasing number of precordial
leads removed.
Number of Absolute ST60 Difference (µV)
Precordial Leads General Patient-specific
Removed Average Maximum Average Maximum
1 15 (10 – 19) 15 (10 – 19) 7 (6 – 9) 7 (6 – 9)
2 16 (13 – 30) 32 (18 – 40) 8 (7 – 11) 12 (10 – 16)
3 20 (16 – 48) 31 (28 – 78) 10 (8 – 24) 17 (13 – 57)
4 24 (18 – 51) 43 (34 – 89) 13 (9 – 26) 24 (18 – 45)
5 37 (26 – 48) 66 (46 – 93) 24 (16 – 33) 47 (29 – 64)
tion. By and large, general reconstruction results for a lead subset of a given size were
comparable with patient-specific results for a subset with two more precordial leads re-
moved. For example, using general reconstruction, the average absolute ST difference for
lead subsets with two precordial leads removed had a median (range) of 16 (13–30) µV,
whereas patient-specific reconstruction for lead subsets with four leads removed gave
differences of 13 (9–26) µV.
For the clinical decision rule, high to very highmedian agreements were obtained for
any lead subset of a given size using both general and patient-specific reconstruction. In
lead subsets with less than five precordial leads removed, the best lead subsets of a given
size had a maximum agreement of 100%, regardless of the reconstruction method.
The best lead subsets with the highest correlation of a given size are presented in
Table 3.4. The same subsets were almost always the ones with the lowest average and
maximum absolute ST difference. When only one or two precordial leads were removed,
several subsets showed a performance almost identical to the best subset. The second
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Table 3.3: Accuracy results of general and patient-specific reconstructionmethods on the baseline
ECGs of the test set (n=117), for lead sets with an increasing number of precordial leads removed.
Number of Accuracy (%)
Precordial Leads General Patient-specific
Removed
1 100 (95.7 – 100) 100 (99.1 – 100)
2 100 (94.9 – 100) 100 (97.4 – 100)
3 96.6 (94.9 – 100) 99.1 (95.7 – 100)
4 95.7 (91.5 – 100) 98.3 (95.7 – 100)
5 94.5 (93.2 – 96.9) 96.4 (94.1 – 99.1)
Table 3.4: Best lead subsets of a given size based on the highest average correlations found in the
baseline ECG recordings of the test set.
Number of Best Lead Set Correlation
Precordial Leads General Patient-specific
Removed
1 I, II, V1, V2, V3, V4, V6 0.995 (0.986 – 0.998) 0.999 (0.999 – 1.0)
2 I, II, V1, V2, V4, V6 0.988 (0.966 – 0.994) 0.999 (0.997 – 0.999)
3 I, II, V1, V3, V5 0.977 (0.952 – 0.988) 0.997 (0.994 – 0.999)
4 I, II, V2, V5 0.964 (0.934 – 0.979) 0.994 (0.988 – 0.996)
5 I, II, V2 0.912 (0.858 – 0.950) 0.978 (0.964 – 0.988)
Note: Correlation values denote median (inter-quartile range)
best lead set with three precordial leads removed was the other set with non-adjacent
precordial leads (V2, V4, V6), performing nearly as well as the best lead set (V1, V3, V5). In
lead sets with four precordial leads removed, the combination of V2 and V6 was second
best, whereas in lead sets with five precordial leads removed, V2 performed clearly better
than other leads.
Performance of general and patient-specific reconstruction over time was evaluated
on the test set for the best lead sets presented in Table 3.4. Figure 3.1 shows a typical
example of lead reconstruction at baseline and after 24 hours using lead subset I, II, V2,
and V5. Note the better performance of patient-specific reconstruction as compared to
general reconstruction, both in a global sense and in preserving the ST elevations after
24 hours.
Figure 3.2 presents medians and inter-quartile ranges of the average correlation be-
tween the original and reconstructed leads at baseline and at 20 minutes, 1, 6, 12, and
24 hours. Similarly, Figures 3.3 and 3.4 present medians and inter-quartile ranges of the
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A Relative recording time: 00:00
Original
I II V1 V2 V3 V4 V5 V6
General
Patient-
specific
B Relative recording time: 24:13
Original
I II V1 V2 V3 V4 V5 V6
General
Patient-
specific
Figure 3.1: Example of general and patient-specific reconstruction of ECG leads at baseline (a)
and after 24 hours (b) using lead subset I, II, V2, and V5. Shaded areas mark the leads that were
reconstructed.
average and maximum absolute ST-amplitude differences, respectively. Patient-specific
reconstruction performed better than general reconstruction over the whole recording
period. General reconstruction remained at the same level over time, while patient-
specific reconstruction showed some decrease in performance. Figures 3.2b, 3.3b and
3.4b suggest an initial worsening of performance, which stabilizes after a few hours. A
possible explanation is that the first ECG was used to compute the patient-specific coef-
ficients and may have yielded higher correlations than ECGs at a later time. Additional
inspection of the correlations at all time instants (data not shown) revealed large varia-
tions between neighboring time instants and showed an overall stabilizing pattern.
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Figure 3.2: Median (inter-quartile range) of the average correlations between original and recon-
structed waveforms using general reconstruction (a) and patient-specific reconstruction (b) of the
best lead sets (cf. Table 3.4). For each lead set, bars indicate results at baseline, and at 20 minutes,
and 1, 6, 12, and 24 hours after baseline (from left to right).
Thedecision rule for detection of ischemia and evolving infarction (Alpert et al., 2000)
was also applied for each lead subset on the ECGs over time. For lead subsets with up
to three precordial leads removed, average agreement was 99.8% (range 99.1–100) re-
gardless of reconstruction method. Overall, agreement remained. For lead subsets with
four and five leads removed, average agreement using general reconstruction was 95.9%
(91.9–100) and 94.3% (92.3–94.9), respectively. For patient-specific reconstruction, aver-
age agreement was 98.1% (96.6–100) and 97.3% (94.9–99.1).
Discussion
In this study, we investigated how well the 12-lead ECG can be reconstructed from dif-
ferent lead subsets. Both general and patient-specific reconstructions were evaluated on
a well-defined set. General reconstruction allows accurate reconstruction of one or two
missing precordial leads, while up to three to four precordial leads can be reconstructed
well by patient-specific reconstruction parameters. Reconstruction of the 12-lead ECG
over time remained accurate using general and patient-specific reconstruction. In all
cases, patient-specific reconstruction performance was better than general reconstruc-
tion performance.
Practical application
ECG reconstruction can be used in the field of continuous monitoring (intensive care,
telemetry or step-down intermediate care), where it can be integrated in clinical practice
by the nurse or technician with minimal effort. For general reconstruction, electrodes
can be placed on the well-known 12-lead positions except for those leads that need to
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Figure 3.3:Median (inter-quartile range) of the average absolute ST60 difference between original
and reconstructedwaveforms using general reconstruction (a) and patient-specific reconstruction
(b) of the best lead sets (cf. Table 3.4). For each lead set, bars indicate results at baseline, and at 20
minutes, and 1, 6, 12, and 24 hours after baseline (from left to right).
be reconstructed. By using a previously recorded ECG, patient-specific coefficients can
be computed and reconstruction can be improved. From a technical point of view, the
reconstruction algorithms require less than a few milliseconds with modern equipment
and can easily be implemented by vendors of medical equipment.
Lead reconstruction
Our findings of the general reconstruction corroborate with previous investigations
(Cady, 1969; Scherer et al., 1989; Drew et al., 2002). In our study, the best 4-lead subset
consisted of leads I, II, V2, and V5. Cady (1969) found the best performance for leads V2
and V6, which was second best in our study. Our best 3-lead subset consisted of I, II, and
V2, which was also recommended by Scherer et al. (1989). However, 4-lead subsets per-
formed substantially better than 3-lead subsets, both using general and patient-specific
reconstruction.
The 5-lead subsets with the highest reconstruction performances were clearly better
than other sets of the same size. A possible explanation for these results is that these
subsets form a quasi-orthogonal set of leads, representing the vectorcardiographic X, Y,
and Z leads that describe the heart vector. Previous work has shown that the 12-lead
ECG can be reconstructed from the vectorcardiogram in good approximation (Kors et al.,
1986; Bjerle and Arvedson, 1986).
In a previous preliminary investigation (Nelwan et al., 2000), we applied 12-lead re-
construction techniques on 10-second ECGs from subjects with chest pain suggestive of
myocardial infarction. Performancewas assessed bymorphology correlation coefficients
only. Results are comparable to those obtained for the baseline ECGs in the present
study. When we used the general reconstruction coefficients from the other study (Nel-
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Figure 3.4:Median (inter-quartile range) of the maximum absolute ST60 difference between origi-
nal and reconstructedwaveforms using general reconstruction (a) andpatient-specific reconstruc-
tion (b) of the best lead sets (cf. Table 3.4). For each lead set, bars indicate results at baseline, and
at 20 minutes, and 1, 6, 12, and 24 hours after baseline (from left to right).
wan et al., 2000) to reconstruct the ECGs in our current data set, similar performance
results were found.
General versus patient-specific reconstruction
Patient-specific reconstruction is clearly superior over general reconstruction, but re-
quires the availability of a 12-lead baseline ECG from which the reconstruction coeffi-
cients can be computed. This would make patient-specific reconstruction particularly
attractive in situations in which some leads of the 12-lead ECG are temporarily unavail-
able. General reconstruction, on the other hand, can always be applied but is more
vulnerable to changes in electrode placement. Since differences are known to exist be-
tween standard limb leads derived from electrode positions on the ankles andwrists, and
those from monitoring positions, (Pahlm et al., 1992; Krucoff et al., 1994) this would re-
quire separate sets of general reconstruction coefficients for each configuration. Patient-
specific coefficients on the other hand would yield a valid reconstruction irrespective of
configuration, provided that the extremity electrodes are located on the same position as
when the baseline ECG was obtained.
Lead reconstruction over time
While general reconstruction remained at a similar performance level over 24 hours,
patient-specific reconstruction was affected by time. A possible explanation is that pos-
tural changes, modifying the location of the electrodes relative to the heart, may have
caused the patient-specific reconstruction to perform less well. General reconstruction
would be less vulnerable to this effect as the general reconstruction coefficients were de-
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rived from a large set of ECGs, with variability between individuals that surpasses the
variation induced by changes in posture. One should also consider that the decrease in
performance is rather small. For example, the median of the maximum absolute ST dif-
ference increases from 30 µV at baseline to 44 µV 24 hours later (Figure 3.4b), a change
that will be difficult to notice for a human observer.
Study limitations
The data set in this study was limited to a group of patients with unstable angina pec-
toris. The presented techniques can be applied on additional data sets containing other
abnormalities to determine their robustness. In this respect, the stable results when the
reconstruction coefficients derived from another data set (Nelwan et al., 2000) were ap-
plied to our current set, are encouraging.
Another limitation is that we focused on continuous ischemia monitoring and did
not include the P wave in our performance assessment. This would be a point of further
investigation, possibly necessitating the derivation of a separate set of reconstruction
coefficients for the P wave only.
Conclusion
Accurate reconstruction of the 12-lead ECG from lead subsets is very well possible. Gen-
eral reconstruction allows one or two precordial leads to be reconstructed well, whereas
patient-specific reconstruction allows reconstruction of up to four leads. Patient-specific
reconstruction performance initially slightly decreases and then stabilizes over time, but
still performs better than general reconstruction after 24 hours.
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Abstract
Background
Twelve-lead ST-segment monitoring is a widely used tool for capturing focal ischemia
and transient intermittent episodes. However, continuous registration of all 10 elec-
trodes is often impractical in clinical settings. This study investigated the accuracy of
2 derived 12-lead strategies that required 6 electrodes, including all limb leads, and 2
precordial leads by using population-based (generalized) and individualized (patient-
specific) reconstruction coefficients to derive the additional 4 precordial leads.
Methods
A total of 26880 simultaneous digital conventional, generalized, and patient-specific 12-
lead ECGs were monitored over 112 hours in 39 patients during percutaneous coronary
intervention, including 159 balloon occlusions in 63 arteries, to test accuracy at rest and
during ischemia. Occlusion duration was 78 seconds (range 42 to 96) in the left main
coronary in 2 patients, the left anterior descending artery in 15, the right coronary artery
in 10, the circumflex artery in 2, and graft segments in 5 patients.
Results and conclusions
Average summated 12-lead ST deviation over the study population at baselinewas 377 µV
(range 104 to 1718), which increased at peak ischemia to an average of 1086 µV (range 282
to 4099). Median absolute differences at peak ischemic ST deviation were 25 µV in lead
V1, 0 µV in lead V2, 35 µV in lead V3, 34 µV in lead V4, 0 µV in lead V5, 11 µV in lead V6,
and 114 µV for summated 12-lead ST deviation with the generalized method and 7 µV
in lead V1, 4 µV in lead V2, 1 µV in lead V3, 5 µV in lead V4, 4 µV in lead V5, 9 µV in lead
V6, and 83 µV for the summated 12-lead ST deviation with the patient-specific method.
Limb leads (I, II, III, aVR, aVL, and aVF) were identical in all patients. Thus, general-
ized and patient-specific methods derived from 12-lead electrocardiography using ac-
tual limb and 2 precordial electrodes accurately derived the additional chest leads at rest
and during ischemia. These approaches appear to be more practical than conventional
10-electrode monitoring, yet preserve high accuracy.
12-lead ECG Reconstruction Before and During PCI 33
Introduction
Twelve-lead ST-segment monitoring is a widely used, noninvasive tool for detection and
quantification of focal ischemia and temporally intermittent episodes (Klootwijk et al.,
1998; Drew and Krucoff, 1999; Johanson et al., 2001). However, continuous registration
of all leads may not always be practical in clinical settings. Derived 12-lead strategies
that require fewer electrodes may decrease patient management and costs and provide
better access to the left precordium when resuscitation or cardiac tests such as echocar-
diograms are required. This study assessed the accuracy of simultaneous recording of
the actual 12-lead electrocardiogram and two derived 12-lead strategies at rest and dur-
ing known ischemia from percutaneous coronary intervention (PCI). In the first strategy,
all limb leads and precordial leads V2 and V5 were directly recorded, and the absent pre-
cordial leads V1, V3, V4, and V6 were derived from a set of population-based coefficients.
The second strategy used the directly recorded limb leads and two precordial leads se-
lected from the baseline 12-lead electrocardiogram recorded at rest for each patient. The
absent four precordial leads were derived with patient-specific coefficients.
Methods
Patient selection
Patients at theDurhamVAMedical Center (Durham, North Carolina, USA) who had been
scheduled to undergo percutaneous coronary intervention (PCI) gave informed consent
to undergo continuous 12-lead electrocardiogram (ECG) monitoring during and after
their PCI procedure. PCI procedures were performed in the usual fashion without sig-
nificant modification for this protocol. Coronary stenting, antiplatelet therapy, and anti-
coagulation therapy were performed according to institutional standards in all patients.
ECGmonitoring
Monitoring was started at least 30 minutes before the first contrast injection and con-
tinued at least 30 minutes after the final contrast injection. Ten electrodes were posi-
tioned on Mason-Likar (ML) compatible monitoring locations (Mason and Likar, 1966)
prior to the PCI procedure. Radiolucent electrodes allowed ECGmonitoring to continue
throughout the PCI procedure without interfering with fluoroscopy. Signal quality was
visualized on a dedicated Siemens 7000 monitor (Siemens Medical Systems, Danvers,
Massachusetts, USA) paired with a laptop personal computer for data collection and a
review tool (CRS, Thoraxcentrum, Rotterdam, The Netherlands (Nelwan et al., 1996)).
The overall system acquired high-fidelity 12-lead ECGs at 500 Hz, from which average
complexes were continuously calculated on a beat-by-beat basis using an incremental
updated moving average filter.
Measurements were done by a computer program (Siemens Medical Systems). The
system provided the user with a 12-lead average complex every 15 seconds over the en-
tire monitoring period. In addition, the system contained a tool to export an isolated 10-
second, 500-Hz, 12-lead ECG strip. This export tool was used to isolate six baseline elec-
trocardiograms (before PCI) that were sent to the Rotterdam ECG laboratory for deriva-
tion of patient-specificmatrices, thus blinding the Rotterdamgroup to other information
from the monitoring session (see data flow diagram in Figure 4.1).
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Figure 4.1: Data flow diagram of the data collection, reconstruction process, and performance
comparisons.
Electrocardiographic derivation
Two kinds of derived electrocardiograms were constructed: a general electrocardiogram
(GEN ECG) and a patient-specific electrocardiogram (PS ECG). These two strategies
used all torso limb leads and two precordial leads and comprised a subset of the con-
ventional 12-lead electrocardiogram. The generalized ECG derivation used limb leads
I and II and precordial leads V2 and V5 in all procedures and derived leads V1, V3,
V4, and V6. A derived lead V1 (dV1) was synthesized using the linear combination of
dV1 = c11I +c21I I +c31V2+c41V5. The coefficients c11 to c41 were computed usingmulti-
ple linear regression from a large, independent ECG database that included normal and
ischemic findings on electrocardiograms (Nelwan et al., 2000). Leads V3, V4, and V6 were
synthesized in a similar manner. The patient-specific ECG derivation strategy used the
patient’s baselineML electrocardiogram to select the pair of precordial leads that had the
highest morphologic correlation. Patient-specific coefficients were computed to derive
the remaining four precordial leads.
Electrocardiographic analysis
For each patient, quantitative and qualitative ECG analyses were performed in three
steps: (1) ML ECG selections, (2) general ECG versus ML ECG analysis, and (3) patient-
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specific ECG versus ML ECG analysis. All ST-segment measurements were digitally mea-
sured at 60 ms after the J point for each lead and summated over all 12 leads.
Superimposition scanning of the actual 12-lead electrocardiograms recorded before,
during, and after PCI was performed at the Duke Core Laboratory with CRS software.
For each patient, electrocardiograms "before PCI" and during "peak ischemia" were se-
lected. An electrocardiogram before PCI was defined as a ML electrocardiogram that
was representative of the patient at rest, subsequent to the "baseline" electrocardiograms
(whichwere sent to Rotterdam) and just before the first contrast injection. An electrocar-
diogram at peak ischemia was defined as a ML electrocardiogram during PCI occlusion
that showed maximum deviation of the summated ST-segment levels relative to the ST-
segment levels before PCI. ST-segment levels were electronically forwarded as ascii files
to the statistician for use in quantitative analyses.
CRS software was used to analyze patient-specific versus ML electrocardiograms to
determine the limb leads and two precordial leads for each patientmonitoring session as
determined from the patient-specific matrix. Waveform and ST-level measurements for
these leads were identical to those for the ML electrocardiogram. The application used
the patient-specific matrix to derive the additional four precordial leads for each elec-
trocardiogram over the course of the monitoring session. Superimposition scanning of
the patient-specific ECG waveforms on the corresponding ML ECG waveforms allowed
direct visual qualitative comparisons of all recorded electrocardiograms. For quantita-
tive comparison, digital ST levels at 60 ms after the J point for every lead for each of the
patient-specific electrocardiograms before PCI and at peak ischemia were electronically
forwarded as ascii files to the statistician for analysis. Generalized ECG versus ML ECG
analysis was conducted identically to the patient-specific ECG versus ML ECG analysis
using limb leads plus leads V2 and V5; leads V1, V3, V4, and V6 were derived from the
general reconstruction coefficients.
Thus, simultaneous electrocardiograms from identical lead positions, using conven-
tional versus derived waveforms, with patients serving as their own controls, were used
for all quantitative analyses and qualitative comparisons.
Quantitative analysis
Absolute differences between ML ECG levels and generalized or patient-specific ST lev-
els were tested as continuous variables. A dichotomous variable threshold for clinically
significant differences between ST levels in any lead on a ML electrocardiogram versus
a generalized or patient-specific electrocardiogram was set at > 50 µV, which is the ap-
proximate width of an ink line on an electrocardiogram or a line width of two pixels on
an average 17-inch computer monitor.
Statistical analysis
All data were archived using coded patient study numbers at the Ischemia Monitoring
Core Laboratory, and all statistical analyses were completed at the Duke Clinical Re-
search Institute (Durham, North Carolina). Subjects’ baseline characteristics were sum-
marized in terms of counts and percentages for categorical variables and asmedians and
inter-quartile ranges for continuous variables. Data were correlated using patients as
their own controls. Differences in STdeviation between theMLandpatient-specific elec-
trocardiograms (D1) and between the ML and generalized electrocardiograms (D2) were
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computed for each lead. D1 andD2 were tested for similarity withWilcoxon’s signed rank
test. This distribution-free test allowedus tomake inferences regarding themedian of the
differences between the two ECG analysis methods and control for non-normality in the
data andmatchedpairs. A dichotomous variablewas also created to evaluate the number
of times D1 or D2 was > 50 µV for each lead. McNemar’s χ2 test for dependent propor-
tions was used to determine whether these proportions were similar. A p-value < 0.05
was considered statistically significant.
Results
A total of 26880 electrocardiograms were acquired over 112 hours of monitoring in 39
patients during PCI procedures, including 159 balloon occlusions in 63 coronary arter-
ies. Patients were men, with an average age of 66 years, average weight of 92 kg, and
average height of 178 cm. Median duration of coronary occlusion by balloon inflation
was 78 seconds (range 42 to 96). In two patients, PCI was performed during evolving
myocardial infarction, and each had a sustained coronary occlusion for > 30 minutes.
Peak ischemia occurred on electrocardiograms during occlusion of the left main coro-
nary in two patients, the left anterior descending artery in 15 patients, the right coronary
artery in 10 patients, the circumflex artery in two patients, and vein graft segments in
five patients. In five patients, PCI did not cross a long-term total occlusion or PCI was
not performed, so contrast injections with transient ST changes were analyzed. Average
summated 12-lead ST deviation over the population before PCI was 377 µV (range 104 to
1718), which increased at peak ischemia to an average of 1086 µV (range 282 to 4099).
Quantitative analysis
Table 4.1 presents absolute ST-level differences for each lead and summated over 12 leads
for electrocardiograms before PCI and during peak ischemia. Differences between ML
and generalized electrocardiograms were compared with differences between ML and
patient-specific electrocardiograms. There were no differences in the limb leads, be-
cause the actual limb leads were used for all derivations. Leads V2 and V5 were also
identical for ML and generalized comparisons, with only leads V1, V3, V4, and V6 being
reconstructed. For the patient-specific electrocardiogram across these 39 patients, the
frequency and distribution of the precordial leads used for reconstruction were 31% for
lead V1, 41% for lead V2, 46% for lead V3, 33% for lead V4, 44% for lead V5, and 5% for lead
V6. Differences on average were 5 µV for patient-specific versus ML electrocardiograms
and 26 µV for ML versus generalized electrocardiograms. Comparisons across leads V1,
V3, and V4 favored the patient-specific versusML electrocardiogramover the generalized
versusML electrocardiogram and the comparison for lead V6 was statistically equivalent.
Differences for leads V2 and V5 were only 4 µV. Although relevant from a technical stand-
point in a digital ECG environment, average differences of 4 to 35 µV are unlikely to be
clinically significant.
Table 4.2 presents comparisons of the incidence of patients in whom any lead varied
fromML by > 50 µV for electrocardiograms before PCI or at peak ischemia. Leads V1, V3,
and V4 were superior for patient-specific electrocardiograms, with no difference in lead
V6.
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Tables 4.3 and 4.4 present absolute ST differences and incidence of differences
> 50 µV for peak ischemia with respect to occlusions in the left anterior ascending artery
and other locations. For occlusions not in the left anterior descending artery, generalized
and patient-specific electrocardiograms were nearly identical.
Qualitative analysis
Visible qualitative differences that underestimated or overestimated P, QRS, ST, and T
waves for generalized and patient-specific electrocardiograms at baseline, before PCI, at
peak ischemia, and over the entire course of monitoring were examined on a superim-
posed display of the derived and actual electrocardiograms for each patient. Occasional
morphologic changes were observed, although the clinical significance of these minor
observations was unclear. Importantly, on no electrocardiogram did derivation produce
significant shifts in fiducial points important to ST-segment level determinations.
Discussion
This study demonstrates the accuracy with which ST-segment levels from a 12-lead elec-
trocardiogram before and during transient ischemia can be reconstructed from a 6-
electrode set. In patient-specific and general variations of the algorithm, limb leads and
two of the standard precordial leads are used, thus decreasing the need to record the
four absent precordial leads. In the two variations, patient-specific waveform elements
are used to augment the accuracy of the derived leads.
In the generalized strategy, standard precordial leads V2 and V5 are used for all ECG
recordings, in contrast to the patient-specific strategy, when leads other than V2 and V5
may be selected, depending on the actual spatial location of key waveform elements. In
the patient-specific strategy, a 12-lead electrocardiogram is mandatory before monito-
ring because it is used to assess the range of derivations across all possible pairs of pre-
cordial waveforms, with two precordial leads selected for each patient based on the best
overall correlation between the actual electrocardiogram and the four derived precordial
waveforms.
The concept of 12-lead ECG monitoring derived from only six electrodes placed on
the patient represents an important logistical advantage to bedside integration and fea-
sibility for clinical use. The accuracy of the ECG reconstruction is critical to patientman-
agement and to widespread acceptance. Current studies have reported that derived 12-
lead electrocardiograms contain more information about ischemia than do traditional
cardiac care unit leads such as leads V1 and II, (Drew et al., 1996) but whether any de-
rived 12-lead electrocardiogram reproduces the 12-lead electrocardiogram sufficiently
and accurately to be clinically useful, remains controversial.
The assessment of derived ECG accuracy has important technical elements. In pre-
vious reports that assessed two or three recording devices cycling independently (Drew
et al., 1997; Krucoff et al., 1993), ischemia from a rapidly moving source (e.g. coronary
occlusion) during PCI may appear differently on different devices simply due to a 10- to
20-second difference in timing from one device to another. In this protocol, the derived
electrocardiograms were created with a subset of leads from fully archived 12-lead elec-
trocardiograms, thus allowing comparison of truly simultaneous actual and derived ECG
waveforms and truly using patients as their own simultaneous controls. Further, even
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if the ST-segment waveform is accurately derived, the location of measurement points
such as 60 ms after the J point may be adversely affected if the derived QRS interval or
other fiducial points in the waveform are inaccurate. In this study, visual superimposi-
tion of the entire derived waveform onto the simultaneous actual waveform was used to
inspect not only the electrocardiograms analyzed quantitatively but also all electrocardi-
ograms in themonitoring session. This qualitative superimposition also allowed the core
laboratory to observe any other obvious inaccuracies in the non-ST-segment waveform
components.
The two reconstruction strategies performed very well in non-ischemic and ischemic
electrocardiograms and during coronary occlusions in the left anterior descending artery
and elsewhere. Although statistically significant differences in this model were de-
tectable at themicrovolt level when comparing digital electrocardiograms of single leads,
differences greater than the threshold of 50 µV were rare.
This study has several limitations. First, the total patient number was small. How-
ever, using patients as their own simultaneous controls provides considerable statistical
power with which to assess accuracy. Second, this study used an arbitrary threshold of
50 µV as the cutoff for accuracy assessments. This threshold represents a measurement
range equivalent to the width of the ink line on a printed electrocardiogram. Although
reasonable for this kind of algorithm assessment, effects on implementation strategies,
such as programmable alarm thresholds in a monitored patient care setting, remain un-
clear.
Conclusion
Generalized and patient-specific methods derived from 12-lead electrocardiograms us-
ing actual limb and two precordial leads accurately derive the absent four precordial
electrodes at rest and during ischemia. These approaches appear to be more practical
than conventional 12-lead monitoring and preserve high accuracy.
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Abstract
Background
In emergency care situations, recording all leads of the 12-lead ECG is often not possible
due to technical or organizational restrictions. The recording of a reduced lead set and
subsequent synthesis of the absent leadsmight be a solution to these problems. The aim
of this study was to evaluate the efficacy of a reduced lead set containing leads I, II, V2,
and V5.
Methods
We used a data set of 2260 10-second, 12-lead ECGs from patients with chest pain sug-
gestive of acute myocardial infarction (AMI). The ECGs were recorded by the ambulance
personnel prior to hospitalization. The data set was split in a training set of 1435 ECGs
and a test set of 825 ECGs. Reconstruction coefficients were derived by linear regression
from the learning set. Performance was evaluated between the actual and reconstructed
leads using correlation coefficients and average and maximum absolute ST differences.
We applied a decision rule for initiation of pre-hospital thrombolysis and a detection rule
for AMI to the original and reconstructed ECGs. Accuracy was determined by percentage
agreement and Cohen’s kappa was computed to correct for chance agreement.
Results
The overall median (inter-quartile range) correlation coefficient was 0.985 (0.971–0.992).
The median absolute ST difference was 25 (16–45) µV with a maximum difference of
49 (29–88) µV. The median performance results of each reconstructed lead were for cor-
relation: V1 0.983 (0.960–0.993), V3 0.953 (0.877–0.980), V4 0.980 (0.954–0.991), and V6
0.986 (0.967–0.994). Median ST differences were for V1 20 (9–41) µV, V3 38 (16–78) µV , V4
23 (11–45) µV, and V6 13 (6–26) µV. For the pre-hospital decision rule, accuracy was 0.987
with a kappa of 0.880. The accuracy of the AMI detection rule yielded 0.981 with a kappa
of 0.941.
Conclusions
The findings in this study show that high overall agreement, correlation, and small ST
differences have been obtained. In emergency situations where a 12-lead ECG cannot
be recorded because of technical or organizational restrictions, a reduced lead set can be
considered.
Reduced Lead Set for Pre-Hospital Use 45
Introduction
Early diagnosis, risk stratification, and initiation of treatment are of importance for pa-
tients with chest pain suggestive of acute coronary syndromes and may result in reduc-
tion of mortality and final infarct size (Boersma et al., 1996; Grijseels et al., 1996). The
12-lead ECG is an important noninvasive tool for diagnosing acutemyocardial infarction
in patients with chest pain and an increasing number of emergency medical services are
being equipped with and are trained to use a 12-lead ECG recorder. Depending on local
regulations, the 12-lead ECG may be evaluated by a cardiologist using facsimile trans-
mission or by a computer program.
However, there are several practical considerations. First, a 12-lead ECG requires
ten electrodes and wires. A reduction in the number of electrodes may save time. Fur-
thermore, there may not always be room in the ambulance for a separate 12-lead ECG
recorder. An integrated solution with a defibrillator would be ideal, but not all defibrilla-
tors can record all 12 leads.
Recording of a reduced subset of leads and subsequent synthesis of a full 12-lead
ECG may provide a solution to these problems. The goal of this study was to evaluate
the efficacy of a reduced lead set consisting of leads I, II, V2, and V5. This lead subset has
previously been shown to give excellent results in a patient monitoring setting (Nelwan
et al., 2004b).
Methods
Study population
The data set for this study was based on the Repair study (Boersma et al., 1996; Grijseels
et al., 1996; Bouten et al., 1990). Repair was used for the development and evaluation
of a computer-assisted decision algorithm for early initiation of thrombolytic therapy in
the pre-hospital setting. Between 1992 and 1994, 2641 patients in the municipality of
Rotterdam with chest pain suggestive of myocardial infarction were evaluated by their
general practitioner, who then asked for ambulance assistance and hospital admission.
After arrival of the ambulance, a 12-lead ECG was recorded by the ambulance personnel
and interpreted by a computerized analysis system.
A final diagnosis was made by the treating cardiologist, and was based on the ad-
mission and discharge ECGs, recurrence of symptoms, laboratory findings, and autopsy
results. These results were also provided to the general practitioner, who used the infor-
mation for further patient management.
Electrocardiographic processing
In 365 patients, an ECG could not be recorded or stored due to technical failure or un-
suitable circumstances on the spot. In 16 patients, the ECG was left out of the analy-
sis because of reversed leads or pacemaker rhythms. The remaining 2260 ECGs were
split into a training set (n=1435) and a test set (n=825). All ECGs were processed by the
Modular ECG Analysis System (MEANS) (van Bemmel et al., 1990). The programMEANS
computes for each of the 12 leads a representative averaged beat from which ECG mea-
surements are derived. MEANS has been extensively evaluated by the developers (van
Bemmel et al., 1990) and by others (Willems et al., 1991).
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Reconstructionmethod
Leads III, aVR, aVL, and aVF can be calculated from leads I and II without error. Lead V1
can be approximated by c11∗ I +c21∗ I I +c31∗V2+c41∗V5. The coefficients c11−c41 are
computed using multivariate linear regression from ECGs in the learning set. Leads V3,
V4, and V6 can be reconstructed in a similar way.
Data analysis
Reconstruction accuracy of the missing leads was evaluated on three different levels.
First, overall waveform similarity for each ECG was assessed by the average of the cor-
relation coefficients and root mean square errors (RMSE) between the QRS-T complexes
of the original and the reconstructed leads.
Second, reconstruction accuracy was determined at themeasurement level, focusing
on the ST amplitude, 60ms after the J point for each lead. Wedetermined the average and
themaximumof the absolute differences (|∆ST|) between the original and reconstructed
ST amplitudes. Furthermore, the sum of the absolute ST deviations (SUMST) was also
computed for the original and reconstructed ECGs.
Third, reconstruction accuracy was assessed at the diagnostic level. For each original
and derived 12-lead ECG, we applied seven decision rules and calculated the sensitivity,
specificity, and accuracy (percentage agreement) between the original and the recon-
structed 12-lead ECG. Cohen’s κwas computed to correct for chance agreement.
The first decision rule, named Repair1988, was the originally developed decision
rule (Bouten et al., 1990) for initiation of thrombolytic therapy. The ECG criteria were:
≥ 300 µV ST elevation in two or more leads of V1-V6 or ≥ 200 µV in two or more leads
in II, III, and aVF. A total ST deviation of at least 1000 µV was also required. The exclu-
sion criteria were: left or right bundle branch block, intraventricular conduction delays,
a Wolf-Parkinson-White pattern, and pacemaker rhythms.
The Repair protocol was optimized in 1996 (Repair1996) (Boersma et al., 2001) and
included additional criteria for ST elevation and depression in the inferior and anterior
leads. In 2001, Repair was extended with recommendations for primary PCI for patients
with a total ST deviation of ≥ 1500 µV (Repair2001) (Boersma et al., 2001).
The fourth decision rule, AMI1, is a classical decision rule for determining in-hospital
acutemyocardial infarction. AMI1 holds true if two ormore leads of V1-V6 show≥ 200 µV
ST elevation or if at least one lead of II, III and aVF shows ≥ 100 µV of ST elevation.
The fifth decision rule, AMI2, is a rule recommended by the European Society and
American College of Cardiology for the detection of myocardial ischemia and evolving
myocardial infarction (Thygesen et al., 2000). The rule holds true when two or more
contiguous leads show ST elevation at J point of ≥ 200 µV in anterior leads V1, V2, or
V3 and ≥ 100 µV ST elevation in the other leads.
Lastly, two additional decision rules were included. ST depression was considered if
two or more leads showed at least 50 µV ST depression. ST elevation was considered if
two or more leads in V1-V6 had ≥ 200 µV ST elevation or two or more limb leads (I-III,
aVL, and aVF) had at least ≥ 100 µV ST elevation.
The decision rules have been designed for different purposes. For example, the Re-
pair decision rules were designedwith a high specificity in order tominimize the number
of false-positive cases, because of the elevated risk of complications when using throm-
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Table 5.1: Median (inter-quartile range) correlation, average, and maximum absolute ST differ-
ences of the test set and subsets according to the discharge diagnosis.
Data set Correlation Absolute ST difference (µV)
Average Maximum
Complete set (n=825) 0.985 (0.971 – 0.992) 25 (16 – 45) 49 (29 – 88)
Myocardial infarction (n=235) 0.984 (0.972 – 0.991) 41 (23 – 76) 76 (42 – 247)
Angina pectoris (n=189) 0.984 (0.968 – 0.992) 24 (15 – 38) 43 (28 – 74)
Atypical chest pain (n=278) 0.978 (0.975 – 0.992) 19 (13 – 33) 38 (24 – 62)
Table 5.2: Median (inter-quartile range) summated ST (SUMST) of the original and derived ECGs
and differences of the test set.
SUMST Original (µV) Derived (µV) Difference (µV)
Complete test set 671 (423 – 1357) 669 (411 – 1339) 2 (-41 – 55)
Myocardial infarction 1479 (904 – 2493) 1472 (789 – 2261) 18 (-41 – 139)
Angina pectoris 585 (380 – 879) 589 (383 – 874) 3 (-36 – 50)
Atypical chest pain 494 (355 – 748) 507 (343 – 714) -10 (-45 – 22)
bolytic therapy. For the AMI1, AMI2, and the ST-depression and ST-elevation rules, a high
sensitivity and low false-negative cases are important.
Results
The median age (inter-quartile range) of patients in the test set was 67 (57–74) years. A
total number of 438 (53.1%) patients weremale. The final discharge diagnoses were: my-
ocardial infarction (28.6%), angina pectoris (22.9%), atypical chest pain (33.6%), severe
cardiac pathologies (2.4%), other or minor cardiac pathologies (3.1%), and a group of
other or non-cardiac diagnoses (9.4%).
The reconstruction technique was applied to the test set and to the largest three sub-
groups (myocardial infarction, angina and atypical chest pain). Performance results are
presented in Table 5.1. SUMST for the myocardial infarction group is higher than for the
angina pectoris and atypical chest pain groups. In Table 5.2, a similar pattern can be ob-
served for the SUMST differences and average and maximum absolute ST differences in
these groups.
Table 5.3 contains the median correlation coefficients, RMSE, and ST differences for
each reconstructed lead, respectively. Overall, lead V3 has the lowestmedian correlation,
highest RMSE and ST difference across the complete test set and subgroups. Recon-
structed lead V6 has the overall highest median performance and lowest ST difference.
For each reconstructed ECG, we determined the lead which had the largest ST-
difference. The number of cases was for lead V1 202 (24%), V3 444 (53.1%), V4 115 (13%),
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Table 5.4: Sensitivity (Sens), specificity (Spec), number of false-negative (FN) and false-positive
(FP) cases, accuracy and chance-corrected accuracy (κ) based on a comparison of the original and
reconstructed ECGs for seven decision rules on the test set (n=825).
Decision rule Sens (%) Spec (%) FN FP Accuracy κ
Repair1988 94.3 99.6 2 3 0.994 0.926
Repair1996 82.1 99.6 7 3 0.988 0.859
Repair2001 84.3 99.6 8 3 0.987 0.880
AMI1 98.1 98.3 2 12 0.983 0.931
AMI2 93.7 99.2 11 5 0.981 0.941
ST elevation 96.2 96.8 16 13 0.965 0.930
ST depression 97.5 98.1 6 11 0.979 0.951
and V6 64 (7%). Overall, lead V3 had the largest ST difference in most cases. Similar re-
sults were found in the subgroups.
Reconstruction performance results of the myocardial infarction group were slightly
lower than the angina pectoris and atypical chest pain groups. However, the myocardial
infarction subgroup contains large changes in the ECG, caused by ischemia or ongoing
infarction at the time of recording, resulting in high SUMST values and higher ST differ-
ences (cf. Table 5.1).
In Table 5.4, performance results are presented for sensitivity, specificity and accu-
racy between the actual and reconstructed ECGs of the described decision rules. The
number of false positive and false negative cases are also reported for each rule. The
current Repair rules had three false positive cases. Two cases would not receive throm-
bolytic therapy, but would be directly transported for PCI. These false positive PCI cases
were found in several rules (Repair1996, Repair2001, AMI1 and ST elevation) and had
mediocre overall correlation and high ST differences. In these two cases, a single, large,
ST elevation (380 µV) was found in a source lead, which propagated in the reconstructed
leads and increased the reconstruction errors. The third false positive case would have
received unjustified thrombolytic therapy based solely on these ECG criteria.
The ST-depression rule with a threshold of ≥ 50 µV had the highest number of false-
negative and false-positive cases. After setting the depression threshold to ≥ 100 µV, ac-
curacy (agreement: 0.977, kappa: 0.945) increased and the number of false negative cases
(13) and false positive cases (6) decreased. These results may indicate that thresholds of
≤ 50 µV are more vulnerable to errors in lead reconstruction (cf. ST differences in Ta-
bles 5.1 and 5.3).
Discussion
The findings in this study show that high overall accuracy (≥0.880), waveform similarity
(≥0.985), and small ST differences (maximum ≤ 49 µV) were obtained between the re-
corded 12-lead ECG and the reconstructed 12-lead ECG based on a reduced lead subset
of leads I, II, V2, and V5.
Overall, the number of misclassifications are low. The accuracy results of Repair2001
indicate three false positive cases of which two would be transported directly to a PCI
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center, and that a single case would receive unjustified thrombolytic treatment based
solely on the ECG data. In practice, the final decision will also be based on other vari-
ables.
Leads V3 and V4 had the lowest reconstruction performance. A possible explanation
is that these leads are often considered as transition leads between the left- and right-
precordial areas on the chest. Because this transition is often specific for a patient, a
reconstruction technique based on a training population does not need to be best for
each individual patient. Lead V6 had the overall highest reconstruction performance,
which does not come as a surprise as V6 is highly correlated with leads I and V5.
In a previous study (Nelwan et al., 2004b), we evaluated this reconstruction technique
for all lead subset combinations on a group of 234 patients who were monitored for 24
hours in the coronary care unit. The lead subset of I, II, V2, and V5 was found best in this
study. We also determined the best lead subsets of varying sizes on the present training
set (data not shown) and found that the best lead subset also included leads I, II, V2, and
V5.
Other investigators also evaluated the use of reduced lead sets. Drew et al. (2002)
considered a lead subset consisting of leads I, II, V1, and V5. Lead V1 was preferred over
V2, because this lead is frequently used for diagnosis of QRSmorphology and atrial activ-
ity. However, lead V1 is not most efficacious for detection of myocardial ischemia (Drew
et al., 2002; Drew and Krucoff, 1999). For this lead subset, we derived coefficients from
the learning set and applied it to our test set. A slight performance loss was observed; the
number of false-positive cases increased from three to seven cases for the Repair rules.
However, further investigation is needed to evaluate both lead set strategies.
Schreck et al. (1998) evaluated the use of a lead subset consisting of leads I, aVF, and
V2. This lead subset corroborates with the best lead subset (I, II, and V2) determined
after a separate analysis on our training set (data not shown). However, we found an
overallmoderate performance loss for this lead subset. For example, the number of false-
positive cases for the Repair rules increased from three to eight. These findings indicate
that inclusion of a left-precordial lead, such as lead V5, increases overall reconstruction
performance.
A study limitation is that we did not evaluate reconstruction accuracy of other ECG
abnormalities, such as cardiac arrhythmias. However, a typical lead selected for arrhyth-
miamonitoring is lead II (Drew et al., 2002; Drew andKrucoff, 1999). As this lead is part of
the lead subset, arrhythmia monitoring will not be influenced by reconstruction errors.
Conclusion
This study shows that high accuracy, highwaveform similarity, and small ST60 differences
can be obtained froma reconstruction of a 12-lead ECGusing reduced lead sets. In emer-
gency care situations, where a 12-lead ECG cannot be recorded because of technical or
organizational restrictions, a reduced lead set can be considered.
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Abstract
Background
In recent years, several derived 12-lead ECG systems have been developed, but have
never been directly compared for accuracy. The aim of the study was to simultaneously
test the EASI lead system and two other derived ECG methods against the standard 12-
lead ECG during percutaneous coronary intervention.
Methods
During 44 percutaneous coronary interventions, a simultaneously recorded 12-lead and
EASI ECG were marked at the start of the recording (baseline) and at known ischemia
caused by balloon inflation (peak). ST deviations were measured 60 ms after the J point
at baseline and peak in all leads and were summated (SUMST) to assess overall changes.
For regional changes, the lead with the highest ST deviation (PEAKST) was marked.
For each patient, derived 12-lead ECGs were computed from the EASI leads and a
lead subset using patient-specific coefficients (PS) and coefficients based on a patient
population (GEN). Absolute differences were computed between each derived and rou-
tine ECG for SUMST and PEAKST. Accuracy was tested with paired t-tests at a level of
p < 0.05.
Results
SUMST was at baseline 567 µV (range: 150–1707) and increased at peak to 871 µV (range:
350–2101). SUMST differences at peak were for EASI: 49 µV (CI: 19–220, p=0.02), GEN:
48 µV (CI: -43–154, p=0.26), and PS: 20 µV (CI: -51–32, p=0.65). PEAKST differences were
for EASI: 163 µV (CI: 90–236, p<0.001), GEN: 46 µV (CI: 2–91, p=0.40), and PS: 16 µV (CI:
3–30, p=0.15).
Conclusion
Simultaneous direct comparison of three derived ECG methods shows overall and re-
gional differences in accuracy across PS, GEN, and EASI. Median SUMST and PEAKST
differences for PS are lower than for GEN and EASI, and show a more accurate recon-
struction.
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Introduction
In patients with acute coronary syndromes, continuous 12-lead ST-segment monitoring
is an important noninvasive diagnostic tool for real-time assessment of evolving my-
ocardial ischemia and infarction (Drew and Krucoff, 1999; Johanson et al., 2003). On-
line analysis of dynamic ST-segment changes before, during, and after treatment make
it possible to quantify the presence, speed, and quality of reperfusion of the infarcted
artery and is a class I recommendation of the recently published practice guidelines by
the American Heart Association (Drew et al., 2004).
However, 12-lead ST-segment monitoring is underused in clinical practice (Patton
and Funk, 2001), even though it is available in modern patient monitoring equipment.
An important limitation of the technology is that the ten electrodes used in standard ECG
present a nursing burden and are sensitive to artifacts, which may result in false alarms
and both of which may actually hinder patient care.
A possible solution to these problems might be to monitor patients with fewer elec-
trodes strategically positioned to support accurate reconstruction of the full 12-lead ECG.
In recent years, several methods to derive the 12-lead ECG from fewer leads have been
proposed. The EASI lead system (Dower et al., 1988; Feild et al., 2002) uses five electrodes
and synthesizes all 12 ECG leads, while another approach uses six electrodes as a subset
of the 12-lead ECG, reconstructing the missing leads using coefficients either obtained
from the patient’s own ECG (PS) (Nelwan et al., 2004b) or from a large archived data set
(GEN) (Nelwan et al., 2004b). However, the accuracy with which derived ECGs from re-
duced lead sets approximate the spatial information of the absent leads could affect key
diagnostic features such as ischemic ST changes, and needs to be precisely defined.
The purpose of this study was to directly compare the three (EASI, GEN, and PS) dif-
ferent derivationmethods of the 12-lead ECG at rest and at ischemia as a result of balloon
inflation during percutaneous coronary intervention (PCI) from simultaneously recor-
ded ECGmeasurements.
Methods
Patient selection
Patients scheduled for PCI at the Durham VA Medical Center gave informed consent to
undergo simultaneous 15-lead ECG monitoring before, during, and after their PCI pro-
cedure. The PCI procedures were performed in the usual fashion following the clinical
standards of the institution.
ECGmonitoring
A total of 14 radiolucent electrodes were attached to the patient to allow simultaneous
registration of the 12-lead and EASI ECG. Of the ten electrodes required for 12-lead ECG
registration, four electrodes (right arm, etc) were placed on the Mason-Likar landmarks
(Mason and Likar, 1966) and six electrodes (V1-V6) were positioned on the conventional
precordial locations. The remaining four electrodes were placed on the EASI locations
(E, A, S, and I) (Dower et al., 1988). The EASI reference electrode was shared with the
electrode RL of the 12-lead system.
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All lead wires were connected to a modified dual pod (Siemens/Dräger Medical Sys-
tems) to allow simultaneous registration of all signals by two Delta patient monitors
(Siemens/Dräger Medical Systems) which facilitated basic arrhythmia and continuous
ST-segment monitoring. Monitoring was started at least 30 minutes before the first con-
trast injection and continued at least 30 minutes after the final contrast injection. A
computer program on a laptop acquired high fidelity 500-Hz ECG data from both pa-
tient monitors simultaneously. The system stored averaged beats every 15 seconds for
all leads during the entire recording period.
ECG analysis
ECGswere analyzedwith theModular ECGAnalysis System (MEANS) (van Bemmel et al.,
1990). MEANS computes representative averaged beats of all leads from which ECG
measurements are derived. The waveform recognition and diagnostic interpretation of
MEANS has been extensively evaluated (van Bemmel et al., 1990; Willems et al., 1991).
A 10-second, 12-lead and EASI ECG were marked at the start of the recording (base-
line) and at balloon inflation (peak). In case of multiple balloon inflations, the first bal-
loon inflation was selected. ST-segment amplitudes weremeasured at J point and at J+60
ms (ST60) for each lead. ST deviations were summated over all leads (SUMST) at baseline
and peak.
The lead with the highest ST deviation (PEAKST) at balloon inflation relative to the
initial baseline ECG (≥ 100 µV) (Krucoff et al., 1988) was defined. We identified the region
(anteroseptal: V1-V4, lateral: I, AVL, V5-V6, and inferior: II, III, aVF) affected by balloon
inflation. ECG changes indicative of acute ischemia were assessed at baseline and peak
when at least two ormore contiguous leads showed ST elevations at J point of≥ 200 µV in
the anterior leads V1, V2, or V3 or≥ 100 µV in other leads (Thygesen et al., 2000). Secondly,
ST depression was defined as ≥ 50 µV below the iso-electric level in one or more leads.
ECG derivation
For each patient, 12-lead ECGs were derived over the complete recording period from
the EASI leads and from lead subsets of the 12-lead ECG using coefficients based on a
archived data set of patients and using patient-specific coefficients.
The first derived 12-lead method (EASI) is based on the EASI lead system. EASI uses
a modified Frank configuration with three leads (A–S, E–S, and A–I). Each lead of the 12-
lead ECG can be derived from EASI using a linear combination of these three EASI leads
and transformation coefficients. Because the 12-lead ECGwas recorded onMason-Likar
positions, we applied the modified EASI coefficients described by Feild et al. (2002).
The second method (GEN) uses a lead subset (I, II, V2, and V5) of the 12-lead ECG
and reconstructs the remaining precordial leads using coefficients obtained from a
large study population consisting of patients with acute myocardial infarction, unsta-
ble angina pectoris and normal ECGs (Nelwan et al., 2004b). The extremity leads III,
aVR, aVL, and aVF are computed from leads I and II in the standard way with no loss of
information.
The third method (PS) is similar to GEN, but uses the patient’s own baseline 12-lead
ECG to select the two precordial leads with the highest morphological correlation. In
addition, patient-specific coefficients are determined from this baseline 12-lead ECG for
derivations of the other four precordial leads.
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Quantitative analysis
The derived ECGs fromEASI, GEN, and PSwere comparedwith the corresponding simul-
taneously recorded 12-lead ECG at baseline and peak. For each recording, absolute ST60
differences were calculated between the original and derived ECG for each lead sepa-
rately, for the summated value of all 12 leads (SUMST) and for the peak ST lead (PEAKST).
Furthermore, the angle differences of the frontal QRS axis in the frontal plane were com-
puted between the original and EASI ECG. Overall waveform similarity for each derived
ECG was assessed by root mean square errors (RMSE) between the original and derived
waveforms based on all samples in the QRS-T complex.
Statistical analysis
Data was recorded, coded, and archived at the Duke University Medical Center, and
all statistical analyses were completed at the Erasmus MC. Baseline characteristics are
presented as mean±SD, or median (inter-quartile range), where appropriate. SUMST
and PEAKST are presented as median (confidence interval). The Wilcoxon signed rank
test was used to statistically compare differences. McNemar’s test was used to measure
agreement in occurrence of maximum ST deviations and regional changes. Percentage
agreement and Cohen’s kappa (κ) were computed for evaluation of the detection of acute
myocardial ischemia (Thygesen et al., 2000) and ST depression. A p-value of <0.05 was
considered significant.
For each reconstruction method, Receiver Operating Characteristic (ROC) curves
were constructed to assess the performance of the derived ECGs at varying levels of
SUMST on the balloon inflation ECG. Mean sensitivity and specificity of SUMST were
determined by the bootstrapmethod (Horacek et al., 2000) using sampling with replace-
ment on the data set of the peak ECGs. For each ROC curve, the area under the curve
(AUC) and 95% confidence intervals were calculated. Differences in AUC were statisti-
cally compared usingHanley’smethod (Hanley andMcNeil, 1982) (MedCalc,Mariakerke,
Belgium).
Results
Recordings were acquired from 44 patients during PCI with balloon inflations in 45 coro-
nary arteries LAD: 11 (24.4%), LCX: 17 (37.8%), RCA: 9 (20%), and graft segments: 8
(17.8%). Patients were all male with an average weight of 88±15 kg, height of 178±6 cm,
and body surface area of 2.07±0.18 m2. The average recording time was 113±45 minutes
(range: 22–238 minutes), with an average time to peak of 79±13 minutes. Average dura-
tion of coronary occlusion by balloon inflation was 67 seconds (range: 10–175).
A total of 33 recordings showed ST deviations ≥ 100 µV at peak relative to baseline.
The most frequent leads with peak ST deviations were observed in V2: 11 (33.3%), fol-
lowed by III: 8 (24.2%), and V4: 4 (12.1%). Regional changes were spatially distributed
over the sites: anteroseptal 18 (54.5%), inferior 10 (30.3%), and lateral 5 (15.2%). SUMST
for all 12 leads was 518 µV (range: 150–1707) at baseline and increased to 730 µV (range:
171–2079) at peak.
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Figure 6.1:Median (inter-quartile range) ST differences between the 12-lead ECG and the derived
ECGs from the EASI, general, and patient-specific methods at baseline and at balloon inflation
(peak); p<0.05; p<0.01 in Wilcoxon rank test.
STmeasurements
Median absolute ST differences for EASI, GEN and PS are presented in Figure 6.1 for all
leads at baseline and peak. For EASI, the highest median absolute ST60 differences were
observed in the inferior leads II, aVF, and III. Median absolute ST differences in the limb
leads for EASI were overall higher than in the precordial leads, but were less pronounced
at peak.
For GEN, the highest absolute ST60 differences were found in the anteroseptal leads
V1-V3 at baseline and at peak. Compared with EASI, the maximum absolute ST60 differ-
ence of 21 µV in V3 at baseline was twice as low as the maximum difference of 43 µV in
lead III observed in EASI. At peak, median differences were overall larger.
The highest median ST60 differences for PS were found in anterior leads V2 and V3.
Overall, absolute median ST60 differences were twice as low as GEN. At peak, median
absolute ST differences in leads V2-V4 for PS remained lower than EASI and GEN, but the
differences and inter-quartile ranges in leads V1, V5, and V6 for PS were similar to GEN
and EASI.
Accuracy of regional and overall ST changes
Overall, regional ST changes were also found in the derived ECGs of EASI (p=0.639), GEN
(p=0.311), and PS (p=0.261). Absolute ST differences between the original and derived
peak leads were for EASI: 163 µV (CI: 90–236, p<0.001), GEN: 46 µV (CI: 2–91, p=0.40),
and PS: 16 µV (CI: 3–30, p=0.15).
SUMST difference was for EASI: 49 µV (CI: 19–220, p=0.02), GEN: 48 µV (CI: -43–154,
p=0.26), and PS: 20 µV (CI: -51–32, p=0.65). SUMST ROC curves for EASI, GEN, and PS
are presented in Figure 6.2. AUC was for EASI: 88.6% (CI: 82.5–94.7, p=0.02), for GEN:
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Figure 6.2: Receiver operator characteristic curves for EASI, general, and patient-specific recon-
struction methods at varying levels of summated ST (SUMST).
96.1% (CI: 93.1–99.1, p=0.45), and for PS: 98.6% (CI: 97.4–99.8, p=0.61). Of these three
reconstruction methods, the AUC of EASI was statistically significant.
Table 6.1 contains the results of the detection of ischemia and evolving infarction
(Thygesen et al., 2000) and ST depression of the ECGs at baseline and peak for EASI,
GEN, and PS. While PS had an almost perfect agreement and kappa for both decision
rules, GEN and EASI missed several cases.
Waveformmorphology
Figure 6.3 contains the median and inter-quartile RMSE between the original and de-
rived ECGs for the three methods at baseline and at peak. At baseline, EASI, GEN and
PS had the largest RMSE in lead V3. Overall, EASI had the largest RMSE across all leads,
while PS had the lowest RMSE. At peak, median RMSE for EASI, GEN, and PSwere overall
higher than at baseline. The leads with the highest RMSE were for EASI and GEN lead V3
and for PS lead V2.
For EASI, frontal QRS axis angle differences were calculated at baseline and peak be-
tween the original and derived ECG. Differences were statistically significant at baseline:
37° (CI: 26–47, p<0.001), and at peak: 36° (CI: 24–47, p<0.001), but the angle difference
from baseline to peak did not change significantly.
Figure 6.4 shows the derived 12-lead ECGs from EASI, GEN, and PS at baseline. The
original 12-lead ECG is presented in row A. Row B contains all 12 ECG leads that were
reconstructed from the EASI leads. In rows C and D, leads V1, V3, V4, and V6 were recon-
structed usingGENandPS, respectively. Visual reconstruction differences are present for
EASI in the inferior leads, for GEN in precordial lead V1, and for PS in lead V3. However,
ST differences were small. Figure 6.5 presents the reconstructed ECGs at peak balloon
inflation. Overall, reconstruction performance was lower for all three derived ECGs. The
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Figure 6.3: Median (inter-quartile range) root mean square errors between the 12-lead ECG and
the derived ECGs from EASI, general, and patient-specific methods at baseline and at balloon in-
flation (peak).
highest ST differences were found for EASI in the inferior leads, and the highest ST dif-
ference for GEN and PS was observed in lead V3.
Discussion
The findings in this study show that several measurable differences were found between
the standard 12-lead ECG and the derived ECGs produced by the three methods tested.
The PS method had the best performance with the lowest absolute differences for lead-
specific peak ST deviations, overall SUMST and RMSE values. PS coefficients are tailored
for each individual, while GEN and EASI provide coefficients mathematically based on
large data sets that may be more applicable to some patients than to others. However,
PS requires the availability of a previously recorded 12-lead ECG for derivation of the in-
dividualized reconstruction coefficients. Thus, based on our findings, in clinical settings
where an initial resting ECG can be acquired, the PS method would support ongoing
monitoring using only 6 electrodes with very good accuracy. In clinical settings where an
initial ECG could not be acquired, 5- or 6-electrode monitoring would be more feasible
but with less accurate waveforms compared to standard 12-lead ECG.
GENdifferenceswere overall higher thanPS, butwere smaller thanEASI. In this study,
we applied a fixed lead subset of I, II, V2, and V5, but GEN performance depends on
placement of electrodes (Nelwan et al., 2004b; Horacek et al., 2002). Lower lead-specific
differences might be obtained if a different combination is selected based on other clin-
ical information, such as the infarct location. Drew et al. (2002) also used lead subset
technology, but used V1 instead of V2 to increase accuracy in atrial QRS morphology.
In this study, EASI showed the highest differences for both overall SUMST and lead-
specific ST measurements, and RMSE. EASI has been investigated in various settings in-
cluding ambulatory monitoring (Denes, 1992), in-hospital patient monitoring settings
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(Drew et al., 1996), and has been commercially available for several years. EASI requires
five electrodes placed on well-defined ECG locations, which may reduce artifacts and
noise. However, an important disadvantage of EASI is that all 12 leads, including the ex-
tremity leads, are derived. For EASI, the highest absolute ST differences and RMSE were
found in the inferior region, while both GEN and PS always contain the directly recorded
leads in this area.
Clinical implications
Statistically significant differences in AUC, SUMST, and PEAKST observed in comparing
digital waveforms in this studymay not always be clinically significant per se. In general,
less than 30 µV differences are about the width of the ink line in paper ECGs, and are
considered of little meaning in routine clinical use. However, for automated ischemia
detection algorithms in digital instruments, a 30 µV variation in borderline conditions
might have an important impact— for instance, if new ST deviation of 90 µV is recorded,
over-estimation by 30 µV would trigger an alarm if the threshold was set for new 100 µV
deviations. Thus, in addition to the direct measurement differences documented in this
study, derived ECG technologies will require careful integration into clinical monitoring
systems.
Another important clinical aspect of using derived ECGs for continuous monitoring
is reduction of noise artifacts resulting in uninterpretable ECG signals. The derived ECGs
showed overall less noise than the actual 12-lead ECG recording, but certain artifacts
can be introduced. In three recordings, the EASI derived ECG was for a certain period
completely unavailable as a result of a lead failure condition of electrode A. For GEN and
PS, monitoring still continues if one or two precordial leads have problems.
Study limitations
This study has several limitations. First, the total number of patients is relatively small.
However, the study was set up as a prospective, comparative, within-subjects study in
which patients served as their own controls. Furthermore, this study uses Mason-Likar
electrode positions instead of the standard extremity locations at the wrists and ankles.
Thus, this study did not directly compare the derived 12-lead ECGswith standard 12-lead
ECG. However, Mason-Likarmonitoring is preferred in clinical settings over the standard
extremity positions because of reduced interference ofmuscle artifacts and patient com-
fort.
Conclusion
Simultaneous direct comparison of the original 12-lead and derived ECGs from the EASI,
GEN and PS methods show significant differences across these methods. Median root
mean square errors, ST60 and SUMST differences were overall lower for the GEN and
PS methods than for EASI at baseline and during balloon inflation. PS has the lowest
measurement differences and the highest overall accuracy, and is preferred over GEN
and EASI.
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Abstract
Background
Electrocardiogram (ECG) variations due to changes in body position are a commonprob-
lem during continuous ECG and STmonitoring. Body position changes (BPC)may cause
QRS and ST-T changes, trigger false alarms, and may complicate diagnostic interpreta-
tion. The purpose of this study was to assess the effects of these changes and to develop
a detection and correction strategy.
Methods
Continuous 12-lead ECG recordings were obtained from 114 patients admitted to the
coronary care unit. Each patient underwent a body position test (supine, left, right,
and upright position). A body position change detector was developed using the Ex-
plore automated rule induction algorithm. To distinguish positional from ischemic
changes, a separate set of 71 PCI recordings was included with ECGs at rest and dur-
ing balloon inflation. ECG variations were corrected using a patient-specific mapping
technique based on a combination of leads. Performance of the correction method
was assessed by Pearson’s correlation coefficient and by similarity coefficient (SC =
1−RMSresidual /RMSsi gnal ).
Results
ST changes ≥ 100 µV in ≥ 1 lead caused by a body position change were observed in 50
(43%) patients. Most pronounced changes were found in the left-lateral position. With a
fixed specificity at 95%, sensitivity of the detection rules was for left: 97.4%, right: 69.9%,
upright: 64.3% and combined: 66.1%. False alarm rate per hour in the PCI set was 2.22
at rest and 4.31 during balloon inflation. Performance of the patient-specific correction
yielded an overall correlation coefficient of 0.970 and similarity coefficient of 0.889.
Conclusion
ECGchanges due toBPCaremost pronounced for the left-lateral position. BPCdetection
rules showed high but varying levels of sensitivity for each position. Accurate reconstruc-
tion of any position to the supine position is possible.
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Introduction
Awell-known problemduring continuous ECGmonitoring is that body position changes
(BPCs) may alter the surface 12-lead ECG. ECG variations may occur, such as changes in
R and S waves in the limb and lateral leads, sudden ST-segment shifts and/or T-wave
inversions, which may trigger false alarms during continuous ECG and ST monitoring
(Adams and Drew, 1997; Jernberg et al., 1997; Norgaard et al., 2000; Pharand et al., 2003).
Detection of body position changes is important to avoid misclassification of is-
chemic episodes. Recently, methods to detect these body position changes have been
proposed on ECG parameters only (Shinar et al., 1999; Astrom et al., 2003; Garcia et al.,
2003), while other investigations (Adams and Drew, 2002; Ng et al., 2003) proposed de-
tection with auxiliary devices such as small accelerometers which detect gravitational
changes. Although these detection methods show promising results, detected episodes
would leave a gap in the ST trends, making retrospective ST-segment analysis difficult.
The aim of this study was to investigate the effects of body position changes on the
ECG, and to develop methods to detect and correct for these changes.
Methods
Data sets
Two different data sets were used. The first data set consisted of patients who were ad-
mitted to the coronary intensive care unit due to chest pain or suspicion of acutemyocar-
dial infarction and who were able to undergo a body position test. A total of 114 patients
participated in the study. The patients were predominantly male (n=93, 83%) with an av-
erage age of 60 years (range 20–85) . Of these patients, 59 (51.8%)were admittedwith (un-
stable) angina pectoris, 44 (38.6%) were diagnosed with acute myocardial infarction and
the remaining 11 (9.6%) patients were admitted for other cardiac reasons. Patients were
prospectively monitored using a patient monitoring device with continuous 12-lead ST
monitoring capabilities (SC7000, Siemens Medical Systems, Danvers, USA). Electrodes
were placed on monitoring compatible locations according to Mason and Likar (1966).
All ECGs were recorded at a sample rate of 500 Hz with a least significant bit of 2.5 µV.
A body position test was performed as soon as the patient was haemodynamically
stable and free of chest pain and ongoing ischemia. During the body position test, the
patient was asked to move into the positions: supine, left-lateral, supine, right, supine,
and in a 60 degrees upright position. Each position was maintained for five minutes. A
10-second, 12-lead ECG was recorded in the middle of this period in order to minimize
possible ST artifacts and heart rate changes as a result of turning. The time of the body
position change was marked on the patient monitor. All body position tests were per-
formed by the same investigator, who was informed of the purpose of this study.
A second data set consisted of 71 patients (allmales, 63± 12 years) undergoing percu-
taneous coronary intervention procedures (PCI data set). For each patient, continuous
12-lead ECG data was recorded 30 minutes prior to and after the PCI procedure with the
same type of Siemens patient monitoring equipment as was used for the body position
data set. At the start of the procedure, a 5-minute 12-lead baseline ECG (baseline) was
marked. ST changes indicative of ischemia during the baseline recordings were consid-
ered unlikely. Another ECG (inflation) was marked at balloon inflation. The inflation
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ECG was started one minute prior to the marked first balloon inflation and continued
for four minutes. An inflation ECG may contain multiple balloon inflations and one or
more ST changes. The study group and protocols have been described previously (Nel-
wan et al., 2004a).
Data analysis
ECG measurements, including QRS and T-wave amplitudes, frontal QRS axis and ST60
values for each lead were processed with the Modular ECG Analysis System (MEANS).
MEANS computes representative averaged complexes for each of the 12 leads fromwhich
ECGmeasurements are derived. MEANS is also capable of reconstructing the vectorcar-
diographic X, Y, and Z leads on the basis of the standard ECG leads. MEANS has been
extensively evaluated and validated in several clinical and preclinical settings (van Bem-
mel et al., 1990; Willems et al., 1991). Average complexes were computed every 10 sec-
onds over the entire observation period for the recordings in both data sets. MEANS also
computed the spatial angle between the QRS and T loops, spatial J amplitude, and max-
imum spatial T amplitude.
Body position detection
The detection method is based on the assumption that a body position change shifts
the chest electrodes relative to the heart. As a result, the dominant R and T peaks may
shift spatially, but the change should not alter global measurements, such as the angle
between the QRS and T wave or the spatial vector magnitude.
Parameter differences between the supine and the left, right, or upright positionwere
computed and each position ECG was labelled. To distinguish position changes from is-
chemic changes, we included the PCI data set (Nelwan et al., 2004a). Parameter differ-
ences were computed between the baseline and the first marked balloon inflation ECG.
Using both data sets, classification rules were automatically generated using the
Explore rule induction algorithm (Rijnbeek et al., 2000, 2001). Explore exhaustively
searches the rule space for optimal decision rules with respect to user-selected perfor-
mancemeasures, such as sensitivity and specificity. Rule inductionwas performed using
10-fold cross validation with separate learning and test sets.
The body position change detector was designed to separate the different positions
from ischemic changes given an ECGwith ST-T changes. Explorewas set up tomaximize
sensitivity with a minimum level specificity of 95% for the detection of each position
change separately and for any position (combined) versus ischemic change. Secondly,
we set up Explore to search for a combined decision rule based on spatial parameters
only in order to reduce dependency of single ECG leads in which noise or lead failure
might cause false positives.
The intendeduse of the body position detectorwould be in a clinical situationwith an
ST alarming functionality. In patientmonitoring, ST alarms are set to detect an ST change
of a certain threshold (≥ 100 µV) in one or more leads lasting ≥ 1 minute (Klootwijk,
1998). In order to rule out ST alarms caused by patient movement, a positive body posi-
tion detection can be used to suppress or advise the clinician to ignore the ST alarm. For
the purpose of assessing the number of false positive body position detections during
patient monitoring, we applied the decision rules on the 5-minute baseline and balloon
inflation ECGs and computed the number of false alarms per hour. In this study, the
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latency time of the ST-change detector was reduced to 30 seconds, because the balloon
inflations in the PCI data set were ≤ 1 minute.
Body position correction
The body position correction method is based on the recorded body position test. Each
knownposition can bemapped to the supine position for each of the 12 leads by stepwise
multiple linear regression (Galassi et al., 2000). With this approach, all available informa-
tion is used to reconstruct each lead, but variables with little contribution are discarded
from the fit.
Because the reconstruction technique is patient-specific, a second body position test
was performed and was used for the test set. Overall reconstruction performance was
assessed for each lead using Pearson’s correlation coefficient and the average of these
12 correlation coefficients was taken. Reconstruction performance per lead was also as-
sessed using the similarity coefficient (SC = 1−RMSer ror /RMSsource ) (Kornreich and
Rautaharju, 1981), and then averaged over the 12 leads.
Statistical analysis
Differences are presented asmean± standard deviation ormedian (inter-quartile range),
where appropriate. Differences in baseline characteristics were evaluated by t-test or by
χ2-test. Paired t-tests were employed for within-patient ECG differences caused by body
position changes. Classificator performances were evaluated with sensitivity, specificity,
and accuracy. A p-value of <0.05 was considered significant.
Results
Initial ECG characteristics
Compared to the reference ECG in supine position, 50 of 114 (43%) patients showed
marked ST changes (|∆ST| ≥ 100 µV in ≥ 1 lead) in one or more positions. A comparison
of the characteristics of patients with or without ST changes is presented in Table 7.1. Pa-
tients with or without position change had a similar age, gender and BMI composition.
In the group of patients with ST changes, initial summated ST60, spatial J amplitude, and
spatial QRS-T angle were larger.
ECG changes
An example of a patient with a frontal QRS axis change of 30 degrees caused by body po-
sition is shown in Figure 7.1. Local T-wave inversion is present in lead V5 of the supine
position (row A) and disappears in the left position (row B). Other ECG changes caused
by turning to the left-sided position are the decrease in RV4 and elevation of STV4 . Fig-
ure 7.2 presents the frontal QRS axis and ST60 trends in leads V3-V6 during the night and
morning of the same patient. During the night, the patient moved into several positions
and sudden shifts in the lateral leads can be observed.
Table 7.2 presents the average ST60 differences and the number of occasions in which
the differences were ≥ 100 µV for each position change. The largest differences were
found for the left-sided position in anterolateral leads V3-V6. The maximum absolute ST
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Table 7.1: Characteristics of patients with or without ST changes ≥ 100 µV in ≥1 lead caused by
body position changes (n=114).
Characteristic No ST Change (n=64) ST Change (n=50) p-value
Demographics
Men (n,%) 54 (84) 39 (78) 0.068
Age (years, range) 58 (32 – 79) 60 (20 – 85) 0.361
BMI (kg/m2) 26.8 ± 3.68 25.6 ± 3.79 0.083
Discharge Diagnosis 0.068
Myocardial infarction (%) 19 (30) 25 (50)
Angina pectoris (%) 39 (60) 20 (40)
Other (%) 6 (10) 5 (10)
ECG
HR (bpm) 67 ± 15 77 ± 19 0.004
LVH (%) 4 (6.3) 9 (18) 0.05
Summated ST60 (µV) 536 ± 244 872 ± 468 <0.001
Frontal QRS Axis (°) 28 ± 51 21 ± 63 0.195
Frontal T Axis (°) 26 ± 82 16 ± 101 0.237
Spatial QRS-T angle (°) 65 ± 49 83 ± 61 <0.001
Spatial J amplitude (µV) 70 ± 48 88 ± 62 <0.001
Spatial Tmax (µV) 321 ± 137 320 ± 139 0.984
Table 7.2: ST differences (µV) caused by a position change and number of leads ≥ 100 µV for all
patients (n=114).
Supine→ Left Supine→ Right Supine→Upright
∆ST (µV) ≥ 100 µV ∆ST (µV) ≥ 100 µV ∆ST (µV) ≥ 100 µV
I 4 ± 21 – 4 ± 17 – 6 ± 25 –
II -4 ± 18 – -3 ± 33 – 0 ± 16 –
III -9 ± 17 – -6 ± 36 – 0 ± 14 –
aVR 1 ± 14 – 0 ± 20 – 0 ± 18 –
aVL 6 ± 21 – 5 ± 23 – 0 ± 13 –
aVF -7 ± 18 – -5 ± 33 – 0 ± 15 –
V1 -3 ± 22 2 11 ± 34 – 5 ± 21 –
V2 -15 ± 39 3 -8 ± 52 4 0 ± 29 1
V3 12 ± 40 5 12 ± 81 2 -6 ± 24 –
V4 30 ± 50 11 16 ± 79 4 -2 ± 26 –
V5 3 ± 60 9 2 ± 55 1 2 ± 16 –
V6 -18 ± 47 9 -3 ± 26 2 0 ± 16 –
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difference was 233 µV in lead V4. For the right-sided position, differences were smaller
and were located in the anterior leads V2-V4. Changes in the upright position were gen-
erally small and were overall 0 in the limb leads. For all positions, ST changes ≥ 100 µV
were not found in the limb leads.
Spatial ECG changes are reported in Table 7.3 for all patients. The smallest and largest
frontal QRS axis differences were observed for the respective changes to upright and left
position. Compared with the frontal QRS axis, the frontal T axis difference was higher for
the left and right position change, but also showed a larger variation. Overall, the largest
differences for the spatial parameters were found for the left position change and the
lowest for the upright position.
Table 7.3: Spatial ECG differences for each body position change (n = 114).
Measurement Supine→ Left Supine→ Right Supine→Upright
∆ Frontal QRS Axis (°) 15.0 ± 17.5 12.7 ± 14.6 6.1 ± 5.1
∆ Frontal T Axis (°) 22.3 ± 41.2 24.6 ± 55.5 8.9 ± 10.8
∆ Spatial QRS-T Angle (°) 17.5 ± 15.5 16.0 ± 18.7 12.4 ± 9.7
∆ Spatial J Amplitude (µV) 11.3 ± 20.1 7.5 ± 23.0 -3.1 ± 15.1
∆ Spatial Tmax (µV) 49.2 ± 62.6 13 ± 71.3 -12.7 ± 42.1
Body position detection
Table 7.4 presents the detection rules for each position and the detector performance
with a fixed specificity of at least 95% in discriminating between any position versus bal-
loon inflation. The upper part of Table 7.4 contains detection rules for use on any ECG.
The lower part of the table contains detection rules which require an ST-change detector
(|∆ST| ≥ 100 µV in ≥ 1 lead).
Sensitivity of the detection rule for the left-lateral position was higher than other
rules. Sensitivity of the rule with spatial measurements only was low. Sensitivity of the
combined detection rule for all body positionswas higher. If specificity was lowered from
95.7% to 91.3%, sensitivity of the combined detection rule would increase to 92.1%. Op-
timal detection rules contain R and S amplitudes of the limb and lateral (I, V5, and V6)
leads.
The detection rules optimized for use after detection of a marked ST change
(|∆ST| ≥ 100 µV in ≥ 1 lead) show increased sensitivity and specificity of up to 100% for
the left-lateral detection rule. Because of the low number of cases with ST changes in
the upright position (cf. Table 7.4), detection rules were computed using the left or right
position only.
Table 7.5 presents the false alarm rate per hour of the body position detection rules
applied on the 5-minute baseline and balloon inflation recordings. The total available
recording time was 10 hours and 45 minutes. A total of 17 ST events were detected at
baseline and 59 during balloon inflation. Multiple balloon inflations may have occurred
in a single patient and ST changes may not have reached the threshold of 100 µV in oth-
ers.
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Table 7.5: False alarm rate per hour of the body position detection rules applied on baseline and
balloon inflation recordings (total recording time 10 hours and 45 minutes).
Detection rule Baseline Balloon inflation
Left 2.03 3.56
Right 1.11 5.81
Upright 0 0.56
Combined Spatial parameters only 3.14 5.95
All parameters 2.22 4.31
|∆ST| ≥ 100 µV in ≥ 1 lead
Left 0 0.75
Right 0 0
Combined Spatial parameters only 0 0.93
All parameters 0 0.75
The highest false alarm rate of the body detection rules was found for the rules using
spatial parameters only at baseline and at balloon inflation. The lowest false alarm rate
was observed for the upright position. In combination with an ST-change detector, the
false alarm rate of all detection rules dropped to 0.75 at balloon inflation.
Body position correction
Table 7.6 presents median correlation and similarity coefficients for the correction of
the left, right, and upright to the supine position. Overall, high median correlation and
similarity coefficients were observed. The highest overall correlation and similarity were
found for the correction of the upright position, but differences with the other two cor-
rections were small.
Table 7.6:Median (inter-quartile range) correlation and similarity coefficients of the body position
correction method between the left, right, and upright position.
Position Correlation Similarity Coefficient QRS Axis Difference (°)
Left 0.964 (0.921 – 0.985) 0.883 (0.802 – 0.921) 2 (1 – 4)
Right 0.967 (0.946 – 0.973) 0.901 (0.830 – 0.933) 2 (-1 – 6)
Upright 0.975 (0.937 – 0.991) 0.911 (0.880 – 0.941) 1 (0 – 3)
Figure 7.2 shows a retrospective patient-specific correction of the left-lateral body
position change during the night based on the body position test that was performed
between 9:00 and 10:00 the following morning.
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Discussion
In this study, ECG changes caused by body position changeswere investigated. Detection
rules and a patient-specific correction method were developed and evaluated.
Body position change
ST changes of ≥ 100 µV as a result of body position changes occurred in 50 of the 114
(43%) patients and could be identified as a clinically significant ST change. Body position
changes were most pronounced in the left-lateral position and least pronounced in the
upright position. Body position changes caused ST changes of≥ 100 µV in the precordial
leads only.
Body position detection
In this study, body position detection rules were developed for two strategies. First, rules
were developed for the detection of body position changes versus ischemic changes. Sec-
ond, detection rules were optimized for use with a standard ST-change detector as com-
monly used in clinical practice. High to very high sensitivities at a fixed sensitivity of 95%
were observed for both strategies.
Automated detection of body position changes can also be performed using scalar
and spatial techniques described in another study by Garcia et al. (2003). These inves-
tigators developed an ECG-based body position detector and report sensitivity between
89% to 95% with a specificity rate up to 97 ± 5% in a group of 20 volunteers performing
several body position tests. The body position detector in our study had a lower sen-
sitivity, but a direct comparison cannot be made because our detector was designed to
separate body positions from ischemia. Garcia et al. (2003) have also tested their method
in a group of 83 angioplasty recordings. A false alarm per hour rate was reported of 2–4
at baseline and 7–11 during balloon inflation. In this study, lower false alarm rates were
found for the detection rules with or without the use of an ST-change detector.
Use of external devices, such as motion detectors or accelerometers might be a more
direct way ofmeasuring the position change and prior studies by Adams andDrew (2002)
andNg et al. (2003) show promising results. An auxiliary device requires additional train-
ing and can be a source of errors as a result of artifacts. Amore advanced approachmight
be video recording and computer image recognition of the patient’s position. However,
the presented body detection rules in this study do not require additional devices and
can easily be applied with the available ECG equipment.
Body position correction
The body position correction method shows very high reconstruction performance re-
sults, but it requires a previously recorded body position test from each patient. If the
body position is known (either from a body position detector or from other observa-
tions), the ECG can be corrected to supine position. An advantage of thismethod is that it
is possible to lessen the effect of body position changes during an ischemic event, so that
only ST changes caused by ischemia may be present. Unfortunately, we did not observe
such events in our data sets.
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Study limitations
Several study limitations can be identified. First, we did not prospectively analyze body
position changes during a long-term stay of the patient at the intensive care. Further-
more, to represent ischemic episodes on the ECG, we used PCI database recordings with
ST changes caused by balloon inflation. In intensive care settings, ischemic events may
appearmore gradual over time and themagnitude of changesmay be less. Further inves-
tigation on a data set of long-term recordings and verifiable body position is advisable.
Conclusion
In conclusion, this study confirms that ECG changes as a result of body position changes
are frequent and can be identified as clinically significant ST changes. Furthermore, the
body position detection rules in this study show high sensitivity and can be applied by
clinicians or by a computer. Lastly, the body position correction method can be applied
to remove body position changes in the waveforms.
Appendix
The presented optimal body position detection rules require measurements from the 12-lead ECG
and VCG. These measurements can be difficult to compute by patient monitoring devices with
limited processing power andmemory resources. The following rules were determined by Explore
and only require 12-lead ECGmeasurements. Minimum sensitivity was set at 95%.
Position Best detection rule Sensitivity (%)
Left ∆RI <−152 or ∆RV6 > 245.5 or ∆SV6 ≤−56.5 97.4
Right STaV F ≤ 37.5 and RAV F > 25.5 and RV 2 ≤ 191 68.8
Combined STaV F ≤ 37.5 and RI ≤−70.5 or RV6 > 276 66.1
Detection rules for use with |∆ST| ≥100 µV in ≥1 lead
Left 1 ∆RV6 ≥ 280 or SV6 ≤−55 100
Right 1 ∆SV2 >−33 and SV5 ≤−127.5 or RaV R > 64.5 80
Combined 2 ∆RV6 > 280 or SV2 ≤−615 or SV6 ≤−42.5 91.2
1 specificity: 100%, 2 specificity: 97.4%
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Abstract
Introduction
Electrode positions for continuous 12-lead ECG monitoring are different from those for
recording a standard 12-lead ECG. To reduce noise and to minimize false alarms, prox-
imal placement of the limb leads is preferred over the standard location at the wrists
and ankles. Differences are often associated with frontal QRS-axis shifts, disappearing Q
waves, and marked changes of R amplitudes in the extremity leads. This study presents
general and patient-specific reconstruction methods to correct for these changes.
Methods
A simultaneously acquired 9-lead ECG in standard and monitoring positions was recor-
ded in 88 patients. Data was split into a learning (n=30) and test set (n=58). General
reconstruction coefficients were computed from the learning set and applied to the test
set. Patient-specific coefficientswere also computed and applied. Performancewas eval-
uated using a similarity coefficient (SC = 1−RMSresidual /RMSsi gnal ) and frontal QRS
axis angle difference (∆ 6 QRS, monitoring – standard). Accuracy was tested with paired
t-tests (p<0.05).
Results
Median (inter-quartile range) SC between standard and monitoring ECGs was for lead I
0.737 (0.595–0.777) and lead II 0.687 (0.613–0.778), and∆6 QRSwas 13 (4–25)°(p< 0.001).
For general reconstruction, SC was for lead I 0.770 (0.672–0.815) and lead II 0.866 (0.783–
0.918), and ∆6 QRS was 2 (-3–12)°(p = N.S.). For patient-specific reconstruction, the re-
spective SC were 0.891 (0.828–0.933) and 0.927 (0.865–0.950), and ∆6 QRS 0 (-1–3)°(p =
N.S.).
Conclusions
Reconstruction of ECG leads from monitoring positions to standard positions is possi-
ble using general and patient-specific coefficients. Patient-specific reconstruction per-
formance is overall higher than general reconstruction, but requires the recording of an
additional ECG.
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Introduction
During continuous ECGmonitoring, proximal placement of the extremity electrodes (LA,
RA, LL, and RL) on the torso is often preferred over the positions of the standard resting
ECG at the wrists and ankles. In these situations, the torso positions proposed by Mason
and Likar (1966) reduce noise andminimize false alarms as a result of motion artifacts.
However, previous investigations (Sevilla et al., 1989; Pahlm et al., 1992; Krucoff et al.,
1994; Bartosik et al., 1995; Jowett et al., 2005) have indicated that the change to proximal
electrode positionsmay produce a different 12-lead ECG. Changes between the standard
and monitoring ECG may vary from sudden frontal QRS-axis shifts, changes in Q waves
in the inferior leads, to marked changes in R amplitudes in the extremity leads (I, II, III,
aVR, aVL, and aVF). The influence of the proximal placements on the precordial leads and
on the ST-T segment during percutaneous coronary interventions was found minimal
(Krucoff et al., 1994).
The primary purpose of this study was to investigate the effect of the lead placement
on the ECG in a routine practice and to investigate methods to correct for these changes
using general and patient-specific reconstruction methods.
Methods
Study population
The study population consisted of 93 subjects who were admitted to the coronary in-
tensive care unit of the Erasmus MC due to chest pain or suspicion of acute myocardial
infarction. The patients were randomly selected over a period of 18 months (January
2000 to June 2001). The study group was predominantly male (71 of 93) with an average
age of 62 years (range 32–86). At the start of each recording, all patients were haemody-
namically stable and free of chest pain, ongoing ischemia or infarction.
ECG recording
For each patient, two 9-lead ECGs were simultaneously recorded using a standard 12-
lead ECG patient monitor (SC7000, Siemens Medical Systems, Danvers, USA). This con-
figuration was described by Pahlm et al. (1992) and allows simultaneous recording of the
limb leads in standard and in monitoring positions. In this modified 12-lead configura-
tion, the electrodes V2, V3, and V5 remain on the standard chest positions, while the V1,
V4, and V6 electrodes aremoved to theMason-Likar (Mason and Likar, 1966) monitoring
positions of RA, LA, and LL. Figure 8.1 contains the positions on the chest. With these
electrode measurements, the limb leads can be computed off-line for the monitoring
positions.
The ECGswere recorded at a sampling rate of 500Hzwith a resolution of 2.5 µV, for 10
seconds and were processed with the Modular ECG Analysis System (van Bemmel et al.,
1990). For both 9-lead recordings, average representative beats and measurements were
computed. All recordingswere inspected visually. A total of five recordingswere excluded
because of excessive noise.
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V1 (RA) V4 (LA)
V6 (LL)
Figure 8.1: Alternative placements of the electrodes V1, V4, and V6 on the monitoring locations
RA, LA, and LL. Illustration © Siemens/Dräger Medical Systems, Inc., used with permission.
ECG reconstruction
The study group was split into a learning set consisting of the first 30 patients and a test
set of the remaining 58 patients. General reconstruction coefficients for leads I and II
were computed by linear regression from the monitoring to the standard leads of the
learning set and were applied to each recording.
The following equations were used for reconstruction of a standard ECG from the
recorded signals on the monitoring positions:
Ir = c1Im + c2I Im
I Ir = c3Im + c4I Im (8.1)
Im and IIm denote the limb leads in monitoring position and, Ir and IIr the recon-
structed ECGs representing the standard position. Patient-specific reconstruction coef-
ficients for each ECG were also computed in a similar way.
Overall waveform similarity was assessed by a similarity coefficient (SC) (Kornreich
and Rautaharju, 1981) between the complexes of the original and reconstructed leads I
and II over the samples of the QRS-T interval. SC is defined as:
SC = 1.0− RMSresidual
RMSsi gnal
(8.2)
In addition, we compared the R amplitudes, ST-segment levels 60 ms after the J point
for leads I and II, the difference of the Wilson central terminal and the angle difference
of QRS axis in the frontal plane between the original and reconstructed ECGs. Corre-
lation coefficients (CC) were also calculated, as these measurements are widely used to
compare similar data. However, a CC is nonlinear and it is only reported next to the SC.
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Figure 8.2: Median R amplitudes and differences, similarity and correlation coefficients of the
standard and monitoring positions for the extremity leads (n=88). p<0.01 for all extremity leads,
except for -aVR (p<0.22).
Results are presented as median (inter-quartile range) or mean±SD, as required.
Paired t-tests were used to compare differences between continuous variables. A value
of p<0.05 was considered significant.
Results
ECG differences
Figure 8.2 contains the R amplitudes and differences, correlation coefficients, and simi-
larity coefficients over the complete data set (n=88). Overall, substantial differences were
found between the ECGs in standard and monitoring positions. R amplitudes of leads
aVL and I were lower in monitoring position (p<0.001), but were higher in the leads -aVR
to III (p<0.001). Differences between the central Wilson terminals were small (2±11 µV)
and remained in the order of the quantization level. Qwaves diminished in six recordings
with the electrodes in monitoring position.
The median (inter-quartile range) frontal QRS axis was for the standard positions 8
(-25–43) degrees and for the monitoring positions 37 (-21–66) degrees. The mean differ-
ence of the frontal QRS axis was 16 (4–25) degrees (p<0.001). Rightward frontal QRS-axis
shifts were observed between the standard and monitoring limb leads. QRS-axis angle
differences > 30 degrees were found in 21 cases (23.8%). In 6 (7%) cases, an abnormal
left-axis deviation in the frontal QRS axis (-90 to -30 degrees) was observed in the stan-
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Table 8.1: Similarity results between leads derived from electrodes in monitoring and standard
position for general and patient-specific reconstruction methods in the test set (n=58).
No reconstruction General Patient-specific
Similarity Coefficient
I 0.737 (0.595 – 0.777) 0.770 (0.672 – 0.815) 0.891 (0.828 – 0.933)
II 0.687 (0.613 – 0.778) 0.866 (0.783 – 0.918) 0.927 (0.865 – 0.950)
∆R amplitude (µV)
I -141 (-236 – -51)a -74 (-156 – 20)b -9 (-24 – 6)
II 163 (80 – 288)a 7 (-30 – 56) 1 (-11 – 10)
∆ST60 (µV)
I 3 (-10 – 18) 8 (-9 – 20) 1 (-9 – 11)
II -5 (-19 – 9)c -4 (-16 – 9)b -3 (-15 – 4)c
Frontal QRS Axis (°) 41 (-17 – 68) 22 (-24 – 53) 17 (-24 – 53)
Angle difference (°) 13 (4 – 25)a 2 (-3 – 12) 0 (-1 – 3)
a p<0.001, b p<0.01, c p<0.05
dard ECG and was shifted into the normal range (-30 to 90 degrees) in the monitoring
ECG. In 4 (5%) cases, a normal QRS axis resulted in a right-axis deviation (> 90 degrees).
ECG reconstruction
Similarity results of the standard and monitoring ECGs, before and after general and
patient-specific reconstruction, are presented in Table 8.1. Results are presented for the
independent limb leads I and II only. Lead III and the augmented leads can be calculated
from leads I and II without error.
Median SCs between the standard and monitoring leads were moderately high
(≥ 0.687) for leads I and II and increased after reconstruction. Patient-specific recon-
struction had higher SCs than general reconstruction. Median SCs of lead II were overall
higher than those computed for lead I. Correlation coefficients (data not shown) showed
a similar performance increase from general to patient-specific reconstruction.
MedianR-amplitude difference in lead I decreased by 50% for general reconstruction,
and were very small for patient-specific reconstruction. For general and patient-specific
reconstruction, median R amplitude difference was small in lead II. However, the inter-
quartile range for general reconstruction was wider than for patient-specific.
ST60 measurements were small in the standard and monitoring ECGs. Median ST60
of the standard positions were for lead I -13 (-50–13) µV and lead II 11 (-21–53) µV, respec-
tively. Median ST60 differences were overall small in the uncorrected situation. General
and patient-specific reconstruction did not reduce these differences.
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The median QRS axis angle difference after general and patient-specific reconstruc-
tion was reduced to 1 and 0 degrees, respectively. However, general reconstruction had a
wider inter-quartile range than patient-specific reconstruction.
Patient-specific performances were overall higher than general. However, the recon-
structed waveforms of general reconstructionwere visually similar to the standard wave-
forms in most patients. Figure 8.3 shows an example of a corrected recording using gen-
eral and patient-specific coefficients.
The general reconstruction coefficients are based on a relatively small subset of 30
patients. To present general purpose coefficients for use in clinical practice, we also
computed generalized reconstruction coefficients from our complete data set. Table 8.2
contains the general coefficients based on the complete data set for the conversion to
and from the standard andmonitoring leads. While we could not compute performance
results, the presented coefficients were very similar to those from the learning set of 30
patients. However, a separate performance analysis should be carried out on an inde-
pendent data set.
Table 8.2: Coefficients calculated over the learning set for reconstruction of amonitoring to a stan-
dard ECG and coefficients calculated over the complete set (n=88).
Coefficient Monitoring to standard Standard to monitoring
C1 0.9897 0.863
C2 0.1091 -0.057
C3 -0.0699 0.116
C4 0.8229 1.121
Discussion
This study shows that extremity electrode positions from standard to monitoring pro-
duce significant changes inmorphology and in QRS and ST-segmentmeasurements, but
changes were small in the central Wilson terminal and in the precordial leads. These re-
sults support observations from earlier studies (Pahlm et al., 1992; Krucoff et al., 1994;
Jowett et al., 2005).
Practical application
In this study, methods were developed that allow reconstruction of the standard ECG
frommonitoring positions using general and patient-specific coefficients and vice versa.
General reconstruction performs worse than patient-specific. A practical application of
thesemethods is that ECGs recordedwith a patientmonitor can be corrected to allow se-
rial comparison with previously recorded standard ECGs. The presented reconstruction
techniques can also be applied to online ECG monitoring and full disclosure waveform
storage. Review and analysis of recorded data with previously recorded standard 12-lead
ECGs is possible. The reconstruction coefficients are well-suited for implementation in
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ECG monitoring equipment. General and patient-specific reconstruction require a lim-
ited amount of extra computer processing time (fourmultiplications) and aminimal user
input for selection of the appropriate electrode configuration. For patient-specific recon-
struction, an additional 9-lead ECG is required, but this increases the accuracy.
In a previous investigation by Bartosik et al. (1995), general coefficients were also
computed from a set of 30 patients. The limb leads in this study were mapped from po-
sitions introduced by Krucoff et al. (1990) to standard positions. The extremity electrode
positions of Krucoff are closely positioned to the Mason-Likar positions. Therefore, we
also applied the coefficients published by Bartosik et al. (1995) to our data set. Median
(inter-quartile) SC for leads I and II were 0.650 (0.389–0.800) and 0.687 (0.613–0.777),
respectively. The median angle difference of the frontal QRS axis was 2 (-6–7) degrees.
These results were slightly worse than the results based on our general reconstruction.
General reconstruction coefficients can only be used on the intended electrode posi-
tions. Patient-specific does not have this restriction, provided that the electrode posi-
tions do not change during monitoring.
Study limitations
There are several study limitations. The study population is of a modest size, which may
restrict the generalizability of the presented results. To address the variability of the re-
construction coefficients, we determined coefficients from the test set and applied those
on the learning set. Overall, reconstruction performance was comparable with the data
in Table 8.1. Differences between the coefficients of Table 8.2 and those from the learning
set and test set were also small.
Furthermore, general reconstruction performance depends on the correct placement
of the extremity electrodes. The Bartosik coefficients perform worse on the monitoring
location we used. We do not know of any standardized electrode placement for ECGmo-
nitoring. For this reason and for additional accuracy, we recommend using the patient-
specific technique, which is not influenced by the exact electrode positions.
Conclusion
Reconstruction of ECG leads from monitoring positions to standard positions is possi-
ble using general and patient-specific coefficients. Patient-specific reconstruction per-
formance is overall higher than general reconstruction, but requires the recording of an
additional ECG.

9Discussion
90 Chapter 9
Introduction
Over the years, the goals of continuous ECG monitoring have expanded from single-
lead rhythm monitoring to the detection and classification of cardiac arrhythmias
and dynamic assessment of ST-segment changes (Krucoff et al., 1988; Veldkamp, 1996;
Klootwijk, 1998). Present day patient monitoring systems are equipped with full 12-lead
ECG acquisition modules, are integrated in a monitoring network, and are able to store
all ECG leads (full disclosure) for retrospective analysis. Despite these technological ad-
vancements, it is often difficult in clinical practice to manage a good quality, long-term,
continuous registration of the ECG for several reasons:
• Technical limitations
Aside from proper recording procedures with appropriate electrodes and careful
skin preparation (Schijvenaars, 2000), slight electrode misplacements are not un-
common in standard and precordial leads. Multiple electrode changes, such as
a change from the standard 12-lead ECG to the Mason-Likar system (Mason and
Likar, 1966), remain difficult to detect without additional user annotation.
Patient monitoring devices are often different from regular 12-lead electrocardio-
graphs in various aspects. For correct interpretation of ECG waveforms, patient
monitors should be set to the correct diagnostic frequency (0.05–150 Hz) (Bailey
et al., 1990) even though these frequencies may fail to remove muscle artifacts or
respiration induced baseline wander. Furthermore, ECG monitoring devices may
not support all ten standard ECG wires, because of technical limitations or as a
result of size and price tradeoffs. In particular, telemetry transmitters often only
support configurations with five electrodes (seven leads).
• Patient variations
Patient variations, such as increased perspiration, may have a detrimental effect
on the quality of the recording. These variationsmay cause low frequency noise, or
baseline wander or high frequency distortions of the ECG. Dynamic changes dur-
ing the recording period, such as body position changes, may also produce chan-
ges in the ECG and may generate false alarms (Adams and Drew, 1997; Jernberg
et al., 1997; Norgaard et al., 2000).
• Patientmanagement
Patientmonitoring systems are designed to process signals and to alarmwhen cer-
tain thresholds are exceeded. The presence of low signal amplitudes or artifacts
results in false alarms, which may burden the medical staff. With an increasing
number of lead wires to manage next to other cables such as infusion lines and in-
struments, false alarmsmay also increase. Systems requiring fewer electrodesmay
alleviate parts of these patient management problems.
An essential part of patient monitoring is the ability to detect changes in a patient’s
condition. For derived 12-lead ECG systems, accurate detection of those changes ismore
important than the precise reproduction of the reconstructed waveforms.
The aims of the thesis were to investigate, develop, and clinically validate solutions to
address the problems listed above. In the introduction, several research questions were
formulated and provisional answers are discussed below.
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Part I: ECG reconstruction
The 12-lead ECG reconstruction methods presented in parts I and II of this thesis have
been based on the recording of reduced lead sets and the subsequent reconstruction of
the absent leads. Before the first research question of how many leads and which leads
are required for a reconstruction is addressed, a definition of accuracy measures is re-
quired.
Accuracymeasures
In Chapters 1–6, leads were reconstructed in various settings and a common question
was how to compare these derived leads with the actual leads. In our investigations sev-
eral quantitative and qualitative assessments were done. Quantitative assessment was
performed on three different levels: overall waveform similarity, reconstruction accuracy
of single measurements, and accuracy of diagnostic decision rules.
First, several methods to compare the original with derived waveforms in an over-
all fashion have been used: Pearson’s correlation coefficient, root mean square error
(RMSE), and Similarity Coefficient (SC) (Horan and Flowers, 1968; Kornreich and Rauta-
harju, 1981). Although the correlation coefficient is highly non-linear, it is a widely used
and reported measure of shape similarity and has a convenient and easy to interpret
scale of -1 to 1. The RMSE is the root mean square of the error signal and is reported in
the units of the source signal. The SC is sensitive to amplitude differences, but it is not
a widely reported measure. As such, there is no single waveform similarity measure to
report. So in our investigations we decided to report several similarity measures.
Second, clinical ECG interpretation is based on global and local measurements. In
our studies, the computer program MEANS was used to determine measurements from
the original and derived leads. The amplitude of the ST segment at 60 milliseconds after
the J point (ST60) for each leadwas selected as a clinically importantmeasurement. Aver-
age and maximum absolute differences (|∆ST60|) between the original and derived am-
plitudes were calculated. Where appropriate, differences of other local measurements,
such as R and S wave differences, and global measurements, such as the frontal QRS and
T axis, were computed.
Third, quantitative accuracy was assessed at the diagnostic level. We applied sev-
eral decision rules that are used in clinical practice. Overall, the ESC/ACC criteria
for acute myocardial ischemia and evolving infarction have simple, sensitive decision
rules (Thygesen et al., 2000)which can also be implemented in ECGanalysis systems. Ac-
curacy between the original and reconstructed ECGs was measured with Cohen’s kappa.
Comparisons on a qualitative level were performedusing visual comparisons of static
ECGs and continuous ECG recordings. Software and printouts facilitated superimposi-
tion of original and derived leads and error signal plots, or a blinded review by several
investigators in Chapters 4 and 6.
Question 1: Howmany leads are required and which lead subset can be used for
reconstruction of the 12-lead ECG?
In Chapters 2 and 3, the reconstruction methods were developed and tested on a large
data set of 10-second, 12-lead ECGs obtained from patients diagnosed with acute my-
ocardial infarction, angina pectoris, or atypical chest pain. The data set was split in
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equally-sized learning and test sets. By systematically removing one and up to six pre-
cordial leads, a total of 62 lead subsets were considered. For each lead subset, general
coefficients to reconstruct the remaining leads were computed on the learning set and
were tested on each ECG of the test set. Reconstruction performance was assessed by
correlation and root mean square errors between the original and reconstructed leads.
Overall, any one or two absent precordial leads can be reconstructed (average corre-
lation ≥ 0.988) very well from the remaining leads using general coefficients. In clinical
practice, where leads may fall off or may cause excessive noise, a potential application
might be automatic reconstruction of an absent lead.
When three or four precordial leads were removed, we found that some lead subset
combinations performed better in reconstructing the missing leads than others of the
same size. For example, in lead subsets with four precordial leads removed, the best lead
subsets included a left and right precordial lead. A possible explanation is that these
subsets form a quasi-orthogonal set of leads, representing the vectorcardiographic X, Y,
and Z leads that describe the heart vector.
The rationale for examining 4-lead subsets in more detail was based on two reasons.
First, it was found in Chapters 2 and 3 that aminimal lead subset for general and patient-
specific reconstruction should contain two or three precordial leads in addition to two
limb leads. Secondly, the use of a reduced lead set was considered by Dräger Medical
Systems for inclusion into their telemetry transmitter system, which was limited to only
seven leads (limb leads and one precordial lead). An additional precordial lead would
increase complexity and result in hardware modifications to the acquisition and trans-
mitter boards.
Question 2: General versus patient-specific reconstruction
In addition to general reconstruction, patient-specific reconstruction coefficients were
computed for each of the lead subsets on the ECGs in the test set. Overall, patient-
specific reconstruction was superior over general reconstruction. Correlation coeffi-
cients were higher. RMSE and absolute ST differences were twice as low.
The availability of a previously recorded 12-lead ECG remains an important limita-
tion of the application of the patient-specific method in the clinical workflow. Integra-
tion of a monitoring system with an ECG management system should be investigated
further. While ECGs in such a system are recorded on the standard electrode positions at
thewrists and ankles, the ECGs could be transformed to themonitoring compatible loca-
tionswith themethods described inChapter 9. For testing purposes, a separate handheld
12-lead ECG recorder was introduced in one of the telemetry wards at the ErasmusMC to
easily obtain a 12-lead ECG and to upload this ECG for analysis at the nurse desk. With
the introduction of wireless communications, it may even be possible to upload these
data on the spot.
For ease of use in clinical situations, a computer algorithm to select the optimal
patient-specific lead subset was developed. The algorithm was designed to only require
a 10-second, 12-lead ECG. No further user intervention is needed, except for final con-
firmation of the selected lead set. The algorithm selects the lead subsets and matrices
based on the highest similarity measure (SC, RMSE, or correlation), but does not evalu-
ate lead subsets with adjacent precordial leads or matrices containing large coefficients.
During visual assessment, we found that matrices with large coefficients perform well in
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the learning phase, but that during the monitoring period noise in the measured leads
can be amplified in the reconstructed leads.
The best patient-specific lead subsets were in concordance with the best lead sub-
sets found for general reconstruction. For example, the most frequently found optimal
patient-specific lead subset with two precordial leads (I, II, V2, and V5) in Chapters 4 and
6 was also found with general lead subset reconstruction (cf. Table 2.1 on page 13).
Question 3: How accurate are derived lead systems over time?
While the ECG reconstruction methods performed well on a set of 10-second, 12-lead
ECGs, it was not known how well the reconstruction methods would perform over time.
For this purpose, the methods were applied on a data set of 24-hour, continuous 12-
lead ECG recordings of patients with acute coronary syndromes without persistent ST-
segment elevation. General and patient-specific reconstruction methods were applied
using correlation and average and maximum absolute ST differences to assess recon-
struction performance.
Accurate reconstruction of the 12-lead ECG over a 24-hour period appeared to be
possible. General reconstruction performance remained at a similar performance level.
Patient-specific performance initially slightly decreased and then stabilized over time,
but remained much better than general reconstruction. It is not known how well the
patient-specific coefficients would perform after days or weeks. It could be hypothe-
sized that the patient-specific coefficients remain valid as long as there are no significant
alterations to the electrical conduction of the heart and electrode placement.
The validity of general and patient-specific coefficients over a time period is a prob-
lem that should be addressed in further research. It is likely that in the busy clinical prac-
tice, a 12-lead ECG for patient-specific coefficients will not be made every day and that
reconstruction performancemay become lower. A possibility that could be used to notify
the user of a suboptimal patient-specific matrix might be a quality index of the reduced
lead set. This index can be calculated for each original lead in the reduced lead set from
the remaining leads. For example, in a reduced lead set of I, II, V2 and V5, the matrices I,
II, V2 and I, II, V5 are also calculated. Of these two 3-lead matrices, reconstruction per-
formance is calculated periodically and if one of the performances becomes lower, the
systemmay warn the user to acquire and recompute the patient-specific coefficients.
Part II: Clinical evaluation
Question 4: How accurate is themethod in a clinical setting?
The general and patient-specific methods were tested in a clinical setting at the VAMed-
ical Center, Durham, NC, USA. Chapter 4 presents a study of 39 ECG recordings that
were made prior, during, and after percutaneous coronary intervention (PCI) executed
according to the clinical standards of the medical center. The aim of this study was to
prospectively assess the reconstruction accuracy in patients with possible ST changes
caused by balloon inflations. The study protocol was designed to blind the Rotterdam
group from the procedure in order to minimize potential bias. In order to perform and
calculate the best patient-specific lead set, the Rotterdam group only had access to the
recording prior to the PCI recording. During each intervention, 12-lead ECG reconstruc-
tion was evaluated at baseline and during ST changes caused by balloon inflation.
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Themain results of the study show that a reduced lead setmay accurately reconstruct
the ST-segment changes caused by balloon inflation. The 4-lead subset with two limb
leads and precordial leads V2 and V5 using general reconstruction coefficients performed
very well. The patient-specific optimal lead subset and coefficients showed even better
results, corroborating the results reported in Chapters 2 and 3.
Question 5: Application of a reduced lead set for pre-hospital triage
In Chapter 5, the general lead reconstruction method with a reduced lead set consisting
of the limb leads and precordial leads V2 and V5 was evaluated for use in a pre-hospital
situation. In these emergency care situations, diagnosis and risk stratification by the am-
bulance service on the spot with a protocol and computerized ECG systems may result
in early initiation of reperfusion therapy. Reperfusion has shown to dissolve or remove
the occluding coronary thrombus, thus recovering blood flow, left ventricular function,
and oxygen delivery to the jeopardised myocardium (Boersma et al., 2001). A reduced
lead set method may save time and can be implemented with existing devices, such as
defibrillators which are not equipped with 12 leads. The reduced lead set of I, II, V2 and
V5 was applied on a data set of 12-lead ECGs obtained from the ambulance service in
Rotterdam. This data set was used to develop the Repair thrombolytic triage algorithm
(Boersma et al., 1996) and consisted of a learning (n=1435) and test set (n=825). Recon-
struction performance was assessed on the accuracy of the Repair (2001) decision rule.
High to very high sensitivity and specificity was observed in the test set (n=825). As a
result of reconstruction differences, three cases would have been referred to a PCI center
instead of receiving thrombolytic treatment. Three false negative cases would not have
received therapy, but would have been referred to the emergency room for further eval-
uation.
Figure 9.1: Example of small electrode misplacements in lead V5 and the effects on the accuracy
of the pre-hospital decision algorithm.
Accurate placement of the electrodes is important for reduced lead set methods, be-
cause misplacements may not only alter the recorded lead, but may also have an effect
on the reconstructed leads. In the best 4-lead subset (I, II, V2, and V5) used in our in-
vestigations, the sites of the extremity electrodes (Mason-Likar placement) and lead V2
(fourth intercostal space, left sternal border) are easier to locate than lead V5 (anterior
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axillary line, horizontal to V4). Therefore, the effect of an incorrectly placed V5 electrode
was evaluated by introducing small changes to lead V5. Leads V4 12
(midway V4 and V5)
and V5 12
(midway V5 and V6) were approximated by cubic spline interpolation (Schijve-
naars et al., 1995) and served as input for the Repair decision rules. Figure 9.1 depicts the
effects of simulated changes of V5 on sensitivity and specificity. Overall, changes were
small; the number of misclassified cases decreased by two with lead V4 12
and increased
by one with lead V5 12
. A possible explanation for the overall low number of misclassi-
fied cases might be that Repair was designed with robust decision rules which are not
sensitive to small changes in particular leads.
Question 6: Comparison of several derived 12-leadmethods
Reconstruction of the 12-lead ECG from a subset of leads for patient monitoring has re-
ceived a lot of attention in the last two decades. In the area of continuous online ST
analysis, vectorcardiographic monitoring systems, such as Ortivus’ MIDA system, are
based on the recording of three orthogonal leads and contain a transformation by Dower
et al. (1980) for presenting a 12-lead ECG. In the mid-nineties, the 5-electrode system,
EASI, was also clinically evaluated (Drew et al., 1996) and has become a widely used lead
system.
In Chapter 6, a study was carried out at the VA Medical Center to evaluate EASI and
the general and patient-specific reconstruction methods with the 12-lead ECG during
PCI. A total of 44 recordings were acquired and it was observed that the performances
of EASI, general, and patient-specific reconstruction differ substantially. In this setting,
EASI had the lowest reconstruction performance.
In addition to the EASI lead system, a number of othermethods have been developed
and have become commercially available. The general and patient-specific method pre-
sented in Chapters 1-2 and Appendix A have been implemented by Dräger Medical Sys-
tems for use in their patient monitoring equipment under the respective names TruST
GEN and TruST PS. A brief overview of thosemethods, manufacturers, and required lead
systems is presented in Table 9.1. Drew et al. (2002), Wei et al. (2004), and TruST are sim-
ilar methods which use lead subsets and reconstruct the remaining leads of the 12-lead
ECG using coefficients determined on a patient-specific ECG or on a learning set.
Table 9.1: Overview of reduced lead set strategies and their commercial availability.
Method Vendor Lead system
Drew et al. (2002) General Electric (GE) I, II, V1, V5
Dower et al. (1980) Ortivus, Danica Frank lead system
EASI, Dower et al. (1988) Philips Medical Systems E, A, S, I
Scherer et al. (1989) - I, II, V2
TruST GEN Dräger Medical Systems I, II, V2, V5
TruST PS Dräger Medical Systems I, II, 2 precordial leads
Wei et al. (2004) Nihon Kohden I, II, V1, V6
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To our knowledge, no studies have been carried out which compare the perfor-
mances of the different reconstruction methods. For this purpose, the PCI recordings in
Chapter 6 were used to simultaneously compare six different methods: EASI, Wei, Drew,
Scherer, TruST GEN, and TruST PS. It was not possible with the existing data set to in-
clude a VCG-based lead system, because not all Frank electrodes were acquired in this
data set. Furthermore, the coefficients and exact algorithm implementation of the other
methods have not been made publicly available. Therefore, we used the coefficients
determined from our learning sets (Nelwan et al., 2000). Coefficients are presented on
page 106.
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Figure 9.2: Median (inter-quartile range) of the root mean square errors and absolute ST60 differ-
ences at balloon inflation of different lead reconstruction strategies (n=33).
Table 9.2 containsmedian (inter-quartile range) RMSE and |∆ST60| of the reconstruc-
tion methods at balloon inflation for each precordial lead. Mean RMSE and |∆ST60| are
summarized in Figure 9.2. Overall, TruST PS had the lowest RMSE and |∆ST60|. The
highest RMSE and |∆ST60| were observed in the Wei method, followed by Scherer. EASI,
Drew, and Trust GEN have similar median |∆ST60|, but the inter-quartile ranges differ.
Based on these results, we conclude that the reconstruction methods greatly differ in
performance.
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Reconstruct or fabricate?
Over the years, methods to reconstruct the 12-lead ECG from a subset of leads or from
alternate lead systems have been scrutinized by different research groups, industry, and
governmental agencies, such as the United States Food and Drug Administration (FDA).
When the EASI lead system was introduced, several research groups (Drew et al., 1996;
Horacek et al., 2000; Rautaharju et al., 2002) investigated the accuracy of EASI in clinical
settings. Based on these investigations, Zymed, at present Philips Medical Systems, was
able tomarket and sell this product for the purpose of ST-segmentmonitoring. However,
in 2003, the British Medicines and Healthcare products Regulatory Agency (MHRA), is-
sued amedical device alert to allmedical personnel concerning the reproducibility of the
EASI lead system ∗:
Problem: The EASI 12-lead ECGderived fromfive electrodes is inappropriate
for diagnosis of acute ischaemic heart disease. (. . . )
The MHRA has received reports where a patient was suspected of having is-
chaemic heart disease or rapidly changing ST segments and the EASI 12-lead
ECG did not correlate with the conventional ECG. Users employing only the
EASI 12-lead ECGmay thereforemisdiagnose certain conditions particularly
myocardial infarction, leading to inappropriate use of thrombolytic therapy.
(. . . )
Action: Diagnosis of acute ischaemic heart disease should not be based
on the EASI 12-lead ECG. Users should instead use the conventional 10-
electrode, 12-lead diagnostic ECG configuration.
In this alert, the MHRA warns about the differences between a conventional and 12-
lead ECG synthesized from EASI. This may have implications for other ECG reconstruc-
tionmethods, such as the VCG to 12-lead ECG transformation and the lead subset meth-
ods includingTruST. WhileEASI and theTruST algorithms differ substantially (cf. Chap-
ter 6), both methods reconstruct unavailable leads with a degree of uncertainty. EASI, a
model-based system, employs a transformation from an orthogonal lead set to the 12-
lead ECG system. This model may not fit all patients, so outliers are inevitable. TruST
reconstruction uses four out of the eight measured leads to reconstruct the remaining
four leads, such that the limb leads and two precordial leads remain identical to the con-
ventional ECG. However, the accuracy of the four reconstructed leads depends for a great
deal on size and composition of the learning set used for computation of the coefficients.
The learning set for the TruST coefficients contained a large variation of patients with or
without acute coronary syndromes (Nelwan et al., 2000). For both EASI and TruST, it
is impossible to predict which patients will have large deviations in the reconstructed
leads.
In addition to uncertainties in waveforms of reconstructed leads, the reconstruction
methods also may affect noise and baseline drift in the reconstructed signals. Figure 9.3
demonstrates a noise reduction effect of lead reconstruction. In the top panel, lead V6
contains baseline wander and high frequency noise, but the reconstructed dV6 is not af-
fected. This is a double edged sword, because if lead V5 would have been constructed
from V6, noise would be propagated into dV5. The lead reconstruction method also de-
pends on other monitoring modules which detect lead-off conditions of the measured
∗Full report available at http://www.rcoa.ac.uk/docs/mda-2003-024.pdf
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V5
V6
 V5
dV6
Figure 9.3: Example of noise reduction after lead reconstruction. The top panel contains the actual
V5 and V6. The bottompanel shows a reconstructed V6 leadwith the low frequency noise removed.
leads. In case of a lead-off condition or asystole alarm, the reconstructed leads should
switch into a lead-off condition.
Limitations
A few study limitations can be noted. First, we have not evaluated the reconstruction
of ECGs containing arrhythmias, such as atrial fibrillation, premature ventricular com-
plexes, or bundle branch blocks. While it may not be expected that these arrhythmias
would not be properly represented in the reconstructed leads, we have not extensively
verified how arrhythmias are visualized in the reconstructed leads. Since the extremity
leads always remain identical, there will be no reconstruction differences if the typically
used lead II is selected for arrhythmia interpretation (Drew and Krucoff, 1999). Further-
more, in a subanalysis of a lead subset consisting of I, II, V1, and V5 (Drew et al., 2002),
high to perfect agreement was found between the original and reconstructed ECGs. The
only difference with the presented best lead set of I, II, V2, and V5 is the change from lead
V2 to V1, because lead V1 is an efficacious lead for atrial rhythmmonitoring.
Second, no prospective studies were performed on the actual day-to-day clinical use
by various users (nurses, physicians, and technicians). In particular, we have not quan-
tified reconstruction accuracy in the presence of small changes in repositioning elec-
trodes. Lastly, the logistics of recording a 12-lead ECG for patient-specific reconstruction
should be investigated.
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Part III: Patientmonitoring
During long-term continuous ECGmonitoring, body position changesmay alter the sur-
face ECG and the electrode positions of the limb leads are often different from standard
positions at the wrists and ankles. Questions 7 and 8 address these interpretation prob-
lems and present detection and correction methods.
Question 7: ECG variations caused by body position changes
Body position changes (BPC) are known to alter the surface 12-lead ECG, resulting in
changes in QRS amplitude, ST-segment shifts, and T-wave inversions. Some of these
changes can be interpreted as ischemia and may trigger false positive alarms by the pa-
tientmonitor. While previous studies (Shinar et al., 1999; Astrom et al., 2003; Garcia et al.,
2003) have quantified and described detection algorithms in small groups of volunteers
and cardiac patients, we have attempted to quantify these body position changes, to
provide an ECG-based detector and a patient-specific correction method. Continuous
12-lead ECG recordings were obtained from 114 patients admitted to the coronary care
unit and each patient underwent a body position test (supine, left, right, and upright
position). A body position detector was developed using the Explore automated rule
induction algorithm. To distinguish positional from ischemic changes, a separate set of
71 PCI recordings was used including ECGs at rest and during balloon inflation. The
ECG variations were corrected using a patient-specific mapping technique based on a
combination of leads. Performance of the correction method was assessed by Pearson’s
correlation coefficient and by similarity coefficient. ST changes of ≥ 100 µV in ≥ 1 lead
caused by BPC were observed in 50 (43%) patients and the most pronounced changes
were found in the left-lateral position. With a fixed specificity at 95%, sensitivity of the
detection rules was for left 97.4%, right 69.9%, upright 64.3% and combined 66.1%. False
alarm rate per hour in the PCI data set was 2.22 at rest and 4.31 during balloon inflation.
Performance of the patient-specific correctionmethod yielded an overall correlation co-
efficient of 0.970 and similarity coefficient of 0.889.
Question 8: Correction of ECG variations due to non-standard electrode positions
Electrode positions for continuousmonitoring are different from those for recording of a
standard 12-lead ECG, because the standard electrode positions at the wrists and ankles
may introduce noise and artifacts. Therefore, most institutionsmove the limb electrodes
to the chest and lower abdomen, the so-called monitoring positions, according to Ma-
son and Likar. However, this position changemay alter the ECG significantly: QRS shifts,
(dis)appearing Q waves and changes in R waves may appear. A study was set up to de-
velop amethod to correct for these changes. Using a data set of 93 subjects with a simul-
taneously recorded 9-lead ECG in standard and monitoring positions, patient-specific
and generalizedmethods were developed and evaluated. Themain results show that the
generalized reconstruction coefficients can be used to map the monitoring leads to the
standard leads with high accuracy.
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Future directions
In order to facilitate an independent evaluation and reproduction of our results, the
TruST reconstruction methods and the coefficients are given in Appendix A. To evaluate
TruST in clinical settings, the algorithmshave beenmade available in patientmonitoring
equipment, such as telemetry transmitters and bedside patient monitors. The data sets
used in Chapters 7 and 8 will be made available in the Physionet databank (Goldberger
et al., 2000).
The methods for body position detection and correction (cf. Chapter 7) and for the
correction of standard to monitoring ECGs (cf. Chapter 8) have not been implemented
and validated in clinical practice. While the standard to monitoring ECG reconstruction
method can be readily applied in a patient monitoring system, because of the limited
amount of required computations, the practical implementation might be difficult. Au-
tomatic export and data exchange standards, such as DICOM for medical imaging sys-
tems, are presently not widely available for ECGdatamanagement systems, despite stan-
dardization efforts such as SCP (Willems et al., 1992) and by the FDA (Kligfield, 2003).
ECG lead systems with reduced lead sets can be applied in locations outside of the
hospital. A possible application in a pre-hospital setting is described in Chapter 5.
Telemedicine (Klootwijk et al., 2004; Rubel et al., 2004) is another possible application
area. For example, a reduced lead set is easier to apply, and is less cumbersome for pa-
tients in homemonitoring settings. However, small changes in precordial and limb elec-
trodes due to improper electrode placementmay result in a performance decrease in the
reconstructed leads.
Furthermore, the coefficients used in our investigations were derived from a specific
learning set of patients who were evaluated for a possible myocardial infarction. These
coefficients may not be appropriate for other groups of patients. Therefore, future work
should focus on evaluating these coefficients on other patient groups.
Finally, it is still unknown how stable patient-specific coefficients will remain over a
long period of time, despite the stabilizing pattern observed in Chapter 2. A prospective
study of ECGs taken over a longer period (week, month, or year) may provide additional
information.
Conclusions
In conclusion, themethods developed and clinically validated in this thesismay alleviate
problems during ECGmonitoring. The following remarks can be made:
• Accurate reconstruction of up to four precordial leads is feasible with general or
patient-specific reconstruction coefficients.
• Patient-specific reconstruction is more accurate than general reconstruction.
• Accurate general and patient-specific reconstruction is possible over time.
• A reconstructed 12-lead ECG based on a reduced lead set containing leads I, II,
V2, and V5 can be used to facilitate pre-hospital decision making on patients with
acute coronary syndromes.
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• ST changes caused by body position changes can be distinguished from ischemic
changes and patient-specific methods have been developed to correct these ST
changes.
• Proximal placement of the extremity leads may result in ECG variations, but these
changes can be corrected by general and patient-specific reconstruction methods
with high reconstruction performance.
Appendix: Methodology
Based on:
US Patent No. 6,690,967 (S. H. Meij and S. P. Nelwan)
US Patent No. 6,643,539 (S. H. Meij and S. P. Nelwan)
US Patent Application. 2004/0030257 (B. Tabbara, S. H. Meij, and S. P. Nelwan)
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Introduction
In chapters 1-3, the reconstruction methods were described in a concise manner. This
appendix contains a more detailed description of the calculations and techniques for
synthesizing electrocardiographic leads. In light of the work of Cady (1969); Smith et al.
(1975); Dower et al. (1988); Scherer et al. (1989); Nelwan et al. (2000); Drew et al. (2002),
and the various similar patented techniques (Nicklas and Scherer, 1993; Dower, 1989;
Wang, 2000; Meij and Nelwan, 2003; Brodnick, 2003; Meij and Nelwan, 2004; Wei et al.,
2004; Tabbara et al., 2004), our reconstruction methods are presented.
Lead reconstruction
As presented in Equation 9.1, the basic algorithm for synthesis of ECG leads (D) is a mul-
tiplication of the available source lead vector( S) and a coefficientmatrix (M). The recon-
struction coefficientmatrixM can be obtained from a large data set (general) or from the
patient’s own ECG (patient-specific). D contains a combination of one or more precor-
dial leads, while S contains the extremity leads and at least one precordial lead. The
precordial lead sets inD and S are disjunct.
D =MS (9.1)
The linear regression algorithm in our reconstructionmethod uses singular value de-
composition (SVD) (Press et al., 1993) without a zero-intercept vector. Although SVD
requiresmore computations than ordinarymultiple linear regression, SVDproperly han-
dles the selection of two or more possible fits with similar reconstruction performance.
In short, the variance-covariancematrix is estimated from the scatter of the observations
around the best fit. An optimized SVDalgorithm is used (Galassi et al., 2000) with column
scaling to improve the accuracy of the singular values. Components with zero singular
value are discarded from the fit.
Ranking techniques
The synthesis techniques can be applied in situations where patients aremonitored with
a reduced number of ECG leads. For example, a patient can be moved from full 12-
leadmonitoring to 7-lead or 8-lead (telemetry) monitoring. Another situation where this
technique can be applied is for ECG monitoring with right-sided chest leads (e.g. V4R,
V5). In this situation, the end-user needs to be assisted in the choice of which and how
many chest electrodes can be moved to the right side while maintaining adequate syn-
thesis of the conventional chest electrodes. For these purposes, the patient-specific ma-
trices that have been derived for all possible lead sets can be ranked so that the end-user
may decide which electrode(s) to select.
Twomethods can be used to rank lead sets:
1. Pearson’s correlation coefficient
The Pearson correlation coefficient is widely used to correlate data. The coefficient
ranges from -1 to 1, where -1 indicates a perfect negative correlation, 0 no corre-
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lation at all and 1 indicates a perfect correlation. Pearson’s correlation coefficient
captures shape rather than absolute differences.
corr(x, y)=
∑
i (xi −µx )(yi −µy )√∑
(xi −µx )2
√∑
(yi −µy )2
(9.2)
2. Similarity coefficient
A second coefficient is modified for the end-user to have the same range as the
Pearson’s correlation coefficient. The similarity coefficient is calculated as follows:
SC= 1.0− RMSer ror
RMSsource
(9.3)
The RMS (root mean square) is defined as:
RMS=
√
1
n
n∑
i=1
xi 2 (9.4)
Technical implementation considerations
Details about technical and practical considerations of the reconstructionmethods were
left out for conciseness in the previous chapters. The lead subset reconstructionmethods
have been implemented in research and commercial systems (Siemens/Dräger Medical
Systems TruST Telemetry). The following remarks can be made:
• Investigation of 4-lead subsets
Telemetry devices are often technically limited to a reduced number of ECG chan-
nels. The TruST telemetry devices transmit leads I, II, and two generic unipolar
leads (V and V+). In Chapters 2 and 3, it was found that the best 4-lead subsets per-
formed well if one precordial lead is selected from V1-V3 and the other from V4-V6.
The best five 4-lead subsets and their coefficients are presented in Table 9.3. Perfor-
mancewas based on the average correlation coefficient over the four reconstructed
leads. Lead sets with adjacent precordial leads had overall lower correlation values.
Users were not allowed to select these combinations in the user interface.
• Quality of the extremity leads
It is not uncommon for patients to have a small or near iso-electric ECG complex
in limb lead I. For those patients, lead I should not be used as a source lead for
reconstruction. The reconstruction methods used in previous chapters detect this
situation and switch to a newmatrix in which lead I is not used.
• User interface
The user interface program (signals and trends) marks a reconstructed lead with a
unique label and code. For example, a reconstructed precordial lead V1 is labelled
as dV1. Patient-specific matrices should always be marked with the date and time
of the ECG from which the coefficients were computed.
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• Computer-based recommendation of the best lead set
The selection process of the best lead set for patient-specific reconstruction was
also implemented in a computer program. The program selects the matrix with
the highest similaritymeasure (correlation coefficient or similarity coefficient), but
does not select a matrix containing unstable reconstruction coefficients (i.e. over-
learning) or lead subsets with adjacent precordial leads.
Table 9.3: Reconstruction performance and coefficients of the five best lead subsets based on av-
erage correlation coefficients.
Correlation Lead subset configuration
Coefficient I II V2 V5
1 0.956 dV1 -0.463 -0.069 0.527 -0.097
dV3 0.170 0.256 0.742 0.518
dV4 0.162 -0.032 0.289 1.139
dV6 -0.083 0.161 -0.115 0.599
2 0.953 I II V2 V6
dV1 -0.478 -0.072 0.514 -0.133
dV3 0.313 0.651 0.750 0.984
dV4 0.400 0.393 0.390 0.840
dV5 0.181 0.086 0.138 1.145
3 0.953 I II V1 V5
dV2 0.692 0.080 1.494 0.054
dV3 0.682 0.420 1.073 0.475
dV4 0.356 0.066 0.444 1.125
dV6 -0.175 0.112 -0.214 0.595
4 0.952 I II V3 V5
dV1 -0.551 -0.290 0.430 -0.352
dV2 -0.168 -0.396 0.857 -0.512
dV4 0.071 -0.111 0.435 0.924
dV6 -0.046 0.187 -0.160 0.683
5 0.950 I II V1 V6
dV2 0.698 0.229 1.429 -0.201
dV3 0.791 0.840 0.970 -0.143
dV4 0.649 0.491 0.505 0.714
dV5 0.276 0.119 0.194 1.114
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Figure 9.4: Front Page of US Patent Number 6,643,539.
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Figure 9.5: Analysis (Figure 1).
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Figure 9.6: Analysis flowchart (Figure 2) and synthesis (Figure 4).
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Figure 9.7:Matrix Calculations (Figure 3).
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Patent Description
Method and Apparatus, Monitoring Method, User Interface, and Analysis System for
Synthesizing and Electrocardiogram
Abstract of the Disclosure
An electrocardiogram (ECG) system provides a set of ECG lead signals. The system includes
a source of a subset of ECG lead signals. A synthesizer, coupled to the ECG lead signal
source, generates a set of synthesized ECG lead signals from the subset of ECG lead signals.
Data is also generated representing the accuracy of the set of synthesized ECG lead signals.
Field of the invention
The present invention relates to electrocar-
diogram (ECG) systems, and in particular
to ECG systems which can provide synthe-
sized signals corresponding to signals gen-
erated from electrodes which provide the
actual ECG signals.
Background of the invention
ECG systems are well known, and pro-
vide information about the physiological
status of a patient’s heart to a physician.
More specifically, so called 12-lead ECG
systems exist which provide twelve wave-
forms, called leads, to the physician. To
provide such a 12-lead ECG, ten electrodes
are placed on the patient’s body, and the
signals from these electrodes are processed
to provide the twelve leads, all in a known
manner. These ten electrodes include four
electrodeswhich provide signals processed
to generate six of what are known as limb
leads, and six electrodes which provide sig-
nals processed to provide six of what are
known as precordial or chest leads.
However, such a system does not al-
ways operate in the ideal manner. Some-
times, electrodes slip on, or work loose
from, a patient’s body and produce a null
signal, or produce signals which are oth-
erwise degraded to the point of being un-
usable. Furthermore, the location on the
patient’s body at which one or more of the
electrodes should be placed may be un-
available due to injury or surgery. In ad-
dition, under some circumstances it may
be desirable to place an electrode at a lo-
cation on the body different from the nor-
mally used locations. It is desirable under
these conditions to still provide the signals
needed to generate the 12-lead ECG.
It is known that the signals repre-
senting the respective lead signals con-
tain mutually redundant information. It is
also known that, should one electrode be
missing or malfunctioning, an appropriate
combination of signals from the other elec-
trodes and/or the other leads, which are
available and functional, can be used to
generate a synthesized signal which closely
approximates the lead signal derived from
the missing or malfunctioning electrode.
To apply this technique, at least some por-
tion of a full 12-lead ECG is recorded, dur-
ing an analysis phase. The recorded signals
are then processed to generate a function,
which may be applied to the lead signals
which are available, to synthesize a lead
signal which approximates the lead signal
which is missing or distorted beyond use.
During a synthesis phase, this function is
then applied to the available ECG lead sig-
nals. Using this technique, a missing lead
may be synthesized.
InU.S. PatentNo. 5,058,598, issuedOct.
22, 1991 to Nicklas et al., a system is dis-
closed for synthesizing a desired precor-
dial lead from what is termed a set of base
leads. First, in an analysis phase, a set
of ECG lead signals, including at least the
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set of base leads (in Nicklas et al, the base
leads are leads I, II, and V2), and the pre-
cordial lead signal (other than V2) which
is desired to be synthesized, is processed
to generate coefficients for a linear equa-
tion. Then, in a synthesis phase, signals
representing only the base leads are re-
ceived, and the values of those base leads
are substituted into the linear equation to
derive values which represent the desired
synthesized precordial lead signal. Nick-
las et al. also discloses partitioning the
ECG complex into segments (e.g. QRS, ST,
etc.), and processing each segment sepa-
rately to generate respective sets of coef-
ficients for a separate linear equation cor-
responding to each segment. In this case,
during the synthesis phase, values for each
segment from the base leads are substi-
tuted into the appropriate linear equation,
to derive values which represent the de-
sired synthesized precordial lead signal in
that segment.
In U.S. Patent No. 5,490,515, issued
Feb. 13, 1996 to Mortara, a system is dis-
closed for synthesizing a single specified
lead from a set of eight lead signals. In
the analysis phase, the set of eight lead sig-
nals, derived from respective electrodes, is
received by the system and a coefficient
table, having entries representing coeffi-
cients of a set of linear equations, is gener-
ated. In the synthesis phase, the coefficient
table is then used to synthesize a selected
one of the eight lead signals, based on the
values of the other seven lead signals. Mor-
tara also discloses simultaneously synthe-
sizing more than one missing lead.
In neither of these systems is any indi-
cation of the accuracy of the synthesized
signal provided to the operator. In addi-
tion, in neither of these systems is any in-
formation provided to the operator to as-
sist in preparation for the ECG, nor in in-
terpreting the displayed 12 ECG lead wave-
forms.
It is desirable to determine the accu-
racy of the synthesized signal relative to
other potential synthesized signals, and to
provide that information to the operator.
It is further desirable to provide informa-
tion to the operator to assist in the prepa-
ration for the ECG and the interpretation of
the results. In some cases, such as teleme-
tered ECGs, it is further desirable to mon-
itor patients with a minimum number of
electrodes, while producing a full 12-lead
ECG and maintaining a desired level of ac-
curacy.
Brief summary of the invention
In accordance with principles of the
present invention, an electrocardiogram
(ECG) system provides a set of ECG lead
signals. The system includes a source of a
subset of ECG lead signals. A synthesizer,
coupled to the ECG lead signal source, gen-
erates a set of synthesized ECG lead signals
from the subset of ECG lead signals. Data
is also generated representing the accuracy
of the set of synthesized ECG lead signals.
Brief description of the drawings
In the drawing:
1. Figure 1 (cf. Figure 9.5) is a dia-
gram in block formwith the database
block also shown in memory layout
form, illustrating a portion of an ECG
system according to principles of the
present invention;
2. Figure 2 (cf. Figure 9.6) is a flowchart
useful in understanding the opera-
tion of the system illustrated in Fig-
ure 1;
3. Figure 3 (cf. Figure 9.7) is a dia-
gram illustrating matrix calculations
which are useful in understanding
the operation of the present inven-
tion; and
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4. Figure 4 (cf. Figure 9.6) is a block di-
agram illustrating a different portion
of a system according to principles of
the present invention.
Detailed description of the invention
Figure 1 is a diagram in block form with
the database block also shown in mem-
ory layout form, illustrating a portion of
an ECG system according to principles of
the present invention. In Figure 1, a plu-
rality 102 of electrodes are intended to be
attached to respective locations on a pa-
tient’s body. The plurality 102 of electrodes
are coupled to respective input terminals
of a preprocessor 104. Respective output
terminals of the preprocessor 104 are cou-
pled to corresponding input terminals of
a memory 106. Respective output termi-
nals of the memory 106 are coupled to cor-
responding input terminals of an analy-
sis circuit 108. An output terminal of the
analysis circuit 108 is coupled to an input
terminal of a database 110.
In operation, the plurality 102 of elec-
trodes are ECG electrodes which are in-
tended to be attached to predetermined
locations on a patient. In the illustrated
embodiment, 10 electrodes are provided.
The preprocessor 104 processes the sig-
nals from the 10 electrodes to generate sig-
nals representing a 12-lead ECG at respec-
tive output terminals. More specifically,
signals from the four limb lead electrodes
are processed to provide limb lead signals
I and II. From limb lead signals I and II,
the remaining limb lead signals III, aVR,
aVL and aVF, may be mathematically de-
rived. In the illustrated embodiment, the
derivation of those other limb lead signals
is not germane to the present invention
and they are not discussed in the remain-
der of this application. The other six elec-
trodes are processed separately to provide
corresponding precordial lead signals (V1,
V2, V3, V4, V5, V6). Thus, signals repre-
senting eight lead signals (I, II, V1, V2, V3,
V4, V5, V6) are generated by the preproces-
sor 104 in a knownmanner and are further
processed in the manner described below.
In the illustrated embodiment this
preprocessing further includes analog-to-
digital conversion. The eight lead sig-
nals, therefore, are in multibit digital form.
The preprocessor 104 may further pro-
vide processing to identify characteristics
of each ECG complex and to time align
and aggregate (e.g. average, median filter,
etc.) somenumber of successive ECG com-
plexes for each lead, all in a known man-
ner. Digital data representing the eight,
possibly averaged, ECG lead complexes is
stored, in a known manner, in respective
locations in the memory 106.
Figure 2 is a flowchart useful in under-
standing the analysis phase operation of
the analysis system illustrated in Figure 1.
The operation starts in block 202. In block
204 a full 12-lead ECG is taken and the re-
sult, as described above, is multibit digi-
tal data representing eight respective ECG
lead complexes (I, II, V1, V2, V3, V4, V5, V6),
possibly aggregated. The data representing
these eight lead complexes are stored in re-
spective locations in thememory 106, all in
a knownmanner.
The analysis circuit 108 retrieves data,
in a known manner, from the locations in
thememory 106 corresponding to the eight
lead complexes. The analysis circuit 108
then analyzes the retrieved data. In gen-
eral, every possible combination of one or
more of the leads is treated as if it were
missing or otherwise unusable. Then, for
each such combination, the other remain-
ing lead complexes, treated as if they re-
main available, are compared to the miss-
ing lead complex or complexes, and a func-
tion of the available lead complexes is cal-
culated which will most accurately synthe-
size the one or more missing leads from
the available leads. A measure of the ac-
curacy of the synthesis is also determined
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and both the calculated function and the
determined accuracymeasure are stored in
the database 110. The processing applied
to each such combination is illustrated in
Figure 2 and described in more detail be-
low.
In block 206 a subset of leads, consist-
ing in the first place of one of the eight
leads, is selected as the missing lead. For
the purposes of the following description,
the selected lead is the precordial lead V1.
In block 208, the stored lead complex data
representing the selected lead V1 is com-
pared to the stored lead data represent-
ing the other seven lead complexes (I, II,
V2, V3, V4, V5 and V6) to calculate a func-
tion of those other seven lead complexes
(I, II, V2, V3, V4, V5 and V6) which will most
closely approximate the selected lead com-
plex (V1).
In the illustrated embodiment, a lead
complex SV1, approximating the selected
lead complex V1, is synthesized by a linear
combination of the other seven lead com-
plexes (I, II, V2, V3, V4, V5 and V6). That
synthesis is represented by a set of coef-
ficients CI(V1), CII(V1), CV2(V1), CV3(V1),
CV4(V1), CV5(V1) and CV6(V1). The nota-
tion Cx(y) is intended to represent the co-
efficient C to be applied to the xth avail-
able lead complex to synthesize the miss-
ing yth lead complex. That is, this set of co-
efficients represents the proportion of the
other seven lead complexes (I, II, V2, V3, V4,
V5 and V6), respectively, in the linear com-
bination representing the synthesized lead
complex SV1 most closely approximating
the missing lead complex V1. In the il-
lustrated embodiment, the coefficients are
calculated using a least squares linear re-
gression with a zero intercept vector, in a
known manner. One skilled in the art will
understand that any form of combination,
such as polynomial or trigonometric, could
also be used.
The calculation in block 208 produces
a synthesis matrix M. Figure 3 is a diagram
illustrating matrix calculations which are
useful in understanding the operation of
the present invention. In Figure 3a, a ma-
trix M[V1] illustrates a matrix which is pro-
duced when the selected lead is lead V1.
The notation M[z] is intended to represent
the synthesis matrix M for synthesizing the
synthesized vector S from an input vector
I missing the set z of ECG lead complexes.
An input vector I contains elements rep-
resenting data points from the eight lead
complexes (I, II, V1, V2, V3, V4, V5, V6).
The matrix M[V1] has as its basis an iden-
tity matrix. However, the row correspond-
ing to the synthesized lead complex SV1
(e.g. the third row from the top) is replaced
by the set of coefficients CI(V1), CII(V1),
0, CV2(V1), CV3(V1), CV4(V1), CV5(V1) and
CV6(V1) calculated in block 208 by the
analysis circuit 108. The column corre-
sponding to the selected lead complex V1
(e.g. the third column from the left) is set
to zero, so that the selected lead complex
V1 makes no contribution to the combina-
tion forming the synthesized selected lead
complex SV1.
One skilled in the art will understand
that when the synthesis matrix M[V1] is
multiplied by the input vector I, the re-
sult is a synthesized vector S. The syn-
thesized vector S contains elements rep-
resenting synthesized data points for the
eight synthesized lead complexes (SI, SII,
SV1, SV2, SV3, SV4, SV5, SV6), in which the
synthesized lead complex SV1 for the se-
lected lead is synthesized from the other
seven leads (I, II, V2, V3, V4, V5, V6) while
the remaining leads (SI, SII, SV2, SV3, SV4,
SV5, SV6) are equal to the corresponding el-
ements in the input vector I.
In block 210 a similarity coefficient SC
is determined in the following manner.
When the matrix M[V1] has been calcu-
lated in block 208, it is used to generate
eight synthesized lead complexes (SI, SII,
SV1, SV2, SV3, SV4, SV5, SV6). Then the syn-
thesized lead complexes (SI, SII, SV1, SV2,
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SV3, SV4, SV5, SV6) are compared to the ac-
tual leads complexes (I, II, V1, V2, V3, V4,
V5, V6) stored in the memory 106 to calcu-
late a similarity coefficient SC. This is des-
ignated in Figure 2 as SC(V1) to indicate
that it is the similarity coefficient SC for
the selected lead V1. In the illustrated em-
bodiment, this coefficient SC[V1] is calcu-
lated from the differences between the root
mean square (RMS) values of the synthe-
sized lead complex data (SI, SII, SV1, SV2,
SV3, SV4, SV5, SV6) and the stored actual
lead complex data (I, II, V1, V2, V3, V4, V5,
V6). More specifically, the synthesis coef-
ficient is calculated as SC = (RMSsource −
RMSer ror )/RMSsource ).
Alternatively, the known Pearson’s cor-
relation technique may be used to gener-
ate a similarity coefficient SC. One skilled
in the art will understand, however, that
any technique of rating the similarity of the
synthesized lead complexes to the actual
lead complexes may be used.
In step 212, the calculatedmatrixM[V1]
and the corresponding similarity coeffi-
cient SC[V1] are stored in the database 110
in a known manner. The database 110 is
maintained on a non-volatile storage de-
vice. For example, the database may be lo-
cated on a disk drive system in a central lo-
cation accessible by a hospital network, in
a known manner. The specific configura-
tion of the storage device and database 110
is not germane to the invention, provided
it is accessible by the ECG system.
One skilled in the art will understand
from Figure 1 that the database 110 con-
tains a plurality of entries respectively cor-
responding to different patients and to dif-
ferent general populations. This will be
described in more detail below. Each pa-
tient and general population entry con-
tains a sequence of synthesis entries cor-
responding to different sets of selected
(missing) lead complexes, derived as de-
scribed above. In Figure 1, the entry for
patient 2 is illustrated. The patient 2 entry
in turn contains a first synthesis entry into
which the matrix M[V1] and the similarity
coefficient SC[V1] is stored. Other data not
germane to the present inventionmay also
be stored in the patient entry and/or the
patient entry’s synthesis entries.
In block 214, if all the synthesis entries
have been filled, then the process ends
in block 216. Otherwise processing re-
turns to block 206 where another subset
of leads is selected and treated as miss-
ing. In the illustrated embodiment, all sub-
sets consisting of a single missing lead are
processed, followed by all subsets consist-
ing of two missing leads, all subsets con-
sisting of three missing leads, and so forth.
One skilled in the art will understand that
the order in which the subsets are deter-
mined and processed is not germane to the
present invention.
More specifically, in the illustrated em-
bodiment, the precordial lead V2 is se-
lected next and the processing described
above performed again. In this case, re-
ferring again to Figure 1, the results of this
processing,M[V2] and SC[V2], are stored in
the second synthesis entry in the patient
2 entry. This continues for all of the re-
maining subsets of a single missing lead.
Then all sets of two simultaneously miss-
ing leads are processed. For example, leads
V1 and V2 are simultaneously selected and
treated as missing and the same process-
ing described above performed and the re-
sults, synthesis matrix M[V1,V2] and sim-
ilarity coefficient SC[V1,V2], are stored in
the appropriate patient 2 synthesis entry.
Then the next set of two missing leads,
V1 and V3 are simultaneously selected and
treated asmissing and the sameprocessing
performed.
Figure 3b illustrates a matrix M[V1,V3]
which is calculated in response to the si-
multaneous selection of leads V1 and V3 as
missing. As before, thematrixM[V1,V3] has
as its basis the identity matrix. But in this
case the row corresponding to the synthe-
116 Appendix: Methodology
sized lead SV1 is replaced with coefficients
CI(V1), CII(V1), 0, CV2(V1), 0, CV4(V1)
CV5(V1) and CV6(V1) and the row corre-
sponding to the synthesized lead SV3 is re-
placed with coefficients CI(V3), CII(V3), 0,
CV2(V3), 0, CV4(V3), CV5(V3) and CV6(V3).
At the same time, the columns correspond-
ing to the selected lead complexes V1 and
V3 are replaced with zeroes to ensure that
input signals from those lead complexes
do not contribute to the synthesized lead
signals. Again, a similarity coefficient
SC[V1,V3] is determined and both the ma-
trix M[V1, V3] and the similarity coeffi-
cient SC[V1,V3] are stored in the appropri-
ate synthesis entry in the patient 2 entry.
This continues for all sets of two missing
leads, followed by all combinations of three
missing leads and so forth until the patient
2 entry is completed and the process ends
in block 216 (of Figure 2).
As was disclosed in Nicklas et al. it
is possible to partition each of the eight
lead complexes stored in the memory 108
into segments, and perform the calcula-
tions described above on each segment in-
dependently. In the present invention, this
would result in a plurality of matrices, one
for each segment, stored in each synthesis
entry in the patient 2 entry. When themiss-
ing lead(s) is synthesized from the avail-
able leads, the appropriate matrix is used
depending on which segment is currently
being synthesized, all as disclosed in Nick-
las et al.
Figure 4 is a block diagram illustrating a
synthesis portion of a system according to
principles of the present invention. In Fig-
ure 4, those elements which are the same
as those illustrated in Figure 1 are desig-
nated by the same reference number and
are not described in detail below. In Fig-
ure 4, the respective output terminals of
the preprocessor 104 are coupled to corre-
sponding input terminals of a synthesizer
306 and a controller 308. Respective output
terminals of the synthesizer 306 are cou-
pled to corresponding data input terminals
of a display device 310. A synthesizer con-
trol output terminal of the controller 308 is
coupled to a control input terminal of the
synthesizer 306, and a display device con-
trol output terminal of the controller 308 is
coupled to a control input terminal of the
display device 310. The display device in-
cludes a display screen 312 and a set of user
controls 314. These user controls 314 may
include, among other controls, knobs, il-
lustrated as circles, and buttons, illustrated
as rounded squares. A user control out-
put terminal of the display device 310 is
coupled to a user control input terminal of
the controller 308. A bidirectional terminal
of the controller 308 is coupled to a corre-
sponding terminal of the database 110.
As illustrated in Figure 4, the display
device 310 can display the 12-lead ECG
waveforms from the synthesizer 306 on the
display screen 312 in the usual manner for
ECGwaveforms. In addition, the controller
308 can respond to user input from the
user controls 314 on the display device 310,
and can condition the display device 310 to
display information on the display screen
312. The controller 308 can also control
the operation of the synthesizer 306 in re-
sponse to the lead signals from the pre-
processor 104, in amanner to be described
in detail below. The synthesizer 306 in turn
performs the matrix multiplication illus-
trated in Figure 3 on the lead signals re-
ceived from the preprocessor 104 to gener-
ate the lead signals, possibly including syn-
thesized lead signals, for the display device
310.
In general operation, the plurality of
electrodes 102 are attached to predeter-
mined locations on a patient by an oper-
ator. The operator then manipulates the
user controls 314 to enter information con-
cerning the monitoring desired, including,
e.g. the identification of the patient. The
controller 308 then conditions the synthe-
sizer 306 to operate in a normal mode. The
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preprocessor 104 provides the eight lead
signals to the synthesizer 306. In the nor-
mal mode, all of the plurality 102 of elec-
trodes are operational, and all lead sig-
nals from the preprocessor 104 are accu-
rate. The controller 308 conditions the syn-
thesizer 306 to pass the input lead signals
through to the outputwithout change. This
may be done by placing an identity matrix
in the matrix 307 of the synthesizer 306.
The synthesizer 306 performs the matrix
multiplication illustrated in Figure 3 using
the identity matrix to transfer the received
12 lead signals to the display device 310.
The display device 310, in turn, displays
the 12-lead ECG waveforms from the syn-
thesizer 306 on the display screen 312 all in
a normal manner. In this mode of opera-
tion, the similarity coefficient has its maxi-
mum value.
As described above, however, it is pos-
sible for one or more electrodes to detach
from the patient. This may be detected au-
tomatically by the controller 308 by any of
a number of known techniques. For exam-
ple, if no pulse component is detected in
a lead signal, then that lead signal may be
identified as inoperative. In this case, the
controller 308 retrieves the entry from the
database 110 for the current patient, e.g.
patient 2 (of Figure 1), and from that en-
try retrieves the matrix M appropriate for
synthesizing the lead or leads which have
been identified as inoperative. The con-
troller 308 then inserts that matrix M into
the matrix 307 in the synthesizer 306. The
synthesizer 306 performs the matrix mul-
tiplication described above with reference
to Figure 3, to provide a synthesized signal
for the lead or leads which are inoperative.
The display device 310 continues to display
the 12 lead waveforms received from the
synthesizer 306, including the synthesized
lead waveform or waveforms.
The controller 308 may further con-
dition the display device 310 to display
an indication on the display screen 312
to alert the operator that one or more of
the displayed leads are being synthesized.
This indication may include highlighting
the synthesized lead waveform(s), or the
background of the synthesized lead wave-
form(s), in some fashion, such as varying
the intensity or color of the synthesized
lead waveform(s) relative to the other lead
waveforms; or placing an indicative sym-
bol in the vicinity of the synthesized wave-
form(s); or displaying a textual identifica-
tion of the synthesized waveform(s) on the
display screen 312. In addition, the con-
troller 308 may retrieve the corresponding
similarity coefficient SC from the database
110 and display that on the display screen
312 as an indication of the expected accu-
racy of the displayed waveforms.
Also as described above, all the desired
locations on the body of the patient may
not be available due to surgery or injury.
In this case, the operator can manipulate
the user controls 314 to provide an indica-
tion of the sites which are unavailable to
the controller 308. The controller 308 will
then generate a list of electrode configura-
tions for the available locations, and access
the data in the database 110 entry associ-
ated with this patient to retrieve the simi-
larity coefficients SC associated with each
of the electrode configurations. The con-
figuration with the highest similarity con-
figuration SC, i.e. generating the most ac-
curate 12 lead ECG waveform synthesis, is
then displayed on the display screen 312
of the display device 310. The controller
308 retrieves the matrix M associated with
that configuration and places it in the ma-
trix 307 in the synthesizer 306. In accor-
dance with the displayed information, the
operator then applies the electrodes in this
desired configuration. Then the display
of the 12 lead ECG waveforms can pro-
ceed as described above, optionally includ-
ing specially highlighting the synthesized
lead waveforms and displaying the similar-
ity coefficient.
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Alternatively, the complete list of avail-
able electrode configurations along with
their similarity coefficients may be dis-
played on the display screen 312 of the dis-
play device 310. The operator can then
select one of the available configurations
based not only on the similarity coeffi-
cients but possibly also on other clinical
considerations. The operator then ma-
nipulates the user controls 314 to indicate
which of the configurations has been se-
lected, and applies the electrodes in that
configuration. The controller 308 retrieves
the appropriate matrix M from the data-
base 110 and supplies it to the matrix 307
in the synthesizer 306. The controller 308
then conditions the synthesizer 306 to syn-
thesize the 12 lead ECG waveforms for that
configuration, as described above.
By either automatically specifying the
electrode configuration with the highest
similarity coefficient, or by providing a list
of electrode configurations with an asso-
ciated similarity coefficient to the opera-
tor for selection, it is assured that an elec-
trode configuration producing 12 lead ECG
waveformswith themaximumaccuracy, or
the maximum accuracy given the existing
clinical considerations, will be displayed.
It is sometimes desired to use a non-
standard electrode configuration. For ex-
ample, a physician may desire data re-
lated to the right side of the heart, or fur-
ther around the left side of the heart. The
former requires one or more electrodes
placed at locations to the right of the heart,
and the latter at locations further to the left
of the heart. There are predetermined such
locations known as V1R, V2R, V3R, V4R, V5R
and V6R on the right side of the chest and
V7, V8 and V9 around the left side of the
patient. Prior systems required either ex-
tra electrodes and circuitry to process sig-
nals and display thewaveforms from them,
or that electrode(s) be removed from the
standard locations V1, V2, V3, V4, V5 and
V6 to be placed at the other location(s) V7,
V8, V9, V1R, V2R, V3R, V4R, V5R and V6R.
Moving a lead from a standard location
meant losing the lead signal generated by
that electrode.
In the system illustrated in Figure 4, the
operatormanipulates the user controls 314
on the display device 310 to indicate that
it is desired to move one or more of the
electrodes from their standard locations to
another location. In response, the con-
troller 308 retrieves the entry in the data-
base 110 corresponding to the patient, and
retrieves all of the similarity coefficients SC
for the configurations missing the num-
ber of leads desired to be moved. That
is, if two leads are desired to be moved,
then the controller 308 retrieves the simi-
larity coefficients SC for all of the configu-
rations missing two leads. The controller
308 then automatically selects the configu-
ration having the highest similarity coeffi-
cient SC from among those retrieved, and
displays information on the display screen
312 of the display device 310 specifying the
electrode configuration corresponding to
that similarity coefficient SC. The opera-
tor places the appropriate electrodes at the
specified locations on the patient, and then
places the remaining leads at the other de-
sired locations.
The controller 308 then retrieves the
matrix M corresponding to the specified
electrode configuration from the database
110 and supplies it to the matrix 307
in the synthesizer 308. The synthesizer
306 then synthesizes the standard 12 lead
ECG waveforms from the available leads
in the standard locations in the manner
described above. The controller 308 may
further condition the display device 310
to simultaneously display the 12 lead ECG
waveforms and the lead waveforms from
the other locations (e.g. from the right side
of the chest) on the display screen 312, in a
known manner. As before, the synthesized
waveforms may be specially identified on
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the display screen and/or the similarity co-
efficient displayed.
As before, alternatively, a list of possi-
ble electrode configurations with their re-
spective similarity coefficients, may be dis-
played on the display screen 312 of the dis-
play device 310, from which the operator
selects one based on the similarity coef-
ficients and other clinical considerations.
The operator manipulates the user con-
trols to select one of the configurations and
the controller 308 conditions the system to
operate in that configuration as described
above. Again, as before, use of the simi-
larity coefficients permits synthesis of the
standard 12 lead ECG waveforms having
the maximum accuracy, or the maximum
accuracy based on existing clinical consid-
erations.
In some situations, the use of the full
set of 10 electrodes to produce the full 12
lead ECG is not desirable, for example, if a
patient is being transported from one loca-
tion to another, or if the ECG is beingmon-
itored by telemetry. In these situations, it
is desired to use the minimum number of
electrodes for patient comfort, while still
maintaining a desired level of accuracy in
the ECG.
Under these situations, the controller
308 retrieves the patient entry from the
database 110. The similarity coefficients
SC for all the synthesis entries correspond-
ing to one missing lead are compared, and
the entry with the largest similarity coef-
ficient is selected. Similarly the similarity
coefficients for all the synthesis entries cor-
responding to two missing leads are com-
pared and the entry with the largest sim-
ilarity coefficient is selected. This is re-
peated for each possible number (three,
four, etc.) of missing leads. Then the
list of selected entries, including the elec-
trode configuration and the similarity co-
efficient, is displayed on the display screen
312 of the display device 310. The operator
then selects the entry which satisfies the
minimum accuracy desired using the user
controls 314, and attaches the electrodes
to the patient according to the configura-
tion represented by that entry. The con-
troller 308 conditions the system to synthe-
size the 12 lead ECG from the selected elec-
trode configuration. In this manner, the
highest accuracy for the number of elec-
trodes selected is guaranteed, while mini-
mizing to the extent possible the number
of electrodes necessary, thus, minimizing
patient discomfort.
In the preceding description, it was as-
sumed that a full 12 lead ECG for the pa-
tient was previously available to be ana-
lyzed. This may not always be the case.
In those cases, of course, there can be
no entry in the database 110 for that pa-
tient. Referring again to Figure 1, 12 lead
ECG data from a large population may be
analyzed by the analysis circuit 108 as a
group, in the manner illustrated in Figure
2. In this case, the eight lead complexes as-
sembled in the memory 106 by block 204
will be generated as the aggregation of all
the available eight lead ECG complexes for
all the people in the population. These
general-population lead complexes will be
analyzed in the manner illustrated in Fig-
ure 2 above to produce a set of general-
population matrices M and corresponding
similarity coefficients SC. This set of matri-
ces M and similarity coefficients SC will be
stored in a general population entry in the
database 110, illustrated in Figure 1 as an
entry labeled General 1. The entry Gen-
eral 1 has exactly the same data structure
as that illustrated for Patient 2. The data in
the General 1 entry is based on the aggre-
gated 12 lead complexes for the entire pop-
ulation, however.
If a patient does not have an entry in
the database 110, then the general pop-
ulation entry General 1 is retrieved, and
the data in that entry used in exactly the
samemanner as described above for any of
the situations described above: e.g. syn-
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thesizing detached electrodes, or synthe-
sizing leads for electrodes whose locations
are unavailable or which have been pur-
posely moved to another location. When
sufficient complete 12 lead ECG complexes
have been accumulated for the patient,
then the analysis described above with ref-
erence to Figure 1 and Figure 2 is per-
formed on those complexes, a new entry
in the database 110 is created for the pa-
tient containing the matrices and associ-
ated similarity coefficients resulting from
that analysis, and the processing continues
as described above using the newly created
entry in the database 110.
It is also possible to partition the peo-
ple in the general population discussed
above into groups termed categories. For
example, groupings may be made by
sex, by weight, by age group, by disease
and/or by cardiac health (e.g. normal, is-
chemic/acute myocardial infarction, bun-
dle branch blockage, etc.). The ECG com-
plexes associated with the general popu-
lation of patients may be partitioned in a
corresponding manner and analyzed sep-
arately as described above with reference
to Figure 1 and Figure 2 to produce fur-
ther category-specific general-population
entries in the database 110, designated as
General 2 to General M in Figure 1.
When a patient is being prepared for
an ECG, the operator manipulates the user
controls 314 on the display device 310 to
supply characteristics of the patient (name,
sex, age, weight, etc.) to the controller
308. As described above, the controller
308 queries the database 110 for a patient
entry for that patient. If a patient does
not have a patient entry in the database
110, then the other characteristics related
to that patient are processed by the con-
troller 308 to assign the patient to one of
the available categories. The controller 308
then retrieves the category-specific general
population entry corresponding to the cat-
egory to which the patient was assigned,
and uses the synthesis entries in that entry
to provide a 12 lead ECG until that patient
is assigned his own entry in the database
11.
Claims
What is claimed is:
1. An electrocardiogram (ECG) system,
comprising: a source of a plurality
of subsets of data representing ECG
lead signals associated with a cor-
responding plurality of sets of ECG
electrode configurations; a synthe-
sizer, coupled to the ECG lead sig-
nal source, for generating a plural-
ity of sets of data representing syn-
thesized ECG lead signals from the
plurality of subsets of data represent-
ing ECG lead signals; a source of data
representing a plurality of accuracy
values corresponding to the plural-
ity of sets of data representing syn-
thesized ECG lead signals; and a dis-
play generator for initiating genera-
tion of data representing at least one
display image identifying a plural-
ity of accuracy values and identifying
the corresponding plurality of sets
of ECG electrode configurations and
enabling a user to select a configura-
tion based on accuracy values.
2. The system of claim 1 wherein the
display image identifies the plurality
of sets of ECG electrode configura-
tions enabling a user to select a con-
figuration based on electrode posi-
tions.
3. The system of claim 1 wherein the
synthesizer comprises circuitry for
calculating a function of the subset
of ECG lead signals to generate the
set of synthesized ECG lead signals
and further comprising
an analyzer, coupled to the synthe-
sizer and the accuracy representative
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data source, and responsive to a set
of preexisting ECG lead signals, for
generating the function of the subset
of ECG lead signals and the accuracy
representative data.
4. The system of claim 3 wherein the
analyzer comprises circuitry, respon-
sive to the set of preexisting ECG lead
signals, for calculating respective co-
efficients of a linear equation rep-
resenting the function and an indi-
vidual coefficient is associated with
an individual ECG lead signal in the
subset of ECG lead signals.
5. The system of claim 1 wherein said
synthesizer adaptively generates a
set of data representing a selected
one of (a) patient specific synthe-
sized ECG lead signals and (b) pa-
tient independent synthesized ECG
lead signals, in response to user
command.
6. The system of claim 1 wherein an ac-
curacy value comprises a similarity
coefficient.
7. The system of claim 6 wherein said
accuracy value is responsive to the
RMS values of the preexisting ECG
lead signals and the synthesized ECG
lead signals.
8. The system of claim 6 wherein
said similarity coefficient SC
comprises SC = (RMSsource −
RMSer ror )/RMSsource ) where rep-
resents RMSsource the root mean
square value of the preexisting ECG
lead signals and RMSer ror repre-
sents the RMS value of the difference
between the preexisting ECG lead
signals and the synthesized ECG lead
signals.
9. The system of claim 1 wherein said
user is able to select a configuration
based on at least one of, (a) accu-
racy values and (b) clinical consid-
erations, by selecting an image ele-
ment in said at least one display im-
age.
10. The system of claim 1, wherein the
ECG lead signal source comprises: a
set of electrodes; and a preproces-
sor, responsive to respective signals
from the electrodes to generate said
plurality of subsets of data represent-
ing ECG lead signals associated with
said corresponding plurality of sets
of ECG electrode configurations.
11. The system of claim 1, wherein: the
ECG lead signal source generates an
input vector representing an individ-
ual subset of ECG lead signals; and
the synthesizer comprises: a ma-
trix for containing a function of said
individual subset of ECG lead sig-
nals; and a processor for performing
a matrix multiplication of the matrix
times said input vector to generate
a corresponding output vector com-
prising a subset of data representing
ECG lead signals.
12. The system of claim 1, further com-
prising a database, containing a plu-
rality of functions respectively corre-
sponding to said plurality of subsets
of data representing ECG lead signals
associatedwith a corresponding plu-
rality of sets of ECG electrode con-
figurations; and a controller, cou-
pled between the database and the
synthesizer, and comprising: cir-
cuitry for retrieving from the data-
base the function corresponding to
an individual subset of ECG lead sig-
nals; and circuitry for conditioning
the synthesizer to apply the retrieved
function to said individual subset of
ECG lead signals.
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13. The system of claim 1, including,
a database containing a plurality of
matrices respectively representing a
plurality of functions; a function re-
trieving processor for retrieving from
the database the matrix correspond-
ing to an individual subset of ECG
lead signals; a conditioning proces-
sor for supplying the retrieved ma-
trix to the synthesizer; and wherein
the ECG lead signal source generates
an input vector representing said in-
dividual subset of ECG lead signals;
and the synthesizer, receives the re-
trieved matrix corresponding to said
individual subset of ECG lead sig-
nals; and multiplies said input vec-
tor and retrieved matrix to generate
a corresponding output vector repre-
senting ECG lead signals.
14. The system of claim 1 wherein: said
synthesizer adaptively generates a
set of data representing a selected
one of, (a) patient specific synthe-
sized ECG lead signals and (b) pa-
tient independent synthesized ECG
lead signals, together with an asso-
ciated accuracy representative value,
in response to user command.
15. The system of claim 14, wherein
said synthesizer adaptively gener-
ates a set of data representing ECG
lead signals in at least one of, (i)
standard electrode positions and (ii)
non-standard electrode positions.
16. The system of claim 1 further com-
prising: a memory, responsive to
the set of preexisting ECG lead sig-
nals, for storing respective ECG com-
plexes respectively corresponding to
the ECG lead signals; and a proces-
sor, coupled to the memory, for cal-
culating a plurality of functions, and
associated accuracy values, in re-
sponse to the stored ECG complexes.
17. The system of claim 16 wherein said
function comprises a matrix.
18. A method supporting operation of
an electrocardiogram (ECG) system,
comprising the steps of: storing a
plurality of subsets of data represent-
ing ECG lead signals associated with
a corresponding plurality of sets of
ECG electrode configurations; gen-
erating a plurality of sets of data rep-
resenting synthesized ECG lead sig-
nals from the plurality of subsets of
data representing ECG lead signals;
storing data representing a plurality
of determined accuracy values cor-
responding to the plurality of sets of
data representing synthesized ECG
lead signals; and initiating genera-
tion of data representing at least one
display image identifying a plural-
ity of accuracy values and identifying
the corresponding plurality of sets
of ECG electrode configurations and
enabling a user to select a configura-
tion based on accuracy values.
19. An electrocardiogram (ECG) system,
comprising: a source of a plurality
of subsets of data representing ECG
lead signals associated with a cor-
responding plurality of sets of ECG
electrode configurations; a synthe-
sizer, coupled to the ECG lead sig-
nal source, for employing the plu-
rality of subsets of data representing
ECG lead signals in adaptively gener-
ating a set of synthesized data rep-
resenting a selected one of, (a) pa-
tient specific synthesized ECG lead
signals and (b) patient independent
synthesized ECG lead signals; and a
display generator for initiating gen-
eration of data representing at least
one display image showing said syn-
thesized data.
20. A system according to claim 19,
wherein said synthesizer automati-
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cally selects to perform said selected
one of, (a) said patient specific ECG
lead signal synthesis and (b) said pa-
tient independent ECG lead signal
synthesis in response to a determi-
nation a subset of data representing
patient specific ECG lead signals is
available.
21. A system according to claim 19,
wherein said synthesizer adaptively
generates said set of synthesized
data in response to user selection,
via said at least one display image,
of synthesis of said selected one of,
(a) patient specific synthesized ECG
lead signals and (b) patient indepen-
dent synthesized ECG lead signals.
22. A system according to claim 19, in-
cluding, a source of data represent-
ing accuracy values corresponding
to sets of data representing patient
specific synthesized ECG lead signals
and patient independent synthe-
sized ECG lead signals and wherein
said at least one display image
shows accuracy values associated
with said patient specific synthe-
sized ECG lead signals and with
said patient independent synthe-
sized ECG lead signals.
23. A method supporting operation of
an electrocardiogram (ECG) system,
comprising the steps of: storing a
plurality of subsets of data represent-
ing ECG lead signals associated with
a corresponding plurality of sets of
ECG electrode configurations; adap-
tively generating a set of synthesized
data representing a selected one of,
(a) patient specific synthesized ECG
lead signals and (b) patient indepen-
dent synthesized ECG lead signals, in
response to user command, said syn-
thesized data being generated using
the plurality of subsets of data rep-
resenting ECG lead signals; and ini-
tiating generation of data represent-
ing at least one display image show-
ing said synthesized data.
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Summary
The electrocardiogram (ECG) is one of the most widely used diagnostic methods for the
evaluation and treatment of patients with (acute) cardiac complaints. Continuous 12-
lead ECG patient-monitoring techniques have gained an important place on intensive
and medium care units, but have practical and technical considerations. The quality of
ECG registration can be distorted by motion artifacts and noise. Electrodes may need
to be removed when certain diagnostic tests, such as echocardiograms or X-rays, are re-
quired. In addition, 12-lead ECG patient monitoring on telemetry or medium care units
is often not practical or technically possible because of the number of electrodes and the
decreased patient comfort.
The aims of this thesis were to investigate, develop, and validate ECG reconstruction
methodswith reduced lead sets of the 12-lead ECG and to address continuous ECG regis-
tration problemswhichmay occur as a result of changes in body position and differences
in standard versus monitoring lead configurations.
Part I: ECG reconstruction
In Chapter 2, a reconstruction method was developed and assessed on a set of 2484 10-
second, 12-lead ECGs obtained from patients diagnosed with acute myocardial infarc-
tion, angina pectoris, or atypical chest pain. A total of 62 lead subsets of the 12-lead ECG
were considered by systematically removing one ormore precordial leads, but always in-
cluding leads I and II. After splitting the data set in an equally-sized learning and test set,
general and patient-specific coefficients were computed. Reconstruction performance
was assessed by correlation coefficients and root mean square errors (RMSE) between
the original and reconstructed leads. General reconstruction allows synthesis of two to
three excluded precordial leads, while for patient-specific reconstruction a minimal set
including the limb leads and at least two precordial leads suffices.
Chapter 3 describes an evaluation of reconstruction performance of the general and
patient-specific methods over time. For this purpose, the general and patient-specific
methods were applied on a data set of 24-hour continuous 12-lead ECG recordings of
patients with transient ischemic episodes. General and patient-specific reconstruction
methods were applied on the test set. Reconstruction performance was assessed by cor-
relation between the original and reconstructed leads over the QRS and T waves. Aver-
age andmaximum absolute ST differences (|∆ST|) were determined between the original
and reconstructed leads. Overall, accurate reconstruction of the 12-lead ECG is possible
over time. General reconstruction performance remained at a similar performance level.
Patient-specific performance initially slightly decreased and then stabilized over time,
but remained much better than general reconstruction.
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Part II: Clinical evaluation
The secondpart of the thesis consists of three chapters containing evaluations of the ECG
reconstruction methods in clinical settings. Chapters 4 and 6 were set up as prospective
studies and were carried out in collaboration with the Duke ECG Ischemia Core Labora-
tory (Durham, NC, USA).
Chapter 4 presents a validation study of the reconstruction methods in recordings of
patients undergoing a percutaneous coronary intervention procedure. The study was set
up in the catheterization laboratory of the VA Medical Center (Durham, NC, USA). In 39
recordings, one or more balloon inflations were performed, which caused ischemia and
ST-T changes on the ECG. The inflations were marked and were compared to a previ-
ously defined baseline ECG recorded prior to the procedure. ECGs were reconstructed
using general and patient-specific methods with reduced lead sets including the limb
leads and at least two precordial leads. Accuracy on the reproductions of the ST-T chan-
ges was assessed in the reconstructed leads. Overall, it was found that the general and
patient-specific reconstruction methods, with the limb and two precordial leads, accu-
rately derive the absent leads at baseline and during balloon inflation.
In Chapter 5, the general reconstruction method with a reduced lead set consisting
of all limb leads and precordial leads V2 and V5, was evaluated for use in a pre-hospital
situation. In these emergency care situations, early diagnosis, risk stratification and ini-
tiation of treatment on the spot by the ambulance service reduces mortality and final
infarct size. Use of a reduced lead set methodmay save time and can be implemented in
devices, such as defibrillators. The general reconstruction method with lead subset I, II,
V2, and V5 was applied on a data set of 12-lead ECGs obtained from the ambulance ser-
vice in Rotterdam. This data set, previously used to develop a computer-assisted throm-
bolytic triage algorithm, consisted of a learning set (n=1435) and test set (n=825). Re-
construction performance was assessed using |∆ST| and misclassifications. High to very
high sensitivity and specificity was observed. As a result of reconstruction differences,
three cases would have been referred to a PCI center instead of receiving thrombolytic
treatment. Three false negative cases would not have received therapy, but would have
been referred to the emergency room for further evaluation. Overall, the general recon-
struction method with the 4-lead subset can be considered in pre-hospital situations.
Chapter 6 presents a comparative assessment of the general and patient-specific re-
construction methods and the well-known EASI lead system. EASI uses five electrodes
on conveniently defined electrode sites fromwhich all 12 leads are derived. The three re-
construction methods were evaluated on a set of 44 recordings of patients undergoing a
percutaneous coronary intervention procedure. Derivation performance was measured
with |∆ST|, RMSE, and several clinical decision rules. The overall highest differences
(|∆ST|, RMSE, and incorrectly classified cases) were found in EASI. General reconstruc-
tion performed better than EASI and patient-specific reconstruction had the overall best
performance.
Part III: Patientmonitoring
Twowell-knownproblems thatmay occur during long-term continuous ECGmonitoring
are described and addressed by methods similar to and based on the earlier described
ECG reconstruction methods.
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First, it is well-known that a body position change (BPC) may alter the 12-lead ECG,
resulting in changes in QRS and ST amplitudes and T-waves. It is likely that these ECG
changes canbe interpreted as ischemia andmay trigger false positive patient-monitoring
alarms. Chapter 7 presents a study which aim was to quantify these body position chan-
ges and to develop a detection method and a patient-specific correction method. The
study was carried out on a set of 114 patients admitted to the coronary care unit at the
Thoraxcentrum. Each patient underwent a body position test (supine, left, right, and
upright position). A body position change detector was developed using the Explore au-
tomated rule induction algorithm. To distinguish positional from ischemic changes, a
separate set of 71 PCI recordings was used including ECGs recorded at rest and during
balloon inflation. The ECG variationswere corrected using a patient-specific reconstruc-
tion method based on a combination of leads. Performance of the correction method
was assessed by Pearson’s correlation coefficient and by similarity coefficient. ST chan-
ges of ≥ 100 µV in ≥ 1 lead caused by BPC were observed in 50 (43%) patients. The most
pronounced changes were found in the left-lateral position. With a fixed specificity at
95%, sensitivity of the detection rules was for left 97.4%, right 69.9%, upright 64.3% and
combined: 66.1%. False alarm rate per hour in the PCI set was 2.22 at rest and 4.31 dur-
ing balloon inflation. Performance of the patient-specific correction method yielded an
overall correlation coefficient of 0.970 and similarity coefficient of 0.889.
Second, electrode positions for continuous monitoring are different from those for
recording of a standard 12-lead ECG, because the standard sites at the wrists and ankles
may introduce noise and artifacts. Therefore, most institutionsmove the limb electrodes
to the chest and lower abdomen on monitoring positions defined by Mason and Likar.
However, this changemay alter the ECG significantly andmay produce alterations in the
frontal QRS axis, Q waves in the inferior leads, and R amplitudes. A study was set up
to develop a method to correct for these changes. With a data set of 93 subjects with
a simultaneously recorded 9-lead ECG in standard and monitoring positions, patient-
specific and generalized methods were developed and evaluated. The main results are
that general reconstruction can be used to map the monitoring leads to the standard
leads with high accuracy.
Discussion and conclusions
Chapter 9 contains a general discussion of the described reconstruction methods. In
conclusion, the methods developed and clinically validated in this thesis may alleviate
problems encountered during ECG monitoring. Reconstruction of up to four precor-
dial leads with general or patient-specific coefficients was shown to be accurate. It was
found that patient-specific reconstruction is superior over general reconstruction over
time, and during known ST changes caused by balloon inflation. In pre-hospital deci-
sion making, a general reconstruction method with a reduced lead subset containing
leads I, II, V2, and V5 might be considered. ST-T changes caused by body position chan-
ges can be distinguished from ischemic changes and correction methods have been de-
veloped to correct for these changes with high reconstruction performance. General and
patient-specific correctionmethods have been developed and evaluated to correct chan-
ges caused by repositioning the standard limb electrodes to the monitoring electrode
positions.

Samenvatting
Het elektrocardiogram is één van de meest gebruikte diagnostische methoden voor de
evaluatie en behandeling van patiënten met (acute) cardiale klachten. Continue 12-
afleidingen ECG-bewakingstechnieken hebben inmiddels een belangrijke plaats gekre-
gen op intensive en medium care afdelingen, maar hebben praktische en technische
beperkingen. Zo kan de kwaliteit van de ECG-registratie worden verstoord door bewe-
gingsartefacten en ruis. Tevens worden elektroden doorgaans verwijderd of verplaatst
ten behoeve van diagnostische onderzoeken, zoals echocardiografie of röntgenfoto’s.
Tenslotte is 12-afleidingen ECG-bewaking op telemetrische en medium care afdelingen
onpraktisch vanwege de hoeveelheid aan kabels en elektroden en het verlaagde patiënt-
comfort.
De onderzoeksdoelen van dit proefschrift bestaan uit het onderzoeken, ontwikkelen
en valideren van ECG-reconstructiemethoden op basis van deelverzamelingen van het
12-afleidingen elektrocardiogram en het aanpakken van problemen bij continue ECG-
registratie, die kunnen voorkomen als gevolg van houdingsveranderingen en de verschil-
len die optreden na het verplaatsen van de extremiteitselektroden van de standaardpo-
sities (polsen en enkels) naar de patiëntbewakingsposities.
Deel I: ECG reconstructie
In hoofdstuk 2 is een reconstructiemethode ontwikkeld en geëvalueerd op een verza-
meling van 2484 12-afleidingen ECG’s van 10 seconden. Deze ECG’s zijn verkregen van
patiënten die gediagnosticeerd zijn met een acuut myocardinfarct, angina pectoris of
atypische pijn op de borst. Een totaal van 62 deelverzamelingen van het 12-afleidingen
ECG werden gedefinieerd door het systematisch verwijderen van één of meerdere pre-
cordiale afleidingen, maar waarbij afleidingen I en II altijd waren opgenomen. Na het
opsplitsen van de dataset in een leer- en testset werden algemene en patiëntspecifieke
coëfficiënten berekend. Reconstructieprestaties werden beoordeeld met correlatiecoëf-
ficiënten en root-mean-square fouten tussen de originele en gereconstrueerde afleidin-
gen. Algemene reconstructie maakt het mogelijk om drie precordiale afleidingen van
het 12-afleidingen ECG te reconstrueren, terwijl het met patiëntspecifieke reconstructie
mogelijk is om vier precordiale afleidingen goed te reconstrueren.
In hoofdstuk 3 was de onderzoeksvraag hoe goed de reconstructieprestaties van de
generale en patiëntspecifieke methoden zouden zijn over een langere periode. Voor dit
doelwerdende algemene enpatiëntspecifiekemethoden toegepast op eendataverzame-
ling van continue 24-uurs, 12-afleidingen ECG-opnamen van patiëntenmet ischemische
episodes. Algemene en patiëntspecifieke methoden werden toegepast op de testverza-
meling. Reconstructieprestaties werden beoordeeld met correlatiecoëfficiënten bere-
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kend tussen de originele en gereconstrueerde afleidingen over de QRS- en T-golven. Ge-
middelde en maximum absolute ST-verschillen (|∆ST|) werden bepaald tussen de origi-
nele en gereconstrueerde afleidingen. Nauwkeurige reconstructie van het 12-afleidingen
ECG is mogelijk gebleken gedurende een periode van 24 uur. Reconstructieprestaties
met algemene coëfficiënten bleven op een gelijk nivo. Prestaties van patiëntspecifieke
reconstructie namen initieel af, maar stabiliseerden na verloop van tijd. Prestaties van
patiëntspecifieke reconstructie bleven over de hele periode hoger dan algemene recon-
structie.
Deel II: Klinische evaluatie
Het tweede deel van het proefschrift bestaat uit drie hoofdstukken, waarin de recon-
structiemethoden worden geëvalueerd in een klinische omgeving. De studies in hoofd-
stuk 4 en 6 zijn prospectief uitgevoerd in samenwerkingmet het Duke Ischemia Core La-
boratory (Durham, NC, VS). Hoofdstuk 4 presenteert een validatiestudie met opnamen
voor en tijdens een percutane coronaire interventie. De studie is uitgevoerd in het cathe-
terisatielaboratorium van het VA Medical Center (Durham, NC, VS), waarbij algemene
en patiëntspecifieke reconstructiemethoden werden gebruikt. In elk van de 39 opnamen
werden één of meerdere balloninflaties uitgevoerd, wat ischemie en ST-T veranderingen
op het ECG tot gevolg kan hebben. De balloninflaties werden gemarkeerd en vergele-
ken met een eerder gedefinieerd basislijn-ECG. Nauwkeurigheid van de ST-T metingen
werd beoordeeld in de gereconstrueerde afleidingen. Het is gebleken dat de algeme-
ne en patiëntspecifieke reconstructiemethoden, met de extremiteitsafleidingen en twee
precordiale afleidingen, nauwkeurig de afwezige afleidingen kunnen reconstrueren op
het basislijn-ECG en het ECG tijdens balloninflatie.
Hoofdstuk 5 bevat een evaluatie voor prehospitale toepassing van de algemene ECG-
reconstructiemethode met een gereduceerde afleidingenverzameling bestaande uit alle
extremiteitsafleidingen en precordiale afleidingen V2 en V5. In deze spoedeisende situ-
aties kan vroege diagnose, risicostratificatie en start van een therapeutische behande-
ling op locatie door het ambulancepersoneel de mortaliteit en infarctgrootte verkleinen.
Het gebruik van een gereduceerde afleidingenset kan tijd besparen en kan worden ge-
ïmplementeerd in apparatuur zonder een 12-afleidingenoptie, zoals defibrillatoren. De
algemene reconstructiemethode is toegepast op een dataverzameling van 12-afleidingen
ECG’s, die zijn verkregen van de ambulancedienst in Rotterdam. Deze dataverzame-
ling, die eerder gebruikt is om een computerondersteunend algoritme voor prehospitale
thrombolyse te ontwikkelen, bestaat uit een leer- (n=1435) en testverzameling (n=825).
Reconstructieprestaties werden beoordeeld met absolute ST-verschillen en misclassifi-
caties. Hoge tot zeer hoge sensitiviteit en specificiteit werd gevonden, met drie misge-
classificeerde (vals negatief) gevallen, die geen therapie zouden krijgen, maar gestuurd
zouden worden naar de spoedeisende hulp. De algemene reconstructiemethode kan in
overweging worden genomen voor gebruik in prehospitale situaties.
In hoofdstuk 6 is een vergelijkende studie gedaan naar de algemene en patiëntspeci-
fieke reconstructiemethoden en het EASI afleidingensysteem. Het EASI systeem gebruikt
vijf elektroden op goed gedefinieerde elektrodelocaties, waarmee alle 12 afleidingen be-
rekend kunnen worden. De drie methoden werden beoordeeld op een set van 44 opna-
men van patiënten die een percutane coronaire interventie ondergingen. Reconstructie-
prestaties werden bepaaldmet absolute ST-verschillen, root-mean-square fouten en ver-
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schillende klinische beslisregels. De grootste absolute ST-verschillen, root-mean-square
fouten en misclassificaties werden gevonden bij de ECG-reconstructies van EASI. De
prestaties van de algemene reconstructiemethode waren beter dan EASI; patiëntspeci-
fieke reconstructie bleek de hoogste prestatie te hebben.
Deel III: Patiëntbewaking
In hoofdstuk 7 en 8 is onderzoek gedaan naar oplossingen voor twee veelvoorkomende
problemen tijdens langdurige en continue ECG-patiëntbewaking. Voor deze oplossingen
zijn methoden ontwikkeld die gebaseerd zijn op de eerder beschreven reconstructieme-
thoden.
Ten eerste, een lichaamspositieverandering (LPV) kan het 12-afleidingen ECG zo-
danig veranderen dat er verschuivingen kunnen optreden in het QRS-complex, het ST-
segment en de T-golf. Deze ECG-veranderingen kunnen geïnterpreteerd worden als is-
chemie en kunnen als gevolg hiervan onterechte alarmen veroorzaken. In hoofdstuk 7
is een studie uitgevoerd met als doel om ECG-veranderingen als gevolg van een LPV te
kwantificeren en om een detectie- en correctiemethode te ontwikkelen. Hierbij is ge-
bruik gemaakt van een dataverzameling van 114 patiënten die waren opgenomen op de
coronary care unit van het Thoraxcentrum. Elke patiënt heeft een lichaamspositietest
ondergaan, waarbij de patiënt verschillende posities (liggend op de rug, linkerzij, rech-
terzij en rechtop-zittend) moest aannemen. Een LPV-detector werd ontwikkeld met het
Explore beslisregel-inductiealgoritme. Om ischemische veranderingen te onderschei-
den van lichaamspositieveranderingen, is een aparte verzameling gebruikt van 71 op-
namen die zijn gemaakt voor en tijdens een percutane coronaire interventie procedure.
Tijdens elke opname zijn één of meerdere balloninflaties uitgevoerd. ECG-variaties kun-
nen worden gecorrigeerd door een patiëntspecifieke reconstructiemethode gebaseerd
op een aantal afleidingen. Reconstructieprestaties werden beoordeeld op basis van Pe-
arson’s correlatiecoëfficiënt en similarity coefficient. ST-veranderingen van ≥ 100 µV in
≥ 1 afleiding veroorzaakt door een LPV werden gevonden bij 50 patiënten (43%). De
meest geprononceerde ST-veranderingen werden gevonden in de links-laterale posities.
De sensitiviteit van de beslisregels met een gefixeerde specificiteit van ten minste 95%
was voor links: 97.4%, rechts: 69.9%, rechtop: 64.3% en gecombineerd: 66.1%. Het aan-
tal onterechte alarmen per uur in de PCI-verzameling was 2.22 bij rust en 4.31 tijdens
balloninflatie. Voor patiëntspecifieke correctie voor alle posities gecombineerd was de
correlatiecoëfficiënt 0.970 en de similarity coefficient 0.889.
Ten tweede worden de extremiteitselektroden voor gebruik bij continue patiëntbe-
waking op een anderemanier geplaatst dan voor het standaard 12-afleidingen ECG, om-
dat de standaardposities op de polsen en enkels ruis en artefacten op het ECG kunnen
veroorzaken. Daarom verplaatsen veel instellingen de extremiteitselektroden naar lo-
caties op de borstkas en de onderbuik, zoals aanbevolen door Mason en Likar. Ech-
ter, deze elektrodeverplaatsingen kunnen het ECG veranderen. Er kunnen veranderin-
gen optreden in de R-toppen en frontale QRS-as en Q-golven kunnen zichtbaar worden
of verdwijnen in de onderwandafleidingen. Hoofdstuk 8 bevat een studie met als doel
een correctiemethode te ontwikkelen en te evalueren op basis van een dataverzameling
van 93 ECG’smet gelijktijdig opgenomen extremiteitsafleidingen op standaard- en bewa-
kingsposities. Patiëntspecifieke en algemene reconstructiemethoden zijn ontwikkeld en
geëvalueerd. Uit de resultaten van het onderzoek is naar voren gekomen dat algemene
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reconstructiecoëfficiënten gebruikt kunnen worden om bewakingsafleidingen met een
hoge nauwkeurigheid te corrigeren naar de standaardafleidingen.
Discussie en conclusies
Hoofdstuk 9 bevat een algemene bespreking van de beschreven reconstructiemethoden.
Samengevat kunnen problemen tijdens patiëntbewaking verminderd worden met be-
hulp van de reconstructiemethoden. Nauwkeurige reconstructie tot en met vier precor-
diale afleidingen met algemene of patiëntspecifieke coëfficiënten is mogelijk gebleken.
Patiëntspecifieke reconstructie is nauwkeuriger dan reconstructie met algemene coëffi-
ciënten, zowel over een langere periode als tijdens ST-veranderingen die door een bal-
loninflatie worden veroorzaakt. Bij prehospitale besluitvorming zou een algemene re-
constructiemethode met een gereduceerde afleidingenverzameling van I, II, V2, en V5
overwogen kunnen worden. ST-T veranderingen, die door lichaamspositieveranderin-
gen zijn veroorzaakt, kunnen worden onderscheiden van ischemische veranderingen.
De ontwikkelde correctiemethoden kunnen deze ST-T veranderingen corrigerenmet ho-
ge reconstructieprestaties. Algemene en patiëntspecifieke correctiemethoden zijn ont-
wikkeld waarmee hetmogelijk is omde bewakingsafleidingen te corrigeren naar de stan-
daardafleidingen.
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zoekstaken en reguliere werkzaamheden zelf kon indelen. Sinds onze eerste ontmoeting
in 1993, toen Saskia Wemelsfelder en ik voor het eerst het Thoraxcentrum betraden, heb
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